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ABSTRACT 
 
Eps15 and Eps15L1 are two endocytic adaptor proteins involved in both clathrin-
dependent and clathrin-independent endocytosis of receptor tyrosine kinases. Due to their 
homology, Eps15 and Eps15L1 are thought to be redundant in several cellular processes. 
Their redundancy, however, has never been demonstrated in in vivo model systems. 
Our laboratory has generated genetically engineered mice to unravel the physiological 
functions of Eps15 and Eps15L1. We found that Eps15-KO (knockout) mice were healthy 
and fertile, while Eps15L1-KO mice died at birth because of neural defects, showing the 
specific function of Eps15L1 in neuronal development. Importantly, Eps15/Eps15L1-DKO 
(double knockout) mice had a more severe phenotype, dying at midgestation, suggesting 
redundancy in one or more fundamental developmental programs.  
The aim of this thesis project was to investigate redundant and non-redundant roles of 
Eps15 and Eps15L1, with the final goal to unmask the underlying causes of embryo 
lethality of Eps15/Eps15L1-DKO mice.  
Since Eps15/Eps15L1-DKO mice displayed a Notch loss-of-function phenotype, 
accompanied by a downregulation of Notch target genes, our initial hypothesis was that 
Eps15 and Eps15L1 were redundantly required in the regulation of the Notch signalling. 
To address this issue, we set-up a co-culture model system to recapitulate Notch signalling. 
In detail, we used MEFs (mouse embryonic fibroblasts) derived from Eps15- and 
Eps15L1-KO mice as a model system for the signal-sending cell and we co-cultured them 
with CHO (chinese hamster ovary) cells expressing the Notch receptor, as signal receiving 
cells. We found that Eps15L1, but not Eps15, played a non-redundant role in Notch 
signalling activation. This finding indicated that impaired Notch signalling was not 
responsible for the more severe phenotype observed in Eps15/Eps15L1-DKO mice 
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compared to single KO mice. Whether Eps15 and Eps15L1 are required in signal-receiving 
cells will be addressed, using MEFs as a model for the signal-receiving cell.  
We found that angiogenesis was seriously compromised in Eps15/Eps15L1-DKO mice and, 
therefore, hypothesized that impaired vascular development might be the major cause of 
midgestation lethality of these mice. To address this issue, we generated cDKO 
(conditional Eps15/Eps15L1-DKO mice), which lack Eps15 and Eps15L1 in endothelial 
and hematopoietic cells. We found that cDKO mice displayed vascular defects but did not 
recapitulate the severe phenotype of constitutive DKO mice. This finding indicated that 
impaired angiogenesis was not the major lethality cause of constitutive DKO mice. 
However, by in vitro studies in endothelial cells, we found that Eps15 and Eps15L1 
redundantly regulated VEGFR-2 turnover, thus indicating a possible cell-autonomous 
function of the proteins in vascular homeostasis, even if not sufficient to cause embryo 
lethality when functionally impaired. 
Previous in vitro studies have demonstrated a role for Eps15 and Eps15L1 in the CDE 
(clathrin-dependent endocytosis) of EGFR (epidermal growth factor receptor) and TfR 
(transferrin receptor). To confirm this role in a clean background, we used MEFs as a 
model system. By using radioactive assays, we found that Eps15 and Eps15L1 redundantly 
regulate the CDE of TfR. Indeed, in DKO cells, the Ke (endocytic rate constant) of the TfR 
was reduced to ~50% and, as a consequence, surface levels of TfR were increased, while 
single KO cells showed only a minor, if any, defect. Moreover, in DKO cells, we found 
that the number of AP-2-positive structures (which label clathrin-structures that form 
during CDE) was increased, but the structures were significantly smaller in size. Whether 
the maturation of clathrin-coated structures is altered in DKO cells will be addressed by 
live imaging studies.  
Next, we asked whether the role of Eps15 and Eps15L1 in TfR internalization had a 
physiological relevance in vivo. In detail, since TfR is essential for the biology of erythroid 
cells, we investigated whether erythroid development was impaired in cDKO mice, lacking 
 20 
Eps15 and Eps15L1 in endothelial and hematopoietic cells. We found that these mice 
suffered from microcytic hypochromic anemia: RBCs (red blood cells) had reduced MCV 
(mean corpuscular volume) and high RDW (red blood cell distribution width, index of 
anisocytosis), and reticulocyte counts were higher. These findings suggest that Eps15 and 
Eps15L1 redundantly regulate erythroid development. However, since cDKO mice did not 
recapitulate the severe phenotype of constitutive DKO mice, altered erythroid development 
per se was not the only cause of the early lethality of constitutive DKO mice. 
Further studies are required to investigate whether altered development of Eps15/Eps15L1-
DKO erytroid cells correlates with increased surface levels of TfR and reduced iron uptake. 
These findings, combined with previous data generated in our laboratory, highlight that 
Eps15 and Eps15L1 regulate several cellular processes, both in a redundant and in a non-
redundant manner. Functional impairment of these processes, together with other 
unexplored processes, might addictively contribute to the DKO phenotype. 
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Chapter 1 
INTRODUCTION 
 
1. Endocytosis 
 
1.1. Role of endocytosis 
Endocytosis is a mechanism by which eukaryotic cells internalize nutrients and/or other 
types of molecules, which, at the same time, regulate the composition of the PM (plasma 
membrane).  
Endocytosis initially evolved as a simple process for nutrient uptake. A consequence of 
endocytosis was the establishment of new endomembrane systems, which lead to cellular 
compartmentalization and, therefore to the acquisition of the eukaryotic cell plan. 
Moreover, throughout evolution, an intricacy of entry portals and sorting modalities for 
different cargoes appeared. Endocytosis was embedded not only with the ability to provide 
nutrients, but also to regulate the presence of specific proteins and lipids on the PM and to 
offer new signalling platforms. As discussed in detail later, these new functions allowed 
endocytosis to act as a master organizer of cell signalling.  
To our knowledge, endocytosis permeates every aspect of cell physiology. Indeed, due to 
its ability to contribute to signalling from membrane receptors, endocytosis regulates 
fundamental cellular processes such as proliferation, differentiation, apoptosis, metabolism 
and development. Due to its ability to differentially distribute membrane receptors within 
the cell, endocytosis controls polarized functions, such as directed cell migration, cell-fate 
decisions, epithelial-cell polarization, growth cone movement, tissue morphogenesis and 
cell invasion. Moreover, due to the acquisition of new functions by the endocytic 
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machinery, endocytosis has become paramount also in cellular programs not directly 
linked to membrane dynamics, such as mitosis, cellular reprogramming, miRNA 
biogenesis and transcription (Sigismund, Confalonieri et al. 2012).  
The deep intertwining between cell physiology and endocytosis explains why perturbations 
in the endocytic pathway are responsible for several inherited, neurological, metabolic, 
autoimmune, infectious and hyperproliferative diseases, among which pathologies of high 
social impact, such as Alzheimer’s disease, diabetes and cancer (Sigismund, Confalonieri 
et al. 2012).  
Deconvolution of the endocytic pathway is therefore important not only for a complete 
understanding of cellular physiology but also for the development of new strategies in 
fighting diseases.  
 
1.2. Multiple entry portals and sorting routes 
Multiple pathways of endocytosis exist. A rough classification of endocytic paths takes 
into account cargo size. Large particles (about 500 nm) are taken up by phagocytosis, as it 
is generally the case for debris, apoptotic cells and pathogens. This type of endocytosis is 
typical of only few specialized cells (Swanson 2008). Uptake of large amounts of fluid 
occurs by macropinocytosis, process that it ubiquitous to almost all eukaryotic cells (Kerr 
and Teasdale 2009). Both phagocytosis and macropinocytosis involve large 
rearrangements of the PM, which are guided by the remodelling of the actin cytoskeleton 
and Rho-GTPases (Insall and Machesky 2009). Micropinocytic events, instead, are 
characterized by smaller invaginations (200 nm) and are classified into two distinct 
pathways, known as CDE (clathrin-dependent endocytosis) and CIE (clathrin-independent 
endocytosis) (Doherty and McMahon 2009) (Figure 1).  
The CDE is the best characterized pathway and its defining feature is the recruitment of 
soluble clathrin from the cytoplasm to the PM. PM receptors that enter through the CDE, 
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may undergo stimulated/ligand dependent-endocytosis, such as EGFR (epidermal growth 
factor receptor) and GPCRs (G-protein-coupled receptors), or constitutive/ligand-
independent endocytosis, such as TfR (transferrin receptor) and LDLR (low-density 
lipoprotein receptor) (McMahon and Boucrot 2011).  
 
 
Figure 1. Endocytic pathways.  
From left to right: large solid particles are internalized through phagocytosis, whereas large fluid 
particles are taken up through macropinocytosis. Both pathways are actin-dependent. Numerous 
smaller cargoes, instead, are endocytosed by CD (clathrin-dependent) and/or CI (clathrin-
independent) mechanisms. CDE, the best-characterized pathway, involves the coat protein clathrin 
and the fission GTPase dynamin. CIE, which includes both caveolin-dependent and caveolin-
indipendent pathways, instead, may require the GTPase dynamin. While material internalized by 
phagocytosis is directly transported into lysosomes, most internalized cargoes are delivered to the 
EE (early endosome) via vesicular (clathrin- or caveolin-coated vesicles) or tubular intermediates 
(knowns as CLICs, that is clathrin- and dynamin-independent carriers). Before reaching the EE, 
some cargoes can traffic to intermediate compartments, such as GEECs (glycosyl 
phosphatidylinositol-anchored proteins enriched early endosomal compartments). Recent findings 
(Hayer, Stoeber et al. 2010), instead, question the existence of the caveosome as an intermediate 
compartment of caveolin-dependent endocytosis (from Mayor and Pagano 2007). 
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The EGFR and the TfR are the most popular experimental systems in the study of 
mechanisms underlying stimulated and constitutive CDE, respectively. In contrast, the 
machinery that regulates the different pathways of CIE has only recently started to emerge. 
Each entry mechanism is related to a specific cellular function. In the case of phagocytosis, 
for example, material has to be promptly processed. For this reason, the resulting vesicle, 
named phagosome, is directly fused with lysosomes for degradation (Gagnon, Duclos et al. 
2002, Jutras and Desjardins 2005). On the contrary, most of the other entry mechanisms 
regulate cargo degradation as well as receptor recycling. For this purpose, internalized 
cargoes are transported to coordinating stations, the EEs (early endosomes), where they are 
either sorted to the degradative pathway, towards lysosomes, or to the recycling pathway, 
towards the PM, or retrotransported to the TGN (trans-Golgi network).  
The endocytic trafficking across the subcellular compartments is regulated by two main 
classes of molecules: the Rab (Miaczynska and Zerial 2002, Galvez, Gilleron et al. 2012) 
(Stenmark 2012) and the Arf families of small GTPases (D'Souza-Schorey and Chavrier 
2006).  
Rab5 regulates the transport from the PM to the EE (Behnia and Munro 2005), where 
cargoes are then recycled back to the PM through either a fast Rab4-dependent or a slow 
Rab8/Rab11-dependent recycling route (Stenmark 2009). In other cases, cargoes are 
destined to degradation in lysosomes via a route depending on Rab7 (Stenmark 2009). 
Arf6, instead, is involved in an additional recycling pathway, which is mainly used by 
receptors internalized through CIE, such as MHCI (class I major histocompatibility 
complex), although some CD-internalized cargoes can also be recycled through this 
pathway (D'Souza-Schorey and Chavrier 2006).  
Regarding commitment into the degradative pathway, a key signal to enter this pathway is 
cargo ubiquitination. Ubiquitinated-cargoes are recognized by protein complexes called 
ESCRT (endosomal sorting complex required for transport). These complexes, composed 
of UBD (ubiquitin-binding domains)-containing proteins, act as follows: ESCRT-0, which 
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is composed of Hrs and STAM, is located in the EE and sequesters ubiquitinated cargoes; 
ESCRT-I and ESCRT-II mediate invagination of the membrane; ESCRT-III drives the 
pinching off and the release of the invaginations that will constitute the ILVs (intraluminal 
vesicles) of the MVB (multivesicular body), an endocytic station that directs cargoes to 
lysosomes. ESCRT-III, moreover, recruits deubiquitinating enzymes that remove ubiquitin 
from the cargo, thus allowing the continuous replenishment of the free ubiquitin pool 
(Raiborg and Stenmark 2009, Hurley and Hanson 2010).  
 
1.3. The CDE  
CDE is an important endocytic mechanism that accounts for a large proportion of 
internalization events. A wide range of molecules, including nutrient-receptor complexes, 
membrane transporters, adhesion molecules and signalling receptors are endocytosed 
through CDE. CDE is also involved in SVR (synaptic vesicle recycling). Moreover, CDE 
is exploited by pathogens, such as toxins, viruses and bacteria, to entry into cells. Anthrax, 
for example, is one of the larger toxins entering the cells through CDE (Doherty and 
McMahon 2009).  
In CDE, cargoes are recruited into PM invaginations called CCPs (clathrin-coated pits). 
Several adaptor proteins, among which AP-2, bridge the cargo to clathrin, whose 
polymerization drives the progressive invagination of the pit. The CCP is then released 
into the cytoplasm as a CCV (clathrin-coated vesicle) trough the action of the GTPase 
dynamin. 
 
1.3.1. The main components of CDE: clathrin, AP-2 and CLASPs  
Clathrin, AP-2 and CLASPs are the main components of CDE (Figure 2). The defining 
feature of CDE is the recruitment of soluble clathrin from the cytoplasm to the PM, where 
it assembles into a polygonal lattice to coat intracellular membrane surface (McMahon and 
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Boucrot 2011). The assembly subunit of a clathrin coat is a three-legged structure referred 
to as triskelion, which is composed of three copies of the CHC (clathrin heavy chain), with 
a mass of 180 kDa, and three copies of the CLC (clathrin light chain), with a mass of 25 
kDa. While CHCs provide the structural backbone of the clathrin lattice, CLCs seem to 
regulate the formation and the disassembly of the clathrin lattice (Brodsky, Chen et al. 
2001). In a CCP, polymerization of clathrin results in the stabilization of membrane 
curvature and displacement of cargoes and adaptor proteins to the edge of the forming 
vesicle (Tebar, Sorkina et al. 1996, Saffarian, Cocucci et al. 2009). In some cell types, a 
substantial pool of clathrin can also be found as flat lattices, referred to as clathrin plaques. 
Clathrin plaques are mostly found at the adherent membrane surface and are longer-lived 
than CCPs (Saffarian, Cocucci et al. 2009). The exact function of clathrin plaques is still 
under investigation.  
Other actors of CDE are the endocytic adaptor proteins, whose function is to bridge 
cargoes with clathrin. To achieve bridging with clathrin, adaptors proteins establish 
multiple and redundant interactions with some or all of the four types of binding partners: 
lipids, cargoes, clathrin and other adaptor proteins. Endocytic adaptor proteins are divided 
into two main groups: multimeric adaptor proteins (e.g., AP-2) and monomeric adaptor 
proteins, also called CLASPs (clathrin-associated sorting proteins).  
AP-2 is the most abundant non-clathrin constituent of purified CCVs and it is the 
prototypal and best characterized multimeric endocytic adaptor. It consists of two large 
subunits (α, β2), one medium subunit (μ2) and one small subunit (σ2). The large subunits 
can be subdivided into a trunk domain (70–75 kDa) and an appendage domain (~30 kDa), 
which are connected by an extended, proteolytically sensitive, flexible linker (Zaremba and 
Keen 1985, Kirchhausen, Nathanson et al. 1989). The large subunit trunk domains plus the 
medium and small subunits represent the biochemically stable AP-2 core domain. AP-2 
has the ability to interact with membrane lipids, clathrin, cargoes and CLASPs. Cargoes, 
specifically, can be bound directly, through the recognition of a tyrosine- or a di-leucine-  
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Figure 2. The endocytic clathrin interactome.  
A network of interactions is assembled during CDE. The core adaptor AP-2 connects 
transmembrane cargoes to the clathrin coat. Cargoes are then recognized either directly, through 
their tyrosine- (YXX∅) or di-leucine- ([DE]XXXL[LIM]) based motifs, or indirectly, through 
several accessory adaptor proteins, named CLASPs. Each class of accessory adaptor proteins 
decodes a specific cargo signal: ARH, Numb and Dab2 recognize the peptide sequence 
[FY]XNPX[YF]; epsin and Eps15 proteins bind to ubiquitinated cargoes; β-arrestins internalize 
phosphorylated receptors. In contrast to these mechanisms, little is known about the packaging of 
SNAREs, which generally lack known sorting signals and do not seem to be ubiquitinated (from 
Traub 2009). 
 
based motif, or indirectly, through CLASPs (Traub 2009). The μ2-domain recognizes PIP2 
(phosphatidylinositol 4,5-bisphosphate) and the YXX∅ (X is any amino acid and ∅ is a 
bulky hydrophobic amino acid) sorting signal in the TfR, while the σ2-subunit binds to the 
acidic di-leucine internalization signal, [DE]XXXL[LIM]. The α and β2 subunits, instead, 
bind to CLASPs, which, as discussed later, regulate assembly and budding of CCPs. 
Among these, AP-2 interacts with the scaffolding proteins Eps15 and Itsn (intersectin), 
 28 
with the membrane bending/curvature-sensing epsin, endophilin and FCHo1/2 proteins, 
with the phosphoinositide phosphatase sinaptojanin and with the GTPase dynamin. Due to 
its ability to interact with different molecules, AP-2 is considered the hub of the endocytic 
clathrin interactome (Traub 2009, McMahon and Boucrot 2011). The observation that the 
number of CCPs is strongly decreased (by >90%) upon KD (knock-down) of its expression 
(Hinrichsen, Harborth et al. 2003, Motley, Bright et al. 2003) further supports the central 
role of AP-2 in CDE. Nevertheless, AP-2 does not account for all CD-endocytic events. 
More recently, indeed, other adaptor proteins, such as epsins and β-arrestins, due to their 
ability to interact with both PM cargoes and clathrin, have been proposed to work as AP-2 
substitutes for certain receptors (Sigismund, Confalonieri et al. 2012).  
CLASPs absolve two main functions: i) they drive efficient sorting of specific cargoes into 
CCPs, thus preventing competition and allowing plasticity in the selection of cargoes for 
internalization, and ii) are involved in the formation and maturation of CCVs. They can be 
classified on the basis of the motif recognized on the cargo. PTB (phospho-tyrosine-
binding) domain-containing CLASPs, for example, recognize the [FY]XNPX[YF] cargo 
signal. The PTB domain is able to bind PIP2 and cargo, simultaneously. Examples of PTB 
domain-containing CLASPs are Dab2, ARH and Numb (Maurer and Cooper 2006). Other 
CLASPs, such as Eps15 and epsin proteins, mediate the recruitment of ubiquitinated 
cargoes (Wendland 2002, Sorkina, Miranda et al. 2006). Neuronal AP180 and its 
ubiquitous counterpart CALM, known as PICALM, instead, do not bind directly to the 
cargo, but link clathrin to membrane phospholipids. These proteins possess an ANTH 
(AP180 N-terminal homology) domain, which binds PIP2, and a binding site for clathrin 
(Norris, Ungewickell et al. 1995, Ye and Lafer 1995). Binding sites for AP-2 and Eps15 
proteins are also present (Figure 3). N-BAR (Bin-amphiphysin-RVS) and BAR domain-
containing proteins, such as SNX9 (sorting nexin 9) and amphiphysin, generate and 
stabilize membrane curvature, bind both clathrin and AP-2, and recruit dynamin to the  
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Figure 3. Structure of the human PICALM protein.  
The figure depicts the structure of the human protein PICALM, an accessory endocytic adaptor 
protein. PICALM contains several binding motifs that allow its interaction with membrane 
phospholipids, clathrin, AP-2 and other CLASPs, such as Eps15. Domains are coloured-coded and 
indicted below the scheme.  
 
neck of the budding vesicle (Lundmark and Carlsson 2003, Peter, Kent et al. 2004). Due to 
their overlapping binding abilities, CLASPs often play redundant roles in CDE. Indeed, 
Eps15 and epsin proteins are redundantly necessary in the CDE of EGFR (Sigismund, 
Woelk et al. 2005). Similarly, Eps15 and Itsn proteins are redundantly involved in the 
internalization of both TfR and EGFR (Henne, Boucrot et al. 2010). To complicate the 
picture even more, the cell may use the same CLASPs to trigger different intracellular 
routes. This is the case of Eps15 and epsin proteins, which have been demonstrated to 
participate also in the CIE of EGFR (Sigismund, Woelk et al. 2005).  
 
1.3.2. The steps of CDE 
CDE proceeds through five steps: initiation, cargo selection, coat assembly, scission and 
uncoating (McMahon and Boucrot 2011). Theses processes involve a hierarchy of 
molecular events (i.e., spatial/temporal cues and cargo-dependent accessory factors) and 
are governed by a checkpoint system that determines the fate of the pit between a 
progressive and an abortive state. 
N CANTH domain
PIP2-binding domain
Clathrin-binding domain
DPF motif (AP-2-binding)
NPF motif (Eps15-binding)
FESVF motif (AP-2-binding)
v-SNARE/VAMP-binding
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The nucleation of productive CCPs at the PM appears to be a stochastic process (Ehrlich, 
Boll et al. 2004, Banerjee, Berezhkovskii et al. 2012). According to a different model, 
there are selected regions of the PM in which assembly and disassembly of CCVs is more 
frequent. Actin participates in the formation of these regions referred to as hot spots 
(Gaidarov, Santini et al. 1999).  
Regardless of how the nucleation of a CCP starts, specific adaptor proteins are recruited to 
the PM that trigger the formation of the pit during the initiation step. These proteins 
include AP-2, FCHo1/2, Eps15 and Itsn proteins (McMahon and Boucrot 2011). Different 
models have been proposed to delineate the functional timing of the mentioned endocytic 
adaptor proteins during CCP initiation, which will be discussed in section “4.2. The role of 
Eps15 and Eps15L1 in CD- and CI-endocytosis”. 
After initiation, endocytic adaptor proteins drive cargo recruitment and clathrin assembly 
to form a CCP, which is then pinched off from the PM to form a CCV. Scission of the 
coated pit is mediated by the GTPase dynamin. Dynamin is recruited by N-BAR domain-
containing proteins (Ferguson, Raimondi et al. 2009, Sundborger, Soderblom et al. 2011), 
among which amphiphysin, endophilin and SNX9, which have a preference for the 
curvature of the vesicle neck. Coordinated dynamin oligomerization and GTP hydrolysis 
mediate membrane scission (Roux, Uyhazi et al. 2006, Bashkirov, Akimov et al. 2008). In 
mammals, three genes encoding for dynamin exist: dynamin1, 2 and 3. Dynamin1 is 
exclusively expressed in the brain, where it is required for efficient SVR during intense 
activity. Dynamin1-KO (knockout) mice die two weeks after birth (Ferguson, Brasnjo et al. 
2007). Dynamin2 is ubiquitously expressed. Dynamin2-KO mice are early embryonic 
lethal due to the house-keeping functions of dynamin2 (Ferguson, Raimondi et al. 2009). 
Dynamin3 is selectively expressed in the brain and in testis. Dynamin3-KO mice do not 
exhibit obvious neurological or male fertility defects (Raimondi, Ferguson et al. 2011).  
When CCVs are in the cytoplasm, the clathrin coat is disassembled by the ATPase HSC70 
(heat shock cognate 70) and its cofactor auxilin, allowing the vesicles to travel and to fuse 
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with their target endosome. Changes in the phosphoinositide composition of CCVs, 
mediated by the phosphatase synaptojanin, are also required for uncoating of the vesicles 
(McMahon and Boucrot 2011), but whether synaptojanin acts by facilitating auxilin 
recruitment (Massol, Boll et al. 2006) or via another mechanism is still unclear.  
 
1.4. The CIE 
CIE is a heterogeneous group of pathways that share the common property of being 
insensitive to clathrin depletion. These pathways are frequently formed from membrane 
microdomains known as lipid rafts, which are enriched in cholesterol, glycosphingolipids, 
GPI-APs (glycosylphosphatidylinositol-anchored proteins) and signalling molecules. Since 
they depend on colestherol-rich PM microdomains, another common feature of these 
pathways is their sensitivity to pharmacological cholesterol depletion (Le Roy and Wrana 
2005).  
Due to the heterogeneity of CIE, attempts to classify these pathways rely on three major 
criteria: 1) dependency on dynamin for vesicle release; 2) presence of “coat-like” proteins 
involved in membrane curvature and stabilization, such as caveolins or flotillins, as in the  
case of caveolin-mediated or flotillin-mediated internalization, respectively; and 3) 
dependency on small GTPases. Figure 4 reports the classification scheme proposed by 
Mayor and Pagano (Mayor and Pagano 2007).  
 
 
 
Figure 4. Pathways of CD- and CI-endocytosis.  
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Molecules are internalized through CDE and/or CIE. CDE requires the fission protein dynamin and 
can be constitutive or induced by ligand binding to the receptor. CIE can either be dynamin-
dependent or dynamin-independent. Clathrin-independent and dynamin-dependent pathways 
encompass caveolin-dependent endocytosis and RhoA-dependent endocytosis, whereas clathrin- 
and dynamin-independent pathways include CDC42-dependent endocytosis and Arf6-dependent 
endocytosis. Other unexplored mechanisms might exist (from Mayor and Pagano 2007). 
 
In this scheme, CI-endocytic events are firstly subdivided into dynamin-dependent and 
dynamin-independent pathways. A second degree of classification takes into account their 
dependency on a specific small GTPase, so that they are classified as RhoA-, CDC42- or 
Arf6-dependent. Caveolin-mediated endocytosis is the best-characterized dynamin-
dependent endocytic route. Caveolin is an integral membrane protein that induces the 
formation of flask-like invaginations at the PM, named caveolae. Caveolar cargoes are 
diverse, ranging from lipids, proteins and lipid-anchored proteins to pathogens, like SV40 
(simian virus 40) and CtxB (cholera toxin B) (Mayor and Pagano 2007). These cargoes, 
however, can be internalized also via other pathways. Another dynamin-dependent 
endocytic pathway involves the small GTPase RhoA, which is responsible for the 
internalization of IL-2R-β (interleukin-2 receptor-β). In contrast to these pathways, 
CDC42- and Arf6-dependent endocytic pathways are dynamin-independent. CDC42-
dependent endocytosis is involved in the uptake of CtxB, the plant protein ricin and the 
Helicobacter pylori VacA (vacuolating toxin A). This route also carries fluid-phase 
markers and GPI-APs. Cargo molecules internalized through Arf6-dependent endocytosis 
include MHCI, β1-integrin, CPE (carboxypeptidase E), E-cadherin and GPI-APs (Mayor 
and Pagano 2007).  
More recently, a new CI-endocytic pathway, called FEME (fast endophilin-mediated 
endocytosis), has been identified. This CI-endocytic route requires dynamin activity and is 
characterized by the formation of fast-acting tubulovesicular structures marked and 
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controlled by endophilin. FEME mediates the internalization of several GPCRs, numerous 
RTKs (receptor tyrosine kinases), among which EGFR, cholera and shiga toxins and IL-2R 
(Boucrot, Ferreira et al. 2015).  
 
1.5. Regulation of cell signalling by endocytosis 
Endocytosis has the ability to orchestrate biochemical pathways by coordinating cell 
signalling variables, such as duration, intensity, integration and spatial distribution (Polo 
and Di Fiore 2006). A first tier of regulation is achieved through the control, by 
internalization itself, of the availability on the PM of all the components participating in a 
specific biochemical pathway, including receptors, ligands, substrates and mediators 
(Sigismund, Confalonieri et al. 2012).  
Cell signalling can be modulated by controlling the number of PM receptors. Regarding 
this point, the classical function of endocytosis is the attenuation of the signal, which 
occurs when activated receptors are degraded through lysosomes. Nevertheless, 
endocytosis can also sustain the signal by moving receptors trough the recycling pathway 
towards the PM, to differently redistribute the proteins.  
The fate of the receptor often depends on the endocytic route through which it is 
internalized. This is the case of EGFR, which, when stimulated with low doses of the EGF 
ligand, is almost exclusively internalized through CDE and then recycled to the PM. At 
higher doses of EGF, instead, EGFR is internalized through CIE. This shift at higher doses 
of EGF correlates with the monoubiquitination of EGFR and its degradation in the 
lysosomes, an event that avoids excessive stimulation (Sigismund, Woelk et al. 2005, Polo 
and Di Fiore 2006).  
Cell signalling can also be modulated by the regulation of ligand accessibility, as 
exemplified by the Notch receptor system, which will be discussed in section “2.4. 
Regulation of Notch signalling by endocytosis”.  
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Another mechanism to achieve signal modulation is the physical separation of the receptor 
from its substrates or mediators located at the PM. As an example, GPCR signalling 
through PM potassium channels requires that receptors and G proteins are present in the 
same membrane (Mathie 2007). Similarly, PLCγ1 (phospholipase Cγ1) and PI3K 
(phosphoinositide 3-kinase) signalling by EGFR are inhibited by receptor internalization 
due to the lack of their lipid substrate, PIP2, in endosomes (Haugh and Meyer 2002).  
Cargo trafficking control is not the only mechanism through which the cell regulates 
signalling. Indeed, a second tier of cell signalling regulation is achieved within endosomes. 
In detail, it has become evident in recent studies that endosomes have numerous unique 
properties that allow them to serve as internal signalling platforms (Sorkin and von 
Zastrow 2009). These properties include: i) a small volume that favours ligand-receptor 
association; ii) a relatively longer resident time of activated receptors here compared to the 
PM; iii) the ability to move long distances (for example towards nucleus); iv) a scaffold-
promoting microenvironment, due to the presence of specific lipids, such as PIP3 
(phosphatidylinositol 3,4,5-trisphosphate), and proteins which favour selected signallings; 
v) an acidic pH that favours specific reactions, such as proteolysis of signalling molecules 
(Sorkin and von Zastrow 2009). Thanks to these properties, endosomes impact on 
signalling mainly in two ways: by sustaining signals originating from the PM or by 
assembling specific signalling complexes that are prohibited at the PM (Sadowski, Groen 
et al. 2008, Gould and Lippincott-Schwartz 2009, Scita and Di Fiore 2010). An example of 
sustained signal is promoted by several RTKs and their ligands, including EGF-EGFR, 
which remain bound and active after internalization in endosomes. Also GPCR signalling 
is sustained in endosomes, via β-arrestins or through cAMP production. In detail, it has 
been shown that β-arrestin act as a specific scaffold protein that anchors ERK1/2 to the 
endosome (DeWire, Ahn et al. 2007), thus sustaining signalling from GPCRs. Moreover, it 
has been demonstrated that some GPCRs, such as PTHR (parathyroid hormone receptor), 
are internalized together with the Gα protein that, in the EE, continues to produce cAMP 
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(Calebiro, Nikolaev et al. 2009, Ferrandon, Feinstein et al. 2009). TGFβR (tumor growth 
factor β receptor) internalization, instead, offers an example of an endosome-specific 
signalling: when internalized, it interacts with the FYVE domain-containing adaptor 
SARA, which is located in EEs. Subsequent interaction of SARA with SMAD2 allows the 
phosphorylation of SMAD2 by the receptor in endosomes. Then, SMAD2 dissociates and 
interacts with SMAD4, forming a complex that translocates into the nucleus to regulate 
gene transcription (Tsukazaki, Chiang et al. 1998).   
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2. The Notch signalling pathway 
 
2.1. The importance of studying the Notch signalling pathway 
Notch is the receptor of an evolutionarily conserved signalling pathway involved in 
metazoan development and in tissue renewal. Notch allows short-range communication 
between cells and, in a context-dependent manner, can promote or suppress cell 
proliferation, cell death, acquisition of specific cell fates or activation of differentiation 
programs (Kopan and Ilagan 2009).  
Due to the critical function covered by Notch in cellular physiology, it is not surprising 
that aberrant gain or loss of Notch signalling components are linked to multiple human 
disorders. These disorders include developmental syndromes (such as Alagille syndrome, 
Tetralogy of Fallot, syndactyly, spondylocostal dysostosis and familial aortic valve 
disease), adult-onset diseases (for example CADASIL, acronym for cerebral autosomal 
dominant arteriopathy with subcortical infarcts and leukoencephalopathy) and cancer 
(Kopan and Ilagan 2009). Concerning cancer, depending on the tumor type, Notch can act 
as an oncogene or a tumor suppressor and can also serve as a cancer stem cell factor (Roy, 
Pear et al. 2007). The clearest example in which Notch acts as an oncogene is represented 
by T-ALL (T-acute lymphoblastic leukemia/lymphoma), an aggressive neoplasm of 
immature T-cells. Recent studies have revealed a role for Notch also in human breast 
cancer and lung cancer (Pece, Serresi et al. 2004, Roy, Pear et al. 2007, Westhoff, Colaluca 
et al. 2009). Moreover, Notch signalling is altered in primary human melanomas and in 
solid tumours, such as medulloblastoma and ovarian cancer (Roy, Pear et al. 2007). It 
seems that the list of neoplasms involving alterations in Notch signalling will continue to 
grow. Since Notch signalling plays such a relevant role in disease, understanding the 
biochemical mechanisms involved in its regulation is of growing interest. 
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2.2. Players of the Notch signalling pathway 
Both Notch receptors and Notch ligands are transmembrane proteins expressed on the PM. 
Cells expressing Notch receptors are called signal-receiving cells, while cells expressing 
Notch ligands are referred to as signal-sending cells. Notch ligands can be presented either 
by a neighbouring cell or the Notch-expressing cell, thus allowing trans- or cis-interactions, 
respectively. 
 
                            
Figure 5. Structure of Notch receptors. 
Drosophila melanogaster possesses only one Notch receptor (dNotch), whereas mammals have 
four Notch paralogs (mNotch1-4). The figure shows the domain organization of Notch receptors 
that is similar both in Drosophila melanogaster and in mammals. They differ only in the number of 
EGF repeats. EGF repeats 11-12 (red) mediate productive interactions with the ligand presented by 
a neighboring cell (trans interactions), whereas EGF repeats 24-29 (green) are involved in cis-
inhibition by ligands expressed on the same cell. EGF repeats may contain consensus motifs for 
fucosylation by O-fut1 and for glucosylation by Rumi. The putative distribution of fucosylation 
sites (common in green, unique in light blue) and glucosylation sites (common in dark blue, unique 
in magenta) are shown for mNotch1 and mNotch2 (adapted from Kopan and Ilagan 2009). 
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Domain organization of Notch receptors is similar in Drosophila melanogaster, in 
Caenorhabditis elegans and in mammals. However, whereas Drosophila melanogaster 
possesses only one Notch receptor (dNotch) and Caenorhabditis elegans possesses two 
redundant Notch receptors, mammals have four Notch paralogs (mNotch1-4) with both 
redundant and unique functions (Figure 5) (Kopan and Ilagan 2009). The extracellular 
domain of all Notch proteins contains 29-36 tandem EGF-like repeats, some of which 
mediate interactions with Notch ligands. Moreover many EGF repeats bind to calcium ions, 
affecting the structure and the affinity with ligands. EGF repeats are then followed by the 
NRR (negative regulatory region) sequence, which is composed of three cysteine-rich 
LNR (Lin12-Notch repeats) sequences and a HD (heterodimerization domain). The 
function of HD is to prevent receptor activation in the absence of ligand. In mammals, the 
HD contains a cleavage site, S1 (site 1), which is recognized by a furin-like convertase. 
The proteolytic cleavage of Notch at S1 results in a NECD-NTMIC (Notch extracellular 
domain-Notch transmembrane and intracellular domain) heterodimer held together by non-
covalent interactions. Inside the cell, after the TMD (transmembrane domain), there is a 
RAM (RBPjk association module) domain, which is connected by a NLS (nuclear 
localization sequence) to seven ANK (ankirin) repeats. At the C-terminus there is a TAD 
(trans-activation domain) that contains two NLS and conserved PEST (proline/glutamic 
acid/serine/threonine)-rich motifs. The PEST region harbours degradation signals, known 
as degrons, which regulate the stability of the effector of the Notch signalling, e.g., the 
NICD (Notch intracellular domain). In Drosophila melanogaster, inside the TAD, there is 
also an OPA region (polyglutamine-repeat containing region) (Kopan and Ilagan 2009). 
Notch ligands differ in domain composition. The largest class of Notch ligands is 
characterized by three related structural motifs: an N-terminal DSL (Delta/Serrate/LAG-2) 
motif, the DOS (Delta and OSM-11-like proteins) domain, composed of specialized 
tandem EGF repeats, and EGF-like repeats, which can bind or not calcium ions (Figure 6). 
Both DSL and DOS domains are involved in receptor binding.  
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Figure 6. Classical DSL ligands. 
Classical DSL ligands contain DSL and DOS domains and EGF motifs. Some of them possess also 
a C-rich domain. S2 and S3 represent sites in which cleavage may occur (adapted from Kopan and 
Ilagan 2009). 
 
Nevertheless, not all Notch ligands possess these sequences: the mammal ligands Dll3 and 
Dll4, indeed, lack the DOS motif. These molecules act alone (this is the case of Dll4) or in 
combination with DOS co-ligands (probably Dll3). All these ligands are called canonical 
DSL ligands and differ from non-canonical ligands, which are a group of structurally 
diverse proteins that lack the DSL domain and that presumably have a role in the 
modulation of Notch receptor activity (Kopan and Ilagan 2009).  
 
2.3. Overview of the Notch signalling pathway 
Activation of the Notch receptor consists of a series of regulated proteolytic events that 
result in the release of the NICD, which travels to the nucleus, where it assembles a 
transcription complex for the activation of downstream target genes (Figure 7). The first 
cleavage occurs during the biosynthetic route at S1 and leads to the formation of NECD-
NTMIC, which is subsequently trafficked to the PM.  
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Figure 7. The Notch signalling pathway.  
The figure shows the steps that lead to the maturation and activation of the Notch receptor in the 
signal-receiving cell. The newly translated Notch receptor is glycosylated in the endoplasmic 
reticulum by the enzymes O-fut and Rumi. When it reaches the Golgi, the Notch receptor is 
cleaved by furin at S1 and O-fucose is extended by Fringe. Mature Notch receptor is then targeted 
to the cell surface, where it is activated by binding to a ligand presented on the signal-sending cell. 
After ligand binding, S2 is cleaved by ADAM metalloproteases and the NEXT fragment is 
generated. The NEXT fragment is subsequently cleaved by γ-secretase complex from S3 to S4, 
with the release of NICD and Nβ peptide. γ-secretase cleavage can occur either on the cell surface 
or in endosomal compartments. Active NICD specie enters the nucleus where it associates with 
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CSL, MAM and additional Co-A proteins to activate transcription. Endocytosis of Notch receptors 
and ligands plays a key role in signal modulation (from Kopan and Ilagan 2009).  
 
After ligand binding, Notch receptor is cleaved by ADAM metalloproteases at S2 (site 2), 
with the formation of the membrane-anchored NEXT (Notch extracellular truncation) 
fragment.  
Two models have been proposed to explain how S2 is exposed to the proteolytic activity of 
ADAM: the mechano-transduction model and the allosteric model. The first model 
proposes that, after ligand binding, the receptor undergoes trans-endocytosis, generating a 
mechanical strain that exposes S2. According to the second model, ligand binding leads to 
an allosteric change in the NRR from a protease-resistant to a protease-sensitive 
conformation (Kopan and Ilagan 2009).  
When the NEXT fragment is formed, it is cleaved by γ-secretase complex from S3 (site 3) 
to S4 (site 4), with the release of NICD and Nβ peptide. γ-secretase cleavage can occur at 
the PM or in endosomal compartments, but cleavage at the membrane favours the 
production of more stable forms of NICD (Kopan and Ilagan 2009). In detail, γ-secretase 
cleavage leads to the formation of NICD variants with diverse N-termini: NICD-V starting 
with valine 1744, NICD-L starting with lysine 1745 or 1746, and NICD-S starting with 
serine 1747. While NICD-S and NICD-L molecules are created in endosomes and then 
rapidly degraded, NICD-V, which is generated at the PM, is stable (Kopan and Ilagan 
2009). Stable NICD, subsequently, enters the nucleus to activate transcription, together 
with the DNA-binding protein CSL (CBF1, Suppressor of Hairless, Lag-1), the 
transcriptional co-activator MAM (Mastermind) and other Co-A (co-activator) proteins. 
Signal downregulation is mediated by the kinase CDK8, which phosphorylates the PEST 
domain, and by E3 ubiquitin ligases (including Sel10/Fbw7), which targets NICD for 
proteasomal degradation (Kopan and Ilagan 2009). 
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2.4. Regulation of Notch signalling by endocytosis 
Endocytosis plays a critical role in the modulation of Notch signalling (Le Borgne 2006). 
The classic function of endocytosis is the downregulation of the signal by sending the 
receptor, the ligand or both towards degradation. However, it has become clear that 
endocytosis can also contribute to signal activation (Le Borgne 2006). Endocytosis of DSL 
ligands, for example, promotes ligand-dependent Notch activation. The key regulators of 
the endocytosis of DSL ligands are Lqf (liquid facet, the Drosophila melanogaster epsin 
gene), Neur (neuralized) and Mib (mind bomb) (Le Borgne 2006). Epsins are part of 
CLASPs (see section “1.3.1. The main component of CDE: clathrin, AP-2 and CLASPs”) 
that bind PIP2, clathrin, AP-2 and other accessory proteins in coated pits. Neur and Mib, 
instead, are two RING-finger-containing E3 ubiquitin ligases that cause the ubiquitination 
of DSL ligands. Ubiquitination is an internalization signal that is recognized by adaptor 
proteins containing UBDs, such as Lqf itself. Monoubiquitinated transmembrane receptors 
are usually targeted to lysosomes for degradation. In the case of Notch signalling, 
ubiquitinated DSL ligands are thought to be targeted to endosomes for their activation and 
then recycled back to the PM (Le Borgne 2006).  
Two alternative, but not exclusive, models have been proposed to explain the requirement 
of Lqf, Neur and Mib in Notch activation. The first model proposes that Lqf targets 
ubiquitinated DSL ligands to a particular subclass of coated pits that have special 
properties for Notch activation. This model is compatible with the hypothesis that S2 (the 
cleavage site that is recognized by ADAM) of ligand-bound Notch becomes unmasked 
when the formation of endocytic pits in the signal-sending cell promotes pulling forces on 
NECD. In the second model, Lqf is proposed to target ubiquitinated DSL ligands, initially 
inactive, to an endocytic recycling pathway where they are converted into active ligands 
(Le Borgne 2006). Different mechanisms have been proposed to explain how ligand 
activation occurs: proteolytic modifications, pH-dependent change of conformation, 
packaging into lipid rafts or targeting into secreted vesicles.  
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Also the Notch receptor undergoes endocytic trafficking, which can promote either 
positive or negative regulation of the pathway, in a context-dependent manner. Notch 
internalization is mediated by Numb, a conserved membrane-associated protein that acts 
upstream of the γ-secretase cleavage to block Notch signalling. Numb is an endocytic 
adaptor that interacts with Notch and AP-2. Numb interacts also with the E3 ubiquitin 
ligase AIP/Itch (in Drosophila melanogaster Su(dx), suppressor of deltex, member of 
Nedd4 family) to promote ubiquitination, endocytosis and degradation of Notch. However 
ubiquitination is not always a signal that leads to Notch degradation. Indeed, when the 
receptor is ubiquitinated by Dx (deltex, an E3 ubiquitin ligase that acts as an antagonist of 
Su(dx)), Notch is protected from entering the degradative pathway (Le Borgne 2006). 
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3. The TfR and its physiological role 
 
3.1. The CDE of the TfR 
The TfR mediates the internalization of iron in complex with the plasma glycoprotein Tf 
(transferrin). Figure 8 depicts the main actors involved in the internalization of TfR. As 
shown, two ions of ferric iron bind to Tf, thus generating differic Tf. When differic Tf 
binds to the TfR, the complex is internalized through CDE into the early endosomal 
compartment. In this compartment, the low pH allows iron to be released from Tf. Within 
the lumen, iron is reduced from ferric iron to ferrous iron by a ferrireductase and then 
delivered to the cytoplasm by NRAMP-2 (natural resistance associated macrophage 
protein 2), otherwise called DMT1 (divalent metal transporter 1). In the cytoplasm, iron is 
used for metabolic functioning, that is, for the synthesis of heme and non-heme iron 
containing proteins, or stored in ferritin. The TfR, instead, is recycled to the PM where the 
neutral pH favors the release of iron-free Tf (apo Tf) back into the circulation (Ponka and 
Lok 1999).  
As previously mentioned, the TfR is the most popular experimental system used to unravel 
the molecular details of constitutive CDE.  
Several proteins regulate the CDE of TfR, as well as the CDE of EGFR and LDLR. Other 
proteins, instead, act as specific adaptor proteins. RNA interference experiments in HeLa 
cells identified clathrin and dynamin2 as common and essential actors in the internalization 
of both TfR and EGFR: the internalization rates of these receptors, indeed, were strongly 
reduced in cells depleted of CHC (but not CLC) or dynamin2. Another common actor was 
AP-2: the internalization rates for both receptors were ~50% reduced in cells depleted of 
β2- or μ2-adaptin. Other endocytic adaptors had a less strong effect.  
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Figure 8. The CDE of the TfR.   
The figure depicts cellular iron uptake via CDE of the TfR, as explained in the text (adapted from 
Ponka and Lok 1999). 
 
For example, in cells depleted of Eps15 or Eps15L1, the internalization rates were reduced 
to 15-30%; however, when both proteins were depleted, the internalization rates were 
reduced to 40%, suggesting a redundant role of these proteins. Depletion of Grb2 or 
CALM, instead, did not affect internalization of TfR but decreased the internalization rate 
of EGFR to 70% and 45%, respectively (Huang et al., 2004), suggesting a role for these 
proteins as specific adaptor proteins in EGFR internalization. TTP, instead, an endocytic 
adaptor protein able to interact with AP-2, clathrin and Eps15, was identified as a specific 
adaptor protein in the internalization of TfR: when TTP was knocked-down in HeLa cells, 
the internalization of TfR, but neither of EGFR or LDLR, was reduced 3-fold (Tosoni, Puri 
et al. 2005). RNA interference experiments in BSC1 cells (monkey kidney epithelial cells) 
identified FCHo1/2 as other common endocytic adaptor proteins in CDE: KD of these 
proteins, indeed, reduced the number of CCPs and almost completely inhibited the 
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internalization of TfR, EGFR and LDLR (Henne, Boucrot et al. 2010). Studies in HeLa 
cells found that TfR did not require the endocytic adaptor protein Dab2, in contrast to β1-
integrin. Eps15 and Itsn proteins, instead, were required for internalization of both TfR and 
β1-integrin: KD of Eps15 plus Eps15L1 or Itsn1 plus Itsn2 reduced internalization of TfR, 
as well as of β1-integrin, to 40%; quadruple KD of all four proteins further reduced 
internalization of both receptors, but not to the same extent as KD of CHC. Moreover, 
quadruple KD of these proteins caused, at the ventral surface of HeLa cells, a decrease in 
the number of CCPs and plaques, and an increase of the median size of plaques 
(Teckchandani, Mulkearns et al. 2012). To complicate the picture even more, some 
endocytic adaptor proteins participate in the internalization of TfR in some cell lines but 
not in others. This is the case of CALM, whose downregulation by RNA interference in 
HeLa cells does not affect TfR internalization (Huang, Khvorova et al. 2004), while KO of 
the protein in murine erythroblasts reduces TfR internalization (Ishikawa, Maeda et al. 
2015). These results indicate the existence of a cell-type specific machinery, besides a 
common one, regulating internalization of receptors.  
 
3.2. Importance of the TfR in the physiology of RBCs 
The TfR plays a fundamental role in cell physiology, as it provides cells with iron. Iron is 
an essential mineral that serves critical cellular functions, such as oxygen transport (as 
heme in hemoglobin), DNA biosynthesis (as a cofactor of ribonucleotide reductase) and 
ATP generation (as a cofactor for proteins involved in the citric acid cycle and electron 
transport chain).  
Due to its broad spectrum, with the exception of mature RBCs (red blood cells), also called 
erythrocytes, and other terminally differentiated cells, TfR is expressed on all cells. Among 
these, cells and tissues with the highest density of TfR are immature RBCs, placental 
tissues and rapidly dividing cells.  
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Figure 9. Erythropoiesis.   
RBCs are produced from precursor cells in the bone marrow. Here a stem cell called hemocytoblast 
is transformed into a committed cell, the proerythroblast, which in turn gives rise to the early 
(basophilic) erythroblast. The early erythroblast produces huge numbers of ribosomes that are 
necessary for hemoglobin synthesis. The synthesis of hemoglobin starts as early as the erythroblast 
is transformed into the late erythroblast and proceeds until the conversion of the late erythroblast 
into a normoblast. After hemoglobin accumulation, most of the organelles are ejected, leading to 
the conversion of a normoblast into a reticulocyte, which is considered a young RBC still 
containing a network of clumped ribosomes and rough endoplasmic reticulum. The reticulocyte is 
then released in the blood stream, where it completes its maturation into an erythrocyte. All the 
development process from the hemocytoblast to the reticulocyte stage takes around 3 to 5 days to 
occur, while the reticulocyte becomes a fully matured erythrocyte within 2 days from its release in 
the blood stream (from Human Anatomy & Physiology, published by Benjamin Cummings; 
Addison Wesley Longman, 2001)  
 
In immature RBCs, in detail, high expression of TfR correlates with their high demand of 
iron for hemoglobin production: in a normal adult, indeed, iron hemoglobin accounts for as 
much as 70% of the total iron content (Ponka and Lok 1999). In the organism, therefore, 
immature RBCs are the most avid consumers of iron. Mature RBCs, instead, loose the 
ability to internalize iron: in these cells, the TfR is downregulated, since all the 
hemoglobin necessary for their functioning has been synthesized and accumulated 
throughout the developmental pathway.  
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Some of the molecular details regarding the developmental pathway of RBCs are described 
here below.  
Mature RBCs are highly specialized cells involved in hemoglobin transport and gas 
exchange in the lungs and peripheral tissues. They have no organelles in their cytoplasm 
and develop directly from reticulocytes, which are defined as erythroid cells that have lost 
their nucleus but still retain residual ribosomes and rough endoplasmic reticulum that will 
be eliminated as the reticulocyte becomes a mature RBC. Reticulocytes, instead, derive 
from precursor cells generated in the bone marrow (Figure 9).  
Throughout their entire maturation process, RBCs undergo an extensive process of cell 
remodelling, during which all the unnecessary proteins and structures are eliminated, in 
order to optimize their function in hemoglobin transport, gas diffusion and deformability. 
The structures that are lost during maturation include the nucleus, the mitochondria, the 
endoplasmic reticulum, the Golgi apparatus, ferritin particles and ribosomes. Moreover, 
several unnecessary proteins are downregulated during the developmental pathway. The 
TfR is one of the proteins that are downregulated during maturation. Downregulation of 
the TfR occurs through exocytosis, a process consisting in the release of exosomes 
(vesicles derived from the ILVs of MVBs) into the extracellular space and regulated by 
ESCRT complexes. Besides TfR, other PM proteins are downregulated by exocytosis, such 
as glucose, nucleoside and amino acid transporters, the Na/K-ATPase and aquaporin1 (Ney 
2011). Also unnecessary cytoplasmic proteins are downregulated during maturation. 
Among these, the one worth mentioning is the endocytic adaptor AP-2, which is degraded 
by the proteasome system. Being necessary for CDE of TfR, downregulation of AP-2 is 
intimately linked to TfR: indeed, it has been suggested that reduction of AP-2 levels favors 
the binding of TfR to the ESCRT machinery (in detail, with Alix) and its secretion via 
exosomes (Geminard, De Gassart et al. 2004). 
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3.3. The role of the TfR in anemia 
As reported in the previous section, immature RBCs express high levels of TfR to sustain 
their high demand of iron for hemoglobin production. Therefore, in vivo disruption of 
proteins participating in iron uptake by TfR has a great impact on the physiology of RBCs.  
The most severe phenotype is observed in TfR-null mice, which die before embryonic day 
12.5 (Levy, Jin et al. 1999). These mice present both erythropoiesis and neural defects. In 
detail, they have signs of fetal hydrops with growth retardation, severe pallor and 
pericardial effusions. Embryonic erythrocytes have an increased frequency of 
multinuclearity (sign of stressed erythropoiesis) and cultured yolk-sac hematopoietic 
progenitors produce smaller erythroid colonies. In the organism the neural tube 
architecture is distorted and exhibits signs of apoptosis. Defective development of the 
nervous system might be secondary to hypoxia and/or directly caused by an inadequate 
supply of iron for its activities (Levy, Jin et al. 1999).  
Reduction of TfR levels or perturbations in other proteins participating in iron uptake by 
TfR, instead, are compatible with life, but are responsible for the onset of an anemic 
condition, referred to as microcytic hypochromic anemia (Levy, Jin et al. 1999, Zhu, 
McLaughlin et al. 2008, Ishikawa, Maeda et al. 2015). This condition, as the nomenclature 
suggests, is characterized by the presence of microcytic and hypochromic RBCs, e.g., of 
RBCs with reduced MCV (mean corpuscular volume) and reduced hemoglobin content, as 
a consequence of impaired iron availability. Microcytic hypochromic anemia is also 
characterized by an increase in the number of immature RBCs and of RDW (red cell 
distribution width) index. High RDW index indicates a high degree of aniso-poikilocytosis, 
e.g. a high variation in RBC size.  
Heterozygous mice for TfR, for example, have a less severe phenotype compared to TfR-
null mice: they survive to adulthood and are indistinguishable from WT (wild type), but 
suffer from microcytic hypochromic anemia due to reduced membrane levels of the TfR. 
In the whole organism hematocrits and hemoglobin levels are normal due to a 
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compensatory increase in RBC number. Moreover, while iron saturation of serum Tf is 
normal, total body iron accumulation is reduced, as indicated by reduced iron in the liver 
and in the spleen, probably due to reduced intestinal iron absorption (Levy, Jin et al. 1999).  
Also hematopoietic-specific null mice for the transcription factors Stat5a/b exhibit 
microcytic hypochromic anemia (Zhu, McLaughlin et al. 2008). In these mice protein 
levels of TfR are reduced to 50%, indicating that Stat5a/b participate in the regulation of 
TfR expression. In contrast to heterozygous mice for TfR, these mice have a decreased 
RBC count, hemoglobin and hematocrit, and an increased iron deposition in the liver. The 
lack of Stat5a/b in the whole organism leads to a more severe anemia compared to 
hematopoietic-specific Stat5a/b-null mice and animals die perinatally.  
More recently, another protein has been found to be essential for the proper development 
of RBCs: the clathrin adaptor protein PICALM (Ishikawa, Maeda et al. 2015). Inactivation 
of PICALM in the hematopoietic system of adult mice leads to anemia, as evidenced by a 
reduced RBC number, hemoglobin and hematocrit. Anemia is microcytic and hypochromic, 
with a high RDW. In these mice, an increased number of reticulocytes in the blood and of 
immature erythroblasts in the spleen has also been found. These phenotypes are indicative 
of a maturation defect, confirmed through the observation that hematopoietic progenitor 
cells KO for PICALM barely develop into an erythroid lineage when cultured in vitro. This 
maturation defect has been linked to reduced TfR internalization due to a role for PICALM 
in the maturation of CCPs: PICALM-KO splenic erythroblasts have increased amounts of 
surface-bound Tf and impaired TfR internalization, which correlate with a reduced number 
of CCPs (Ishikawa, Maeda et al. 2015). 
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4. Eps15 and Eps15L1 
 
4.1. Structure and binding partners of Eps15 and Eps15L1 
In the beginning of the nineties, several proteins were found to be tyrosine phosphorylated 
upon EGF stimulation of NIH EGFR cells (NIH 3T3 mouse fibroblasts overexpressing 
human EGFR) (Fazioli, Bottaro et al. 1992). A screening on a λgt11 cDNA expression 
library prepared from NIH 3T3 fibroblasts led to the identification of a partial cDNA 
encoding for a new protein. Being tyrosine phosphorylated upon EGF stimulation, this new 
protein was named Eps15 (from EGFR pathway substrate 15) (Fazioli, Minichiello et al. 
1993). In order to obtain the full-length sequence of Eps15, the partial cDNA was used as a 
probe to screen a mouse keratinocytes cDNA library (Fazioli, Minichiello et al. 1993). 
Subsequently, using a specific probe derived from the cDNA encoding for the first domain 
of Eps15, another EGFR substrate was identified. Because of its homology to Eps15, the 
new protein was designed as Eps15R (for Eps15-related) (Wong, Schumacher et al. 1995) 
and later, according to the official nomenclature, as Eps15L1 (for Eps15-like1). Further 
studies addressed their biochemical features and functions.  
The structure of Eps15 and Eps15L1 and their binding partners are described here below. 
Eps15 and Eps15L1 are 47% identical and share high co-linearity and homology (Wong, 
Schumacher et al. 1995). The two proteins are characterized by a modular structure 
composed of three main domains. Through their domains, Eps15 and Eps15L1 bind to a 
number of different partners, thus taking part in several intermolecular networks and 
serving diverse cellular functions (Figure 10).  
Eps15 has a predicted molecular weight of 142-kDa and is composed of 897 amino acids, 
while Eps15L1 is predicted to be a 125-kDa protein of 907 amino acids.  
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Figure 10. Structure of murine Eps15 and Eps15L1.  
Eps15 and Eps15L1 are modular proteins displaying 47% identity and composed of three EH 
domains at the N-terminus (magenta), a central α-helical coiled-coil region (green) and a C-
terminal domain containing several DPF motifs (orange), an AP-1-binding domain (red) and two 
UIMs (blue). For each domain, the main binding partners of Eps15 and Eps15L1 are indicated.  
 
The first domain is located in the N-terminal region and includes three imperfect repeats of 
95 to 97 amino acids, corresponding to a protein-protein interaction domain that was first 
identified in Eps15: the EH domain (for Eps15 homology). EH domains mediate binding 
with NPF (asparagine-proline-phenylalanine)-containing proteins, such as the endocytic 
proteins Numb, epsin, Hrb, synaptojanin, stonin, STAM and others. 
The second domain of Eps15 and Eps15L1 contains 24 heptad repeats and has a α-helical 
coiled-coil structure. This structure, commonly found in cytoskeleton-related proteins, 
serves as a dimerization interface: through it, Eps15 and Eps15L1 form hetero- or homo-
dimers and oligomers (Cupers, ter Haar et al. 1997, Tebar, Confalonieri et al. 1997, Coda, 
Salcini et al. 1998). Moreover, this region mediates binding with other endocytic adaptor 
proteins, such as Hrs and Itsn. The third domain is located in the C-terminal region and 
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contains a proline-rich domain and several DPF (aspartic acid-proline-phenylalanine) 
repeats. The proline-rich domain mediates interaction with Crk and Grb2 (van Bergen En 
Henegouwen 2009). The DPF motifs mediate binding with AP-2 (through α-adaptin), 
SGIP1 and FCHo. SGIP1 and FCHo bind to Eps15 proteins through their μ–homology 
domain (Uezu, Horiuchi et al. 2007, Hollopeter, Lange et al. 2014, Ma, Umasankar et al. 
2016). The C-terminus of Eps15 and Eps15L1 harbours two UIMs (ubiquitin interacting 
motif), which are shared by other endocytic proteins, such as epsins and Hrs. These motifs, 
which mediate the binding to ubiquitin, allow endocytic proteins to interact with 
ubiquitinated receptors and to be ubiquitinated in a process called coupled ubiquitination 
(Polo, Sigismund et al. 2002).  
Since the discovery of Eps15 and Eps15L1 in 1993 as substrates of the tyrosine kinase 
activity of the EGFR, several studies delineating their cellular functions have arisen. Taken 
together, it emerges that Eps15 and Eps15L1 are two accessory adaptor/scaffolding 
proteins that serve pleiotropic functions within the endocytic machinery: they regulate the 
early events of CDE and CIE of several cargo molecules, their sorting in the EEs and 
protein trafficking from the TGN to the PM. 
 
4.2. The role of Eps15 and Eps15L1 in CD- and CI-endocytosis  
Eps15 and Eps15L1 were initially proposed to participate in endocytosis. Indeed, it was 
known that other EH-containing proteins were involved in endocytosis, like End3p and 
Pan1p, the yeast homologs of Eps15. Moreover, they were found to interact with several 
endocytic proteins, such as epsin1 and epsin2 (Chen, Fre et al. 1998), AP-2 (Benmerah, 
Begue et al. 1996), Grb2 (Schumacher, Knudsen et al. 1995), Itsn, dynamin (Sengar, Wang 
et al. 1999) and Numb (Salcini, Confalonieri et al. 1997).  
Many evidences pointed to a major role for Eps15 and Eps15L1 as scaffolding proteins 
involved in the CDE of EGFR, prototype of ligand-dependent endocytosis, and TfR, 
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prototype of constitutive endocytosis: i) Eps15 was found to ubiquitously and 
constitutively bind AP-2 (Benmerah, Gagnon et al. 1995); ii) Eps15 and Eps15L1 co-
localized with AP-2 and clathrin (Tebar, Sorkina et al. 1996, vanDelft, Govers et al. 1997, 
Coda, Salcini et al. 1998); iii) membrane-associated Eps15 was located at the rims of CCPs 
(Tebar, Sorkina et al. 1996); iv) antibodies blocking Eps15 or Eps15L1 inhibited 
endocytosis of EGFR and TfR in CV-1 cells (monkey kidney cells) (Carbone, Fre et al. 
1997); v) fragments encompassing the C-terminal region of Eps15 inhibited endocytosis of 
EGFR in CV-1 and COS-7 cells (monkey kidney cells); vi) fragments encompassing either 
the EH domains or the C-terminal region of Eps15 inhibited infection by Sindbis virus in 
NIH 3T3 cells (Carbone, Fre et al. 1997); vii) mutant forms of Eps15 containing only the 
C-terminal region inhibited internalization of TfR in HeLa cells and of EGFR and TfR in 
A431 cells (human squamous carcinoma cells) (Benmerah, Lamaze et al. 1998, Benmerah, 
Bayrou et al. 1999). The effects on EGFR and TfR internalization have been recently 
revisited and quantified through radioactive internalization assays, following KD of Eps15 
and Eps15L1, alone or in combination, in HeLa cells (Huang, Khvorova et al. 2004). As 
reported in section “3.1. The CDE of the TfR”, it emerges that Eps15 and Eps15L1 have a 
less drastic effect on the internalization of these receptors: indeed, it has been reported that 
in HeLa cells depleted of Eps15 or Eps15L1, the internalization rates of TfR and EGFR 
were reduced to 15-30%; when both proteins were depleted, the internalization rates were 
decreased to 40%, thus suggesting a redundant role of these proteins (Huang, Khvorova et 
al. 2004). 
Targeting of Eps15 to CCPs has long been described to be AP-2-dependent (Benmerah, 
Poupon et al. 2000), in line with the traditional view that CCP initiation is triggered by the 
recruitment to the PM of AP-2 as a first adaptor protein. This view has been challenged by 
a model according to which initiation of a CCP requires the formation of a putative 
nucleation module that defines the sites on the PM where AP-2 will be recruited. This 
putative nucleation module is composed of FCHo, Eps15 and Itsn proteins (Stimpson, 
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Toret et al. 2009, Henne, Boucrot et al. 2010). However, a more recent study has taken 
advantage of live-cell TIRF imaging to reconstruct, at high temporal resolution, the initial 
events of CCP formation. According to this study, pits are initiated by clathrin and AP-2, 
which arrive concomitantly at the PM. In detail, the initial molecular complex is composed 
of one triskelion and two AP-2 complexes, followed by another similar complex, which 
binds to the membrane through interaction of AP-2 with PIP2. In this scenario, FCHo1/2, 
and probably also Eps15 and Itsn proteins, are not essential for initiation but are required 
for sustained growth of CCPs (Cocucci, Aguet et al. 2012).  
Besides playing a role in CDE, it has been demonstrated that Eps15 and Eps15L1 take part 
also in the CIE of EGFR (Sigismund, Confalonieri et al. 2012). Indeed, triple KD of Eps15, 
Eps15L1 and epsin1 in HeLa cells results in the inhibition of this pathway.  
 
4.3. Post-translational modifications of Eps15 and Eps15L1 
During endoytosis, Eps15 undergoes a serie of post-translational modifications. Upon EGF 
stimulation, Eps15 is tyrosine phosphorylated. This event is essential for EGFR 
internalization but not for constitutive uptake of the TfR (Confalonieri, Salcini et al. 2000). 
Phosphopeptide experiments demonstrate that phosphorylated tyrosines in Eps15 likely 
serve as binding sites for PTB domain-containing proteins (Confalonieri, Salcini et al. 
2000).  
Eps15 is also monoubiquitinated upon EGF stimulation (vanDelft, Govers et al. 1997) via 
a mechanism called coupled monoubiquitination (Polo, Sigismund et al. 2002), where 
monoubiquitination depends on a functional UIM domain. The precise role of adaptor 
monoubiquitination in RTK endocytosis is still a matter of debate. Monoubiquitination of 
adaptors might permit the formation of several tiers of ubiquitin-dependent interactions, 
resulting in the progression of ubiquitinated cargoes along the endocytic pathway. 
Alternatively, it has been proposed that ubiquitination (coupled monoubiquitination) could 
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represent a signal to “switch off” the binding activity of the adaptor by allowing 
intramolecular interactions between the UBD and the ubiquitin moiety present in cis 
(Hoeller, Crosetto et al. 2006). This mechanism could cause the release of the 
ubiquitinated cargo that, thus, becomes available for other interactions along the endocytic 
route. Nevertheless, the hypothesis that adaptor monoubiquitination inhibits the cargo 
binding has recently been challenged by the finding that monoubiquitination of Eps15 does 
not change its ability to interact with EGFR and that it is necessary for EGFR 
internalization, already at low doses of EGF ligand when EGFR is internalized only by 
CDE (Savio, Wollscheid et al. 2016). 
Finally, it has also been demonstrated that Eps15, together with epsin, is phosphorylated 
during mitosis. This phosphorylation inhibits the interaction of the two proteins with AP-2 
and causes dissociation of the two proteins from CCPs, thus resulting in the mitotic block 
of endocytosis (Chen, Slepnev et al. 1999). 
 
4.4. Other cellular functions of Eps15 and Eps15L1  
In the literature, there are reports revealing that Eps15 proteins participate also in late 
endocytic events. Indeed, the finding that Eps15 co-localizes with EGFR in the early and 
late endosomes suggests that Eps15 is involved not only in the early steps of EGFR 
internalization, but also in the sorting of the receptor at the EE (Torrisi, Lotti et al. 1999). 
Further studies found that protein sorting was regulated by two different isoforms of Eps15, 
Eps15b and Eps15s. In detail, Eps15b, an Eps15 isoform lacking the EH domains, was 
shown to interact with the ubiquitin-binding proteins Hrs and STAM at the EE and to form 
a complex (ESCRT-0) responsible for receptor degradation (Roxrud, Raiborg et al. 2008). 
Instead, Eps15s, an Eps15 isoform lacking the 111 terminal amino acids, including the 
UIM domains, was shown to co-localize with Rab11 in recycling endosomes (Chi, Cao et 
al. 2011).  
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Other studies unmasked a role for Eps15 in the secretory pathway: Eps15 was found to 
interact with AP-1 (Kent, McMahon et al. 2002, Chi, Cao et al. 2008) trough a 14 
aminoacid motif located immediately C-terminally from the AP-2 binding site. In the TGN, 
Eps15 promotes the formation of tubular-carrier precursors by targeting polyubiquitinated 
coronin7, a stabilizer for F-actin, at the TGN (Yuan, Lee et al. 2014). 
More recent studies have dissected the role of Eps15 in the internalization of other proteins 
rather than the EGFR and the TfR. Indeed, it has been demonstrated that Eps15 proteins 
participate in the CDE of β1-integrin through an AP-2-independent and Dab2-dependent 
mechanism (Teckchandani, Mulkearns et al. 2012), and in the internalization of 
connexin43, a base component of gap-junctions (Girao, Catarino et al. 2009). These 
studies, therefore, unveil a role for Eps15 proteins in cell adhesion and cell-cell contact.  
Due to the ability of Eps15 to interact with Hrb, a protein involved in nuclear 
import/export, a role for Eps15 proteins has also been postulated in the nucleus, similar to 
other endocytic adaptors. However, whether they function in nucleocytoplasmic transport 
or transcriptional regulation still remains to be elucidated (Doria, Salcini et al. 1999, 
Vecchi, Polo et al. 2001, Poupon, Polo et al. 2002, Pilecka, Banach-Orlowska et al. 2007). 
 
4.5. The functions of Eps15 in lower organisms  
Some in vitro studies suggest a function for Eps15 proteins in the regulation of signalling 
pathways of the nervous system. Eps15 proteins, indeed, were found to interact with neural 
endocytic proteins, such as sinaptojanin (Haffner, Takei et al. 1997), parkin (Fallon, 
Belanger et al. 2006), spartin (Bakowska, Jenkins et al. 2005) and stonin2 (Martina, 
Bonangelino et al. 2001). Moreover, Eps15 was found to be enriched at the presynaptic 
nerve terminals, the site of a specialized form of CDE (Chen, Slepnev et al. 1999), 
necessary to efficiently recycle synaptic vesicle proteins (De Camilli and Takei 1996). 
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In line with these findings, studies in lower organisms, where only one Eps15 gene exists, 
pointed to a major role for Eps15 proteins in the development of synaptic structures and in 
SVR.  
Studies in Caenorhabditis elegans revealed that ehs-1, the orthologue of Eps15, was 
essential in synaptic transmission under unfavourable conditions (Salcini, Hilliard et al. 
2001). Deletion of the gene caused uncoordinated movements and reduction in the number 
of synaptic vesicles in a temperature-sensitive manner. Interestingly, ehs-1 mutants 
displayed also reduced levels of Itsn1 (Rose, Malabarba et al. 2007, Wang, Bouhours et al. 
2008), suggesting a role for Eps15 in the stabilization of this endocytic protein.  
In Drosophila melanogaster, deletion of Eps15 causes lethality during the pupal stage. 
Eps15-null mutants have defects in the development of synaptic structures, which 
exhibited an extra number of boutons and branches (Koh, Korolchuk et al. 2007). Both 
electron microscopy analyses and dye uptake experiments revealed that the number of 
recycled vesicles was reduced in Eps15-null mutants (Koh, Korolchuk et al. 2007). 
Because of SVR impairment, Eps15-null mutants exhibit cisternae and large invaginations 
still associated with the PM (Koh, Korolchuk et al. 2007). Of note, Eps15-null mutants 
have reduced levels of Itsn and dynamin and, in a subtle way, of AP-2, stonedB, 
synaptotagmin and endophilin1 (Koh, Korolchuk et al. 2007). 
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5. Physiological functions of Eps15 and Eps15L1 in mammals 
 
5.1. Eps15, Eps15L1 and Eps15/Eps15L1 KO mice  
In order to characterize the physiological functions of Eps15 and Eps15L1 in mammals, 
single and double KO (DKO) mice for Eps15 and Eps15L1 were previously generated in 
our laboratory. Both the Eps15 and Eps15L1 null alleles were generated by deletion of the 
first exon and the upstream region of each gene. In detail, the Eps15 null allele was 
obtained by homologous recombination. Instead, the Eps15L1 null allele was obtained by 
homologous recombination combined with the Flp-FRT and the Cre-loxP strategy.  
 
       
Figure 11. Eps15-KO mice, but not Eps15L1-KO ones, survive at weaning according to the 
expected Mendelian ratio. 
The bar graph depicts the percentage of wild type (WT), heterozygous (HET) and knockout (KO) 
pups for Eps15 (blue bars) and Eps15L1 (red bars) that survived at weaning, compared to the 
expected Mendelian ratio (black bars).  
Eps15-KO mice were viable, healthy and fertile, with no obvious phenotype, except for a 
defect in B cell lymphopoiesis (Pozzi, Amodio et al. 2012). In contrast, Eps15L1-KO mice 
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were postnatal lethal, with only 10% of the pups surviving to adulthood (Figure 11). 
Newborn Eps15L1-KO mice had no obvious morphological defects, but the great part of 
them had no milk in the stomach. Moreover, Eps15L1-KO mice displayed neurological 
deficits, as assessed by reduced reactivity in any neurological tests and by difficult 
respiratory activity. Deeper investigations highlighted a fundamental role of Eps15L1 in 
the nervous system. In detail, biochemical analysis of newborn brain lysates revealed that 
Eps15L1-KO mice had reduced levels of the endocytic proteins synaptophysin and Itsn1. 
Moreover, ultrastructure analysis of in vitro cultured hippocampal neurons showed that the 
lack of Eps15L1 led to a reduced number of synaptic vesicles, thus indicating a defect in 
SVR (Alberici et al., unpublished results).  
Eps15/Eps15L1-DKO displayed a more severe phenotype than single KO mice: they died 
at midgestation between 10.5 and 11.5 dpc (days post coitum) (Table 1) and had severe 
developmental defects. At 9.5 dpc, more severely affected embryos had growth defects and 
absence of turning. All embryos, moreover, had an open neural tube, an enlarged 
pericardium and the limb bud was absent (Figure 12A). Less severely affected embryos 
had also reduced vascularization, as assessed by PECAM-1 staining (Figure 12B, C).  
 
 
dpc 
 
Litters 
Eps15-KO/ 
Eps15L1-WT 
Eps15-KO/ 
Eps15L1-HET 
Eps15-KO/ 
Eps15L1-KO 
 
Total 
9.5 19 39 (27%) 75 (53%) 28 (20%) 142 
10.5 2 1 (7%) 11 (78%) 2 (14%) 14 
11.5 1 4 (57%) 3 (43%) 0 7 
12.5 2 8 (40%) 12 (60%) 0 20 
 
Table 1. Eps15/Eps15L1-DKO mice die between 9.5 and 11.5 dpc.  
The table represents the number and the percentage of Eps15-KO/Eps15L1-WT, Eps15-
KO/Eps15L1-HET and Eps15-KO/Eps15L1-KO embryos, from different litters, which were found 
viable from 9.5 to 12.5 dpc. 
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Figure 12. 9.5 dpc Eps15/Eps15L1-DKO have severe development defects.  
A. The photographs compare 9.5 dpc DKO and Eps15-KO mice. White arrows indicate 
midbrain/hindbrain boundary (Bd), lim bud (Lb) and heart (Ht). Star indicates absence of forelimb 
bud in DKO mice. B. Immunohistochemical staining with the endothelial marker PECAM-1 of 9.5 
dpc DKO and Eps15-KO mice. Magnifications represent portions of the head. C. IF staining with 
the endothelial marker PECAM-1 (red) of 9.5 dpc DKO and Eps15-KO mice. The head, somitic 
and yolk sac regions are shown.  
 
5.2. Functions of Eps15 and Eps15L1 in mammals: hypothesis on Notch 
signalling regulation  
Studies from Eps15/Eps15L1-DKO mice revealed that lack of both proteins lead to 
morphological defects that phenocopyed characteristics of Notch signalling loss-of-
function mutants, such as Notch1-KO (Swiatek, Lindsell et al. 1994, Limbourg, Takeshita 
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et al. 2005), Notch1/Notch4-DKO (Krebs, Xue et al. 2000), Dll1-KO (Hrabe de Angelis, 
McIntyre et al. 1997), Dll4-KO (Duarte, Hirashima et al. 2004), Jagged1-KO (Xue, Gao et 
al. 1999), Numb-KO (Zilian, Saner et al. 2001), epsin1/2-DKO (Chen, Ko et al. 2009) and 
Mib1-KO (Koo, Lim et al. 2005) (Table 2). 
 
Gene 
Name 
Receptor/ 
ligand/ 
other 
KO 
lethality 
Cardiovascular 
defects 
Placental 
and yolk sac 
defects 
Defects in 
nervous 
system 
Reference 
Notch1 Receptor < 11.5 dpc YES YES YES 
(Swiatek, 
Lindsell et al. 
1994) 
Tie2Cre/ 
Notch1 Receptor < 11.5 dpc YES YES YES 
(Limbourg, 
Takeshita et al. 
2005) 
Notch1/ 
Notch4 Receptor < 11.5 dpc YES YES YES 
(Krebs, Xue et 
al. 2000, Krebs, 
Xue et al. 2000) 
Dll1 Ligand < 11.5 dpc YES / YES 
(Hrabe de 
Angelis, 
McIntyre et al. 
1997) 
Dll4 Ligand < 11.5 dpc YES YES / 
(Duarte, 
Hirashima et 
al. 2004) 
Jag1 Ligand < 11.5 dpc YES / / (Xue, Gao et al. 1999) 
Numb Endocytic adaptor < 11.5 dpc YES YES YES 
(Zilian, Saner 
et al. 2001) 
Epsin1/2 Endocytic adaptors < 11.5 dpc YES YES YES 
(Chen, Ko et al. 
2009) 
Mib1 E3 ligase < 11.5 dpc YES YES / (Koo, Lim et al. 2005) 
Eps15/Eps15L1 Endocytic adaptors < 11.5 dpc YES YES YES (unpublished) 
 
Table 2. Notch loss-of-function mutants. 
The table summarizes the main phenotypic defects (lethality and presence of cardiovascular, 
placental, yolk sac and neural defects) of embryos KO for the principal components of the Notch 
signalling pathway.   
 
To understand whether and which signalling pathways were deregulated in the absence of 
Eps15 and Eps15L1, a microarray analysis was performed on 9.5 dpc Eps15-KO, 
Eps15L1-KO and Eps15/Eps15L1-DKO embryos.  
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The majority of genes that were altered in DKO mice recapitulated the morphological 
changes in the embryos. Indeed, genes involved in cardiac and neural development, in 
hematopoiesis and in metabolism were deregulated. Numerous genes were also found 
altered in the signalling category. Major signalling pathways, such as SMAD, β-catenin 
and hedgehog, were not deregulated (data not shown). However, the Notch target genes 
HES1, HES5 and NRARP were downregulated in DKO embryos. To confirm these 
findings, a QPCR analysis of 9.5 dpc embryos was performed, using epsin1/2-DKO 
embryos as a control. The Notch target genes HES1, HES5 and NRARP were confirmed to 
be downregulated in Eps15/Eps15L1-DKO to the same extent as in epsin1/2-DKO mice 
(Figure 13). Taken together, these observations suggest that loss of both Eps15 and 
Eps15L1 correlate with a Notch loss-of-function phenotype.  
Besides morphological defects and downregulation of the Notch target genes HES1, HES5 
and NRARP in Eps15/Eps15L1-DKO mice, previous data pointed to a role for Eps15 and 
Eps15L1 in the endocytic regulation of Notch signalling: i) Eps15 and Eps15L1 physically 
interact with Numb and epsin (Salcini, Confalonieri et al. 1997, Chen, Fre et al. 1998), key 
regulators of Notch receptor and ligand activity, respectively; ii) Eps15 and Eps15L1 act in 
complex with epsin1 to modulate EGFR endocytosis (Chen, Fre et al. 1998, Sigismund, 
Woelk et al. 2005); iii) Eps15 and Eps15L1 possess two UIM domains, one of the two 
essential domains needed for epsin-dependent activation of Notch ligands (Xie, Cho et al. 
2012).  
                              
Figure 13. Downregulation of Notch target genes in 9.5 dpc Eps15/Eps15L1-DKO mice. 
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The bar graph depicts the relative expression levels of the Notch target genes HES1 (white bars), 
HES5 (grey bars) and NRARP (black bars) in wild type (WT), Eps15/Eps15L1-DKO (DKO), 
Eps15L1-KO (15L1), Eps15-KO (15) and epsin1/2-DKO (epsin1/2) embryos at 9.5 dpc, as 
determined by QPCR. All values were normalized on GAPDH and on the relative expression levels 
of WT embryos. At least 3 independent embryos were analysed for each gene, except for epsin1/2-
DKO (n=1). Results are expressed as mean ± standard deviation. 
These observations lead to the hypothesis that Eps15 and Eps15L1 might regulate Notch 
signalling, either in the signal-sending or in the signal-receiving cell.  
To study the biology of Notch ligands and receptors in vitro, our laboratory employed a 
luciferase-based co-culture cell model system in which a signal-sending cell, expressing a 
Notch ligand, and a signal-receiving cell, expressing a Notch receptor, come into close 
contact (Lucano et al., unpublished results). As a model for the signal-sending cell, the 
bone marrow, stromal, murine cell line OP9, overexpressing the Notch ligand Dll1 (OP9-
Dll1 cells) was used. The OP9-Dll1 cell line was generated in 2002 by Schmitt and 
Zuniga-Pflucker as a tool to study the role of Dll1 in thymocyte development in vitro 
(Schmitt and Zuniga-Pflucker 2002). As a model for the signal-receiving cell, the murine, 
myoblast cell line C2C12, a subclone of the myoblast cell line established by Yaffe and 
Saxel (Yaffe and Saxel 1977), constitutively expressing the Notch1 receptor (C2C12-
Notch1 cells), was used. In this co-culture cell model system, it was found that transient 
KD of Eps15 and Eps15L1, alone or in combination, in OP9-Dll1 cells lead to a ∼50% 
reduction of Notch activation. On the contrary, no effect was observed when Eps15 and 
Eps15L1 were knocked-down, alone or in combination, in the signal-receiving cell. Of 
note, no further reduction of Notch signalling was observed when Eps15 and Eps15L1 
were knocked-down in combination both in the signal-sending and in the signal-receiving 
cell. This in vitro work suggests that Eps15 and Eps15L1 regulate Notch signalling in the 
signal-sending cell.  
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6. Aims of this project 
Most of the in vitro studies found in literature have been focused on Eps15, while fewer 
studies have addressed the in vitro functions of Eps15L1. The reason of this discrepancy 
resides on the fact that Eps15 and Eps15L1 have always been thought to be redundant in 
several cellular processes, due to their homology, their common binding partners and their 
similar cellular localization. Nevertheless, this redundancy has not always been 
demonstrated by in vitro studies. In addition, their role in a physiological setting has never 
been investigated. 
Our laboratory addresses whether Eps15 and Eps15L1 exert redundant and/or non-
redundant roles in mammals, using genetically engineered mice as a model system. In 
these organisms, the genetical removal of components of endocytosis rarely impinges on 
its efficiency, likely because functionally redundant proteins or pathways compensate for 
their lack. This is the case for Eps15, whose removal has no evident effect (Pozzi, Amodio 
et al. 2012), suggesting that other proteins, more likely its homologous Eps15L1, could 
absolve its functions. Nevertheless, during evolution, homologous proteins are differently 
shaped, so that some functions can be lost and others acquired.  
Up to now, studies in genetically engineered mice indicate that while Eps15 functions can 
be redundantly compensated by Eps15L1 and/or other endocytic proteins, Eps15L1 plays a 
non-redundant role in the regulation of SVR, which is reminiscent of the role played by its 
orthologous in lower organisms (Alberici et al., unpublished results). Since studies in 
single KO mice indicate that Eps15 and Eps15L1 have both redundant and non-redundant 
functions, the severe phenotype of Eps15/Eps15L1-DKO might result from the impairment 
of a redundant function that is essential for embryo development or from the combined 
impairment of redundant and non-redundant functions, which, even if not essential, might 
addictively contribute to embryo lethality.  
 66 
The aim of this project was to investigate redundant and non-redundant functions of Eps15 
and Eps15L1 in order to unmask the underlying causes of embryo lethality in 
Eps15/Eps15L1-DKO mice.  
To this end, by combining in vivo, in vitro and ex vivo approaches, we have investigated 
whether: i) Eps15 and Eps15L1 play a role in the regulation of Notch signalling in mouse 
embryonic fibroblasts (MEFs) derived from KO mice for Eps15 and Eps15L1, in order to 
extend previous findings (see section “5.2. Functions of Eps15 and Eps15L1 in mammals: 
hypothesis on Notch signalling regulation”); ii) whether midgestation lethality of DKO 
mice is caused by impaired vascular development; iii) whether Eps15 and Eps15L1 play a 
role in EGFR and TfR internalization in MEFs, due to the extensive literature claiming 
their role in the internalization of these receptors in various cellular systems; iv) whether 
Eps15 and Eps15L1 affect RBC development, similarly to other endocytic adaptor proteins, 
such as PICALM (Ishikawa, Maeda et al. 2015).  
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Chapter 2 
MATERIALS AND METHODS 
 
 
1. Materials 
 
1.1. Solutions 
Gietscher buffer 10X  
NH4SO4      166 mM 
Tris-HCl pH 8.8     670 mM 
β-Mercaptoethanol    5 mM 
EDTA pH 8.0 10 mM   67 μM 
Store at -20 °C. 
 
JS buffer 1X 
HEPES, pH 7.4     50 mM 
NaCl       150 mM 
Glycerol      1% 
Triton X-100     1% 
MgCl2      1.5 mM 
EGTA      5 mM 
Just before use, add the following phosphatase and protease inhibitors: PMSF 1 
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mM, sodium orthovanadate 10 mM, sodium fluoride 50 mM and Protease 
inhibitor cocktail Set III 100X (Calbiochem).  
 
Laemmli buffer 5X 
SDS       10% 
Tris HCl, pH 6.8     250 mM 
DTT      500 mM 
Glycerol      50 % 
Bromophenol blue     0.005 % 
Store at -20 °C. 
 
Paraformaldehyde 4% 
Paraformaldehyde    4 gr 
PBS 1X     100 ml 
Store at -20 °C. 
 
Phosphate-buffered saline (PBS) 1X 
NaCl      137 mM 
KCl      2.7 mM 
Na2HPO4     10 mM 
KH2PO4     2 mM 
 
Ponceau S 
Ponceau      0.1% (w/v) 
Acetic acid     5% 
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RIPA lysis buffer 1X 
Tris HCl, pH 7.6     50 mM 
NaCl       150 mM 
NP-40      1% 
SDS       0.1% 
Deoxycholic acid     0.5% 
Just before use, add the following phosphatase and protease inhibitors: PMSF 2 
mM, sodium orthovanadate 10 mM, sodium pyrophosphate pH 7.5 20 mM, 
sodium fluoride 50 mM and Protease inhibitor cocktail Set III 200X 
(Calbiochem).  
 
SDS-PAGE running buffer 10X 
Glycine      192 mM 
Tris HCl, pH 8.3     250 mM 
SDS       1% 
 
Tail buffer 
Gietscher buffer    1X 
Triton X-100     0.5% 
Proteinase K (PK)    500 μg/ml 
 
Tris-Acetate-EDTA (TAE) 50X 
Tris base      2 M 
Acetic acid      1 M 
EDTA, pH 8     10 mM 
Adjust the pH to 8.5 with HCl.  
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Tris-EDTA (TE) 1X 
Tris base      10 mM 
EDTA      1 mM 
Adjust the pH to 8 with HCl.  
Tris-buffered saline (TBS) 1X 
NaCl       137 mM 
KCl       2.7 mM 
Tris HCl pH 7.4     25 mM 
Adjust the pH to 7.4 with HCl.  
 
Tris-HCl 1 M 
Tris base      121.1 gr 
ddH2O     to 1 L 
Adjust the pH to 7.4, 7.6 or 8.0 with HCl.  
 
Western transfer buffer 10X 
Glycine      192 mM 
Tris HCl, pH 8.3     250 mM 
For Western transfer buffer 1X, dilute the 10X stock 1:10 with ddH2O and 20% 
v/v methanol or ethanol. 
 
1.2. Reagents 
The manufacture has been indicated for each reagent used in this thesis project. 
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1.3. Antibodies 
The antibodies used in this thesis project are listed in Table 3.  
Home made antibodies were raised as indicated: 
• rabbit polyclonal anti-Eps15, home made against full-length murine Eps15 protein 
fused to GST; 
• rabbit polyclonal anti-Eps15L1, home made against the N-terminal region of 
murine Eps15L1 (aminoacids: 216-266) between the EH2 and EH3 fused to GST; 
• rabbit polyclonal anti-Itsn1, home made against the central region of human Itsn1 
(aminoacids: 583-888), kindly provided by Simona Polo. 
 
1.4. RNAi oligos 
The sequence of the scrambled Stealth RNAi siRNA oligo (Invitrogen) used in this thesis 
project is: AGACGAACAAGUCACCGAC. 
The sequence of the Stealth RNAi siRNA oligo against murine Mib1 (Invitrogen) used in 
this thesis project is: GGUGCUAAGCUAGACAUUCAGGAUA.  
 
1.5. Constructs and plasmids 
pLenti TetR Blast was purchased from Addgene (Plasmid #17492). 
pcDNA5/TO-Delta-mCherry was kindly provided by Elowitz MB (Sprinzak, Lakhanpal et 
al. 2010). 
pBABE-mycEps15L1 has been previously described (Coda, Salcini et al. 1998). 
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2. Methods 
 
2.1. Cloning techniques 
2.1.1. Agarose gel electrophoresis 
DNA samples were loaded on 0.8%-2% agarose gels along with DNA markers (1 kb DNA 
Ladder, Promega). Gels, containing Gel Red (Biotium), were run in TAE buffer 1X at 80 
Volts, until desired separation was achieved. DNA bands were visualized under a UV 
lamp. 
 
2.1.2. Minipreps 
Individual colonies were used to inoculate 10 ml LB (lysogeny broth) medium (containing 
the appropriate antibiotic) and grown overnight at 37°C. Bacteria were centrifuged for 5 
minutes at 16,000 x g using a 5415 R centrifuge (Eppendorf). Minipreps were performed 
with the Wizard Plus SV Minipreps Kit (Promega), according to manufacturer’s 
instructions. The plasmids were eluted in 50 μl nuclease-free H2O. 
 
2.1.3. Diagnostic DNA restriction 
0.5 μg DNA were digested for 2 hours at 37 °C with 10-20 units of restriction enzyme 
(New England Biolabs). For digestion, the volume was made up to 20 μl with the 
appropriate buffer and ddH2O. 
 
2.1.4. Large scale plasmid preparation 
Bacterial competent DH5α, transformed with the desired plasmid DNA, were grown 
 73 
overnight at 37 °C into 250 ml LB medium (containing the appropriate antibiotic). Plasmid 
DNA was isolated with the Qiagen Maxi-prep kit, according to manufacturer’s 
instructions. 
 
2.1.5. Transformation of bacterial competent cells 
An aliquot of bacterial competent cells DH5α (Invitrogen) was thawed on ice and 
incubated with the desired plasmid DNA for 30 minutes on ice. Cells were then subjected 
to a heat shock for 45 seconds at 42 °C and returned to ice for additional 5 minutes. 300 μl 
of SOC were added and the cells were left at 37 °C for further 60 minutes before plating 
onto LB agar plates containing the appropriate antibiotic. Two plates for each reaction 
were used, one plated with 100 μl of the transformed bacterial cells and the other one with 
the rest. Plates were incubated overnight at 37 °C. 
 
2.2. Cell culture techniques 
2.2.1. Cell lines and culture conditions 
MEFs were generated from 13.5 dpc Eps15flp/flp/Eps15L1+/+/tgCreERT2 and 
Eps15flp/flp/Eps15L1-/-/tgCreERT2 mice, as described in section “2.8.3. Preparation of MEFs” of 
this chapter. MEFs were used for radioactive assays, Co-IP and IF analysis. They were 
grown in HEPES buffered GlutaMAX-DMEM (Gibco Invitrogen), supplemented with 10% 
FBS (fetal bovine serum) south american (HyClone).  
MEFs were immortalized upon continuing passaging in sub-confluent conditions. 
Immortalized MEFs were used as a model for the signal-sending cell. In detail, for the 
generation of immortalized MEFs expressing doxycycline-inducible Dll1-mCherry (MEF-
Dll1 cells), cells were firstly transduced with pLenti TetR Blast by lentiviral particles and 
selected for 15 days with 1 μg/ml blasticidin (Thermo Fisher Scientific). Cells were then 
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transfected with pcDNA5/TO-Delta-mCherry using Lipo2000 reagent (Invitrogen), 
according to the manufacturer's instructions, and selected with 75 μg/ml hygromycin 
(Thermo Fisher Scientific) for 5 days. Cells, stably expressing doxycycline-inducible Dll1-
mCherry, were sorted by FACS after induction of Dll1-mCherry expression by treatment 
with 50 ng/ml doxycycline for 24 hours. KD in MEF-Dll1 cells was performed by 
transfection of 10 nM Stealth RNAi siRNA oligos (Invitrogen) with Lipofectamine 
RNAiMAX transfection reagent (Invitrogen), according to the manufacturer's instructions. 
MEF-Dll1 cells were grown in HEPES buffered GlutaMAX-DMEM (Gibco Invitrogen), 
supplemented with 10% tetracycline-free FBS (HyClone). 
Deletion of Eps15 in primary and immortalized fibroblasts was obtained by treatment of 
the parental cell line (Eps15flp/flp/Eps15L1+/+/tgCreERT2 and Eps15flp/flp/Eps15L1-/-/tgCreERT2) with 
250 nM (Z)-4-hydroxytamoxifen (Sigma) for 10 days.  
CHO-hN1Gal4 cells were a gift from Elowitz MB (Sprinzak, Lakhanpal et al. 2010).  
CHO and CHO-hN1Gal4 cells were grown in GlutaMAX-MEMα (Gibco Invitrogen), 
supplemented with 10% tetracycline-free FBS (HyClone). CHO-hN1Gal4 cells were 
cultured in the presence of the following antibiotics: 10 μg/ml blasticidin (Thermo Fisher 
Scientific), 400 μg/ml zeocin (Thermo Fisher Scientific) and 600 μg/ml geneticin (Thermo 
Fisher Scientific). 
Immortalized endothelial cells were generated from lungs of Eps15flp/flp/Eps15L1-/- newborn 
mice by Polyoma middle T (PmT) infection, as described in section “2.8.4 Preparation of 
endothelial cells” of this chapter (Balconi, Spagnuolo et al. 2000). Cells were grown on 
culture dishes coated with 0.1% gelatin (Sigma), in the presence of HEPES buffered 
GlutaMAX-DMEM (Gibco Invitrogen), supplemented with 20% FBS north american 
(HyClone), 50 μg/ml ECGS (endothelial cell growth supplement) (Sigma) and 100 μg/ml 
heparin (Sigma). To obtain endothelial cells stably expressing myc-Eps15L1, cells were 
transduced with pBABE-mycEps15L1 by retroviral particles and selected for three days 
with 1 μg/ml puromycin (Thermo Fisher Scientific). Deletion of Eps15 was obtained by 
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treatment, for two consecutive days, with 100 µg/ml Tat-Cre recombinase for 1 hour at 37 
°C. 
All cell lines used in this thesis project were cultured under sterile conditions in a 
humidified incubator at 37 °C and 5% CO2. Culturing media were changed every 2/3 days. 
Cells were harvested at 80-90% confluency and plated at a ratio of 1:5/1:10 for CHO and 
CHO-hN1Gal4 cells, and 1:2/1:3 for all the other cell lines. Harvesting of the cells was 
performed as follows: cells were washed twice with sterile PBS 1X, without calcium and 
magnesium, and subsequently incubated with 0,05% trypsin/0,02% EDTA solution in PBS 
1X (EuroClone) at 37 °C for 5 minutes. After the detachment of the cells, trypsin was 
inhibited by addition of the appropriate medium supplemented with FBS. Cells were 
diluted to the desired concentration in growth medium and plated. 
For long-term storage, cells were frozen and stored in liquid nitrogen as follows: after 
trypsinization, 1 million of cells was suspended in 1 ml of freezing solution, composed of 
90% FBS (HyClone) and 10% DMSO (Sigma), and placed in cryovials (Nalgene). Vials 
were immediately placed at -80 °C in a cryobox and, after overnight storage, transferred to 
liquid nitrogen. 
 
2.2.2. Transfections 
RNAi transfection 
MEF-Dll1 cells were transfected with 10 nM Stealth RNAi siRNA oligos (Invitrogen) 
through Lipofectamine RNAiMAX transfection reagent (Invitrogen), according to the 
manufacturer's instructions. Lipofectamine RNAi Max is a cationic lipid, optimized for 
RNA molecules transfection. Cationic lipids establish electrostatic bonds with the negative 
charges of the nucleic acid and the negative charges of PM, thus facilitating the entry of 
the nucleic acid into the cell. 
To perform RNAi transfection, on day 1 cells were detached from the plate, counted and 
 76 
suspended in fresh medium at 0,5x105 cells/ml concentration. 2 ml of cell suspension (for a 
total of 1x105 cells) were transferred in a sterile 15 ml falcon. 500 μl of transfection mix 
were added dropwise to the cell suspension and the content of the falcon was then plated in 
1 well of a 6-well plate. 
Transfection mix was prepared as follows: 
• Mix 1: 5 μl of Lipofectamine RNAi MAX (Invitrogen) in 250 μl of Opti-MEM 
fresh medium (Gibco). 
• Mix 2: Oligos at the desired final concentration in 250 μl of Opti-MEM fresh 
medium (Gibco). 
• Transfection mix: mix 1 was added to mix 2 and incubated 20 minutes at room 
temperature before use. 
RNA interfered cells were transferred in a humidified incubator at 37 °C and 5% CO2 for 
24 hours. On day 2 the culture medium was changed and transfection was repeated, as 
described before, on adherent cells. On day 3 cells were used for the co-culture assay 
experiment, until day 5. KD efficiency was evaluated by WB at the fifth day. 
 
DNA transfection 
Immortalized MEFs were transduced with pcDNA5/TO-Delta-mCherry using Lipo2000 
reagent (Invitrogen), according to the manufacturer's instructions. In detail, cells were 
plated in 10 cm plates so that they were 90% confluent on the day of transfection. The day 
after, the culture medium was replaced by 7.5 ml of complete medium plus 2.5 ml of 
transfection mix. 
Transfection mix was prepared as follows: 
• Mix 1: 10 μg DNA in 1250 μl of Opti-MEM fresh medium (Gibco). 
• Mix 2: 30 μl Lipo2000 reagent in 1250 μl of Opti-MEM fresh medium (Gibco). 
• Transfection mix: mix 1 was added to mix 2 and incubated 20 minutes at room 
temperature before use. 
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Transduced cells were transferred overnight in a humidified incubator at 37 °C and 5% 
CO2. On day 2 the culture medium was changed. 24 hours after transfection, cells were 
selected with 75 μg/ml hygromycin (Thermo Fisher Scientific) for 5 days and continuously 
cultured in the presence of the antibiotic. 
 
2.2.3. Infection 
Retroviral infection 
Endothelial cells were transduced with murine Eps15L1 by retroviral infection. 
Retroviruses were produced by overnight transfection of the Phoenix helper cell line with 
10 μg of pBABE-mycEps15L1 DNA. In detail, Phoenix cells were plated in 10 cm plates 
so that they were 70-80% confluent on the day of transfection. The day of transfection, the 
medium was replaced by 9 ml of complete medium, 20 μM cloroquine and 1 ml of 
transfection mix. 
Transfection mix was prepared as follows: 
• Mix 1: 500 μl of HBSS (Hanks’ balanced salt solution) 2X. 
• Mix 2: 10 μg pBABE-mycEps15L1, 61 μl CaCl2 2M, ddH2O up to 500 μl. 
• Transfection mix: mix 2 was added to bubbling mix 1 and incubated 5 minutes at 
room temperature before use. 
On day 2, endothelial cells were plated on 6-well plates. 48 hours after transfection of the 
Phoenix helper cell line, supernatant was collected and passed through a 0.45 μm filter. 
After the addition of 8 μg/ml polybrene (Sigma), the supernatant was added to endothelial 
cells. Cells were then centrifuged for 45 minutes at 18,000 rpm. After infection, the viral 
supernatant was replaced with the standard medium (see section “2.2.1. Cell lines and 
culture conditions”). 48 hours after infection, infected cells were selected with 1 μg/ml 
puromycin (Thermo Fisher Scientific) and continuously cultured in the presence of the 
antibiotic. 
 78 
 
Lentiviral infection 
Immortalized MEFs were transduced with pLenti TetR Blast by lentiviral particles. 
Lentiviruses were produced by overnight transfection of the 293T helper cell line with 10 
μg of pLenti TetR Blast DNA. In detail, on day 1, 293T cells were plated in 10 cm plates 
at 5x106 cells/plate. In the evening, the medium was replaced by 9 ml of complete medium 
and 1 ml of transfection mix. 
Transfection mix was prepared as follows: 
• Mix 1: 500 μl of HBSS 2X. 
• Mix 2: 10 μg pLenti TetR Blast DNA, 2.8 μg ENV, 5 μg pMDL, 2.5 μg REV, 62.4 
μl CaCl2 2M, sterile TE 0.1X up to 500 μl. 
• Transfection mix: mix 2 was added to bubbling mix 1 and incubated 5 minutes at 
room temperature before use. 
On day 2, target cells were plated on 6-well plates. On day 3, supernatant from 293T cells 
was collected and passed through a 0.45 μm filter. After the addition of 8 μg/ml polybrene 
(Sigma), the supernatant was added to MEFs. Cells were then centrifuged for 45 minutes at 
18,000 rpm. After infection, the viral supernatant was replaced with the standard medium 
(see paragraph “2.2.1. Cell lines and culture conditions”). 48 hours after infection, infected 
cells were selected with 10 μg/ml blasticidin (Thermo Fisher Scientific) for 15 days and 
continuously cultured in the presence of the antibiotic. 
 
2.3. Protein procedures 
2.3.1. Cell lysis 
Cell culture plates were put on ice, washed with PBS 1X and then lysed in JS or RIPA 
buffer with a cell-scraper. Lysates were clarified by centrifugation at 13,000 rpm for 20 
minutes at 4 ºC, using a 5415 R centrifuge. Protein concentration was measured by BCA 
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Protein assay (Thermo Fisher Scientific), according to manufacturer’s instructions, using 
BSA (bovine serum albumin) as standard. 
 
2.3.2. WB (Western blot) 
Proteins were dissolved in Laemli buffer 1X, boiled at 95 °C for 5 minutes and spun. 
Desired amounts of proteins were loaded onto 4-20% Criterion TGX Stain-Free precast 
gels (Biorad) for electrophoresis, together with a WesternC Western Blotting Protein 
Standard (Biorad) for MW (molecular weight) determination. Gels were run at 200 Volts 
in running buffer 1X within a Criterion electrophoresis cell (Biorad). After electrophoresis, 
proteins were transferred to a nitrocellulose membrane by a Trans-Blot Turbo blotting 
apparatus (Biorad). Ponceau staining was used to determine the efficiency of protein 
transfer onto the filters. Filters were blocked for 1 hour in 5% BSA-TBST 1X, where 
TBST 1X is TBS 1X supplemented with 0.1% Triton X-100. After blocking, filters were 
incubated overnight at 4 °C with the primary antibody diluted in 5% BSA-TBST 1X and 
then washed in TBST 1X (three washes of 5 minutes each). Filters were then incubated 
with the appropriate HRP (horseradish peroxidase)-conjugated secondary antibody diluted 
in TBST 1X for 1 hour at room temperature. After incubation with the secondary antibody, 
filters were washed in TBST 1X (three washes of 5 minutes each). The bound secondary 
antibody was revealed under a ChemiDoc Imaging System, after incubation with 
SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Fisher Scientific), an 
ultra-sensitive ECL (enhanced chemiluminescent) substrate. Quantification of blots was 
performed with ImageJ Software. All statistical analyses were performed using Excel. The 
statistical significance was obtained applying t-test. 
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2.3.3. IP (Immunoprecipitation)  
WT, Eps15-KO, Eps15L1-KO and Eps15/Eps15L1-DKO MEFs were generated from 
Eps15flp/flp/Eps15L1+/+/tgCreERT2 and Eps15flp/flp/Eps15L1-/-/tgCreERT2 cells. In detail, 
Eps15flp/flp/Eps15L1+/+/tgCreERT2 were used as WT, while Eps15flp/flp/Eps15L1-/-/tgCreERT2 were 
used as Eps15L1-KO. By (Z)-4-hydroxytamoxifen treatment, Eps15-KO and 
Eps15/Eps15L1-DKO cells were generated from WT and Eps15L1-KO cells, respectively. 
Cells of each genotype were lysed in JS buffer for 10 min at 4 ºC. Lysates were centrifuged 
for 30 minutes at 4 ºC at 13,000 rpm and then ultra-centrifuged for 1 hour at 4 ºC at 45,000 
rpm. After protein determination with BCA protein assay, one part of the lysates was 
collected as input, while another part was used for IP. In detail, same amounts of proteins 
from each genotype were incubated overnight at 4 ºC, under rotation, with mouse anti-
alpha Adaptin antibody [AP6] (0.5 ug antibody/100 ug proteins) or home made rabbit anti-
Itsn1 antibody (1.2 ug antibody/100 ug proteins). The following day lysates were 
incubated with Dynabeads Protein G (Invitrogen) (300 ug beads/100 ug proteins), 
previously washed with JS buffer, for 1 hour at 4 ºC, under rotation. The beads, bound to 
mouse anti-alpha Adaptin antibody [AP6] or home made rabbit anti-Itsn1 antibody, were 
then separated from supernatant with the magnetic particle concentrator DynaMag-2 
(Invitrogen) and washed with JS buffer. The supernatants, containing unbound proteins, 
were collected as post-immunoprecipitated. Proteins bound to beads were eluted in 
Laemmli Buffer 2.5X, boiled at 95 ºC, separated from the beads with the magnetic particle 
concentrator and then processed for WB analysis, together with input and post-
immunoprecipitated.  
 
2.4. Analysis of the Notch signalling pathway  
2.4.1. Measurement of Dll1 levels in MEF-Dll1 cells by FACS analysis 
Flow cytometry assay is a technique for counting, examining and sorting cells suspended 
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in a stream of fluid. It allows simultaneous multi-parametric analysis of the physical and/or 
chemical characteristics of single cells flowing through a fluidic, optical and electronic 
detection apparatus. A beam of laser light of a determined single wavelength is directed 
onto a hydro-dynamically focused stream of fluid. Each suspended cell passes through a 
small nozzle, one cell at a time, and scatters the light in a certain way. Moreover 
fluorescent chemicals found in the cell or attached to the cell membrane can be excited into 
emitting light at a higher wavelength than the light source. The detectors pick up this 
combination of scattered and fluorescent light and, by analyzing fluctuations in brightness 
at each detector (one for each fluorescent emission peak), it is then possible to derive 
information about the physical and chemical structure of each individual cell. FSC 
(forward scatter) correlates with the cell size and SSC (side scatter) depends on the inner 
density and granularity of the cell (e.g. shape of the nucleus, the amount and type of 
cytoplasmic granules or the membrane roughness). 
WT, Eps15L1-KO, Eps15-KO and Eps15/Eps15L1-DKO MEF-Dll1 cells were used. 
Eps15-KO and Eps15/Eps15L1-DKO MEF-Dll1 cells were generated from WT 
(Eps15flp/flp/Eps15L1+/+/tgCreERT2) and Eps15L1-KO (Eps15flp/flp/Eps15L1-/-/tgCreERT2) cells, 
respectively, by treatment with 250 nM (Z)-4-hydroxytamoxifenefore for 10 days. WT 
MEF-Dll1 cells were treated with different amounts of doxycycline (50, 100, 150 ng/ml) 
for 24, 48 and 72 hours, in order to determine the optimal mode for Dll1-mCherry 
induction. Since Dll1-mCherry induction was similar in all conditions, for further 
experiments, MEF-Dll1 cells of each genotype were treated with 50 nM doxycycline for 
48 hours. To measure surface levels of Dll1-mCherry, cells were washed with PBS 1X 
without calcium and magnesium, trypsinized for 3 minutes with 0.05% trypsin/0.02% 
EDTA, suspended in complete medium and counted. For each staining, 1x105 cells were 
blocked for 1 hour in 10% BSA-PBS 1X on ice. Cells were then stained overnight at 4 °C 
with 1 µg/ml anti-Dll1 HMD1-3 Alexa Fluor 647 (Biolegend) in 100 µl of 5% BSA-PBS 
1X. After staining, cells were washed in cold PBS 1X, suspended in 2% BSA-PBS 1X and 
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immediately analyzed using flow cytometer. Data generated by flow-cytometer were 
analyzed by FlowJo (version 10.1) and plotted in two dimensional dot plots. In detail, cells 
were first gated based on the size (FSC) and on density and granularity of the cells (SSC). 
Next, cells were gated into four subpopulations: cells not expressing Dll1-mCherry (double 
negative cells for mCherry and Alexa Fluor 647 and single negative cells for mCherry), 
cells expressing Dll1-mCherry but not exposing the ligand on the PM (single positive cells 
for mCherry) and cells expressing Dll1-mCherry that was exposed on the PM (double 
positive cells for mCherry and Alexa Fluor 647). These gates were defined by fluorescence 
analysis of mCherry and Alexa Fluor 647, after surface-staining, of the parental MEF cell 
line not expressing doxycycline-inducible Dll1-mCherry: being this cell line double 
negative for both mCherry and Alexa Fluor 647, it was used to determine background 
fluorescence intensities for mCherry and Alexa Fluor 647.  
 
2.4.2. Co-culture assay among MEF-Dll1 and CHO-hN1Gal4 cells 
MEF-Dll1 cells were co-cultured with CHO-hN1Gal4 cells in a 24-well plate. For each 
well, 6x104 MEF-Dll1 and 4x104 CHO-hN1Gal4 cells were mixed and plated. Control 
experiments were performed with WT MEF-Dll1 cells previously transfected with a 
siRNA oligo against Mib1 or a scrambled siRNA oligo, as above described (the sequence 
of siRNA oligos and technical procedures are reported in sections “1.4. RNAi oligos” and 
“2.2.2. Transfections” of this chapter, respectively). To investigate the role of Eps15 and 
Eps15L1 in Notch signalling activation, WT, Eps15L1-KO, Eps15-KO and 
Eps15/Eps15L1-DKO MEF-Dll1 cells were used. Co-culture was performed for 48 hours 
in presence or absence of 50 ng/ml doxycycline. In control experiments, co-culture was 
also performed in presence of 1 μM of the Notch signalling inhibitor DAPT (Sigma) or 
0.01% DMSO vehicle (Sigma). Drugs were administered for the total co-culture time. 48 
hours after co-culture, cells were trypsinized and collected for cytofluorimetric analysis. In 
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detail, cells where washed 3 times in PBS 1X (containing calcium and magnesium) and 
trypsinized with 0.25% trypsin without EDTA for 10 minutes. After centrifugation at 2,500 
rpm for 5 minutes at 4 °C, cells were suspended in 200 μl of PBS 1X containing 2% 
tetracycline-free serum and transferred into FACS tubes for detection of mCherry and YFP 
fluorescence. Data generated by flow-cytometer were analyzed by FlowJo and plotted in 
two dimensional dot plots. In detail, mixed MEF-Dll1 and CHO-hN1Gal4 cells were firstly 
gated based on the size (FSC) and on density and granularity of the cells (SSC). To 
determine Notch induction through YFP fluorescence, negative and positive cells for YFP 
(YFP- and YFP+, respectively), among CHO-HN1Gal4 cells, were gated based on the 
FACS analysis of the parental CHO cell line, which was used to define background 
fluorescence intensity of YFP. Among YFP positive cells (YFP+), cells expressing high 
levels of YFP (YFP++) were defined based on the shift of the cellular cloud. To determine 
Dll1 induction in MEF-Dll1 cells, negative and positive cells for mCherry were gated 
based on the FACS analysis of the parental MEF cell line, which was used to define 
background fluorescence intensity of mCherry.  
 
2.5. Analysis of Notch and VEGFR-2 signalling pathways in endothelial 
cells  
For the analysis of the Notch signalling pathway, confluent endothelial cells were treated 
with 10 μM of the Notch signalling inhibitor DAPT (Sigma) or 0.1% DMSO vehicle 
(Sigma) for 24 hours, followed by a second drug dose for other 8 hours. Cells where then 
lysed in JS buffer for WB analysis of NICD levels. 
For the analysis of the VEGFR-2 signalling pathway, endothelial cells were plated in sub-
confluent conditions in 6-well plates. Cells were then starved overnight in MCDB 131 
medium (Gibco Invitrogen) containing L-glutamine and 1% BSA. The day after, cells were 
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stimulated with 80 ng/ml VEGF (PeproTech) for 0, 5, 15 and 30 minutes and then lysed in 
JS buffer for analysis of VEGFR-2 signalling pathway by WB. 
 
2.6. Radioactive assays with 125I-EGF and 125I-Tf 
2.6.1. Radioactive internalization assays with 125I-EGF and 125I-Tf 
Radioactive internalization assays with 125I-EGF or 125I-differic Tf (Perkin Elmer) were 
performed in WT, Eps15L1-KO, Eps15-KO and Eps15/Eps15L1-DKO MEFs. Eps15-KO 
and Eps15/Eps15L1-DKO cells were derived by (Z)-4-hydroxytamoxifen treatment of 
Eps15flp/flp/Eps15L1+/+/tgCreERT2 (WT) and Eps15flp/flp/Eps15L1-/-/tgCreERT2 (Eps15L1-KO) cells, 
respectively. The day before experiment, cells were plated in a 24-well plate in order to 
have 90% of confluency the day after (9x104 cells/well). Cells were plated in the presence 
of HEPES buffered GlutaMAX-DMEM, supplemented with 10% FBS. The following day 
cells were serum starved in HEPES buffered GlutaMAX-DMEM supplemented with 0.1% 
BSA for 2 hours. For the analysis of internalization kinetics of the TfR, cells were 
incubated at 37 °C with 1 ug/ml 125I-differic Tf for 2, 4 or 6 minutes. Unspecific was 
determined by incubation of cells with excess of cold ligand (500 X). For the analysis of 
internalization kinetics of the EGFR, cells were incubated at 37 °C with high doses and 
low doses of EGF ligand for 2, 4 or 6 minutes, in order to follow CDE and CIE of EGFR, 
respectively. For stimulation at high doses, 3 ng/ml of 125I-EGF were combined to 27 ng/ml 
of cold ligand, for a total of 30 ng/ml of EGF. For stimulation at low doses, 1.5 ng/ml of 
125I-EGF were used. Unspecific was determined by incubation of cells with excess of cold 
ligand (300 X). After internalization, cells were put on ice, washed with cold PBS 1X and 
incubated for 5 minutes with an acid wash solution, pH=2.5 (0.2M acetic acid, 0.5M NaCl), 
to remove the quote of ligand bound on the membrane receptors. The acid wash solution 
was removed from the cells for radioactivity measurements. This sample represented the 
amount of 125I-EGF or 125I-differic Tf bound to the receptors on the cell surface (Bound). 
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Cells were then dried at room temperature and lysed with 300 μl of a solution containing 
1N NaOH. The lysates, representing the amount of internalized 125I-EGF or 125I-differic Tf, 
were collected for radioactivity measurements. After being corrected for non-specific 
binding, the ratio between Internalized and Bound was determined for each time point. 
These data were used to obtain the internalization curves, representing the time in minutes 
and Internalized/Bound ratios on the x- and y-axis, respectively. The Ke  (endocytic rate 
constant) were extrapolated from the internalization curves and correspond to the slopes of 
the best-fitting curves.  
 
2.6.2. Measurement of the number of EGFR and TfR at the cell surface by saturation 
binding with 125I-EGF and 125I-Tf 
For the count of PM receptors/cell, after serum starvation, cells were cooled on ice and 
incubated at 4 °C for 5 hours in the presence of 50 ng/ml EGF (HOT/COLD=1/9) or 2 
μg/ml Tf (HOT/COLD=1/3). Unspecific binding of EGF or Tf to cell surface was 
determined by incubation of cells with excess of cold ligand (300 X and 500 X, 
respectively). After incubation at 4 °C, cells were put on ice, washed with cold PBS 1X, 
dried at room temperature and lysed with 300 μl of a solution containing 1N NaOH. The 
lysates were collected for radioactivity measurements. This sample represented the amount 
of 125I-EGF and 125I-Tf bound at equilibrium, which is dependent on the number of EGFR 
or TfR on the cell surface. After correction for non-specific binding, the assay provided the 
quantitative measurement of the number of EGFR or TfR for each well and, by counting 
the number of cells plated in each well, the number of surface EGFR or TfR for each cell. 
 
2.7. IF (immunofluorescence) 
WT, Eps15L1-KO, Eps15-KO and Eps15/Eps15L1-DKO MEFs were used for IF analysis. 
Eps15-KO and Eps15/Eps15L1-DKO cells were generated by (Z)-4-hydroxytamoxifen 
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treatment of Eps15flp/flp/Eps15L1+/+/tgCreERT2 (WT) and Eps15flp/flp/Eps15L1-/-/tgCreERT2 
(Eps15L1-KO) cells, respectively. All cells were plated on glass coverslips at a density of 
1x104 cells/cm2. The following day cells were put on ice, fixed in cold 4% 
paraformaldehyde for 10 minutes and then washed with PBS 1X. After fixation, cells were 
incubated in blocking solution (TBS 1X, enriched with 0.05% Triton-X100 and 5% BSA) 
for 1 hour at room temperature in the dark. Cells were then stained overnight at 4 ºC in the 
dark with the following primary antibodies diluted in blocking solution supplemented with 
3% normal donkey serum: mouse anti-Adaptin alpha antibody, together with rabbit anti-
Eps15, anti-Eps15L1 or anti-Itsn1 antibody. The next day, cells were washed with TBS 
1X-0.05% Triton-X100 and then incubated with the following secondary antibodies in 
TBS 1X: donkey anti-mouse antibody conjugated with Alexa Fluor 488 and donkey anti-
rabbit antibody conjugated with Alexa Fluor 647. Cells were then washed with TBS 1X-
0.05% Triton-X100 and stained with DAPI for 5 minutes in the dark at room temperature. 
After being washed with ddH2O, coverslips were mounted with mowiol on glass slides and 
then analysed with a SP5 inverted confocal.  
For the detection of endothelial markers, endothelial cells were plated on 8 well μ-slides 
(Ibidi) coated with 0.1% gelatin (Sigma). Cells were stained, as before described, with the 
following primary antibodies: anti-PECAM-1 and anti-VE-cadherin. The following 
secondary antibodies were used: donkey anti-mouse or donkey anti-rabbit antibody 
conjugated with Alexa Fluor 647. Stained cells were examined under a wide-field 
fluorescence microscope (Olympus) with the help of the associated software MetaMorph 
(Molecula Devices).  
Confocal and wide-field images were further processed with the ImageJ software. 
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2.8. In vivo methods 
2.8.1. Maintenance and generation of the mouse strains 
Generation and description of breedings necessary for this study are listed in Table 4.  
Mice were kept at the following stabulation conditions: 
• temperature: 22±2 °C; 
• humidity: 55±10 %; 
• light/dark cycle of 12 hours (light from 7 a.m. to 19 p.m.); 
• standardized diet with pellets (Harland tekland) and ad libitum H2O. 
Experiments involving animals were performed in accordance with the Italian Laws 
(D.L.vo 116/92 and following additions), which enforce EU 86/609 Directive (Council 
Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and 
administrative provisions of the Member States regarding the protection of animals used 
for experimental and other scientific purposes). 
 
2.8.2. DNA extraction for genotyping 
Genomic DNA was isolated from head regions or tail biopsies of mouse embryos or 
newborn mice, respectively, as follows: head regions or 2-3 mm tail biopsies were digested 
overnight at 56 °C (optimal temperature for PK activity), in 100 μL of tail buffer. 
Following short agitation, the mixtures were centrifuged for 5 seconds at 13,000 rpm. To 
inactivate the PK, digested tissues were left 5 minutes at 95 °C and then centrifuged for 5 
seconds at 13,000 rpm, after short shaking. Digested tissues were stored at 4 °C until 
genotyping. The components of the tail buffer serve the following functions: NH4SO4 to 
precipitate proteins; tris pH 8.8 as solution buffer; β-mercaptoethanol to inactivate cellular 
enzymes; EDTA pH 8.0 to inactivate proteinases and DNAses depending on divalent ions; 
Triton X-100 to solubilize; PK for digestion. 
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2.8.3. Preparation of MEFs  
Pregnant mice were sacrificed at 13.5 dpc by CO2 asphyxia. Embryos were separated from 
the placenta and the yolk sac and sacrificed by decapitation. The head was used for 
genotyping. For the isolation of MEFs, the belly was cut and internal organs were removed. 
Embryos were dissociated with a blade, transferred in 1 ml of 0.05% trypsin/0.02% EDTA 
and incubated for 10 minutes at 37 °C, under agitation. Embryos were incubated for 
additional 10 minutes after addition of 100 μg/ml DNase I (Roche). Digested tissues were 
passed three times through a 1 ml syringe with a 18 gauge needle. After addition of 
complete medium, cells were passed through a 70 μm cell strainer and plated in 10 cm 
petri dishes. Cells were grown at 37 °C in 9% CO2.  
MEFs were immortalized upon continued passaging at 37 °C, in 5% CO2, under sub-
confluent conditions: most of them underwent senescence by passage 17, while immortal 
clones, which overcome senescence, were propagated and expanded in culture.  
 
2.8.4. Preparation of endothelial cells 
Endothelial cells were prepared from lungs of Eps15flp/flp/Eps15L1-/- newborn mice. 
Newborn mice were sacrificed by decapitation. Tail biopsies were cut for genotyping. 
Lungs were extracted, dissociated with a blade and transferred in 1 ml of DMEM 
containing 1.5 mg/mL collagenase A and 25 µg/mL DNase (Boehringer-Mannheim 
GmbH). Lungs were then incubated in this solution for 30 minutes at 37 °C, under 
agitation. The resulting cell suspension was passed through a 70 µm cell strainer and 
centrifuged for 5 minutes at 16,000 rpm. Cells were then plated in complete medium in a 
24-well plate coated with 0.1% gelatin and incubated at 37 °C. 48 hours later, the cells 
were immortalized with PmT. In detail, cells were incubated with 1 mL of complete 
medium containing ~105 neomycin-resistant colony-forming units of the retrovirus vector 
N-TKmT, in the presence of 8 µg/mL polybrene (Sigma). The virus-containing medium 
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was replaced 4 hours later with fresh complete medium. Fresh medium was replenished 
three times per week. Colonies of endothelial cells, usually observed after 20 to 30 days, 
were detached, pooled and reseeded in wider wells. PmT specifically immortalizes 
endothelial cells and not any other cell type (Garlanda, Parravicini et al. 1994), which are 
lost within 2 or 3 passages.  
 
2.8.5. Whole mount staining with PECAM-1 primary antibody  
Eps15flp/flp/Eps15L1+/-/tgTie2Cre adult male mice and Eps15flp/flp/Eps15L1+/- adult female mice 
were crossed to generate Eps15flp/flp/Eps15L1+/+ (WT), Eps15flp/flp/Eps15L1+/+/tgTie2Cre 
(conditional Eps15-KO, referred to as cEps15-KO), Eps15flp/flp/Eps15L1-/- (constitutive 
Eps15L1-KO) and Eps15flp/flp/Eps15L1-/-/tgTie2Cre (conditional DKO, referred to as cDKO) 
embryos. Embryos were collected at 9.5 dpc and fixed overnight at 4 °C in 100% MetOH 
(methanol). After fixation, whole mount staining with PECAM-1 was performed as 
follows: embryos were rehydrated through series of diluted MetOH in PBS 1X (75% 
MetOH, 50% MetOH, 25% MetOH) for 15 minutes each. Embryos where then blocked 
overnight at 4 °C in PBS 1X containing 5% donkey serum, 1% BSA and 0.5% Triton-
X100. After blocking, embryos were washed with PBS 1X and incubated overnight at 4 °C 
in a rocking platform with PECAM-1 primary antibody, diluted 1:3 in PBS 1X containing 
0.5% BSA and 0.25% Triton-X100. Embryos were washed three times (each wash of 15 
minutes) at room temperature in PBS 1X containing 0.01% Triton-X100. Embryos were 
then incubated for 2 hours at room temperature with anti-rat Alexa 488, diluted 1:500, and 
TO-PRO-3 (Thermo Fisher Scientific), diluted 1:1000, in PBS 1X containing 0.5% BSA 
and 0.25% Triton-X100. Embryos were then washed three times (each wash of 15 minutes) 
in PBS 1X containing 0.01% Triton-X100. Embryos were post-fixed in 4% 
paraformaldehyde for 15 minutes on ice and then washed with PBS 1X. Post-fixed 
embryos were mounted with ProLong Gold and analyzed by confocal microscope.  
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2.8.6. Blood collection and May-Grünwald Giemsa staining of blood smears from 
newborn mice 
Eps15flp/flp/Eps15L1+/-/tgTie2Cre adult male mice and Eps15flp/flp/Eps15L1+/- adult female mice 
were crossed to generate Eps15flp/flp/Eps15L1+/+ (WT), Eps15flp/flp/Eps15L1+/+/tgTie2Cre 
(cEps15-KO), Eps15flp/flp/Eps15L1-/- (constitutive Eps15L1-KO) and Eps15flp/flp/Eps15L1-/-
/tgTie2Cre (cDKO) newborn mice. At birth, these mice were sacrificed by decapitation for 
blood collection. Collected blood (50 μl from each newborn) was diluted 1:5 with an 
EDTA solution containing 18,6% EDTA and 2% NaOH (EDTA final concentration was 
100 mM). One part of the blood was analyzed in a hemocytometer (Beckman Coulter), 
while another part was smeared on glass slides and stained for May-Grünwald Giemsa 
(Sigma). May-Grünwald-Giemsa staining is the stain usually employed for blood and bone 
marrow films. It consists of a mixture of methylene blue (which dyes acidic cell 
components blue), azure (which dyes basic cell components red and violet) and eosin 
(which dyes alkaline cell components orange-red). The cellular components are stained as 
follows: residual RNA, cytoplasm and nucleoli are blue; DNA and primary granula are red 
and violet; hemoglobin and eosinophilic granula are orange-red. Among RBCs, 
reticulocytes are identified due to the presence in their cytoplasm of dark blue dots and 
curved linear structures, stained by methylene blue and corresponding to the reticular 
network of ribosomal RNA present in these cells. May-Grünwald Giemsa staining was 
performed according to the manufacturer's instructions, as follows: blood smears were 
incubated for 5 minutes in May-Grünwald solution (Sigma), washed for 1,5 minutes in 
PBS 1X, incubated for 20 minutes in 0.4% p/v Giemsa solution (Sigma) diluted 1:20 in 
ddH2O, and briefly washed with ddH2O. After staining, blood smears were air-dried and 
examined under a stereomicroscope (Leica).   
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Antibody Species Company WB IF CF IP 
anti-Adaptin alpha  mouse BD Bioscience (610501) 1:1000 1:500   
anti-AKT  rabbit 
Cell Signalling 
Technology 
(9272) 
1:1000    
anti-alpha adaptin 
[AP6] mouse 
Abcam 
(ab2730)    0.5 
anti-Cleaved Notch1 
(Val1744)  rabbit 
Cell Signalling 
Technology 
(2421) 
1:1000    
anti-Dll1 HMD1-3  
conjugated to Alexa 
Fluor 647 
armenian 
hamster  
Biolegend 
(128311)   1:250  
anti-Eps15 rabbit home made (130820A)  1:500   
anti-Eps15 (H896) rabbit Santa Cruz (sc-1840) 1:1000    
anti-Eps15L1 rabbit home made (130821A) 1:1000 1:500   
anti-Itsn1 rabbit home made (130131) 1:1000 1:500  1.2 
anti-Mib1 rabbit Sigma (M5948)  1:1000    
anti-mouse  
conjugated to Alexa 
Fluor 488 
donkey 
Jackson Immuno 
Research 
(715-545-150) 
 1:400   
anti-mouse  
conjugated to Alexa 
Fluor 647 
donkey 
Jackson Immuno 
Research 
(715-605-151) 
 1:400   
anti-mouse IgG  
linked to HRP horse 
Cell Signalling 
Technology 
(7076) 
1:10000    
anti-PECAM-1  rat home made (Mec 13.3)  1:3   
anti-phospho-AKT 
(Ser473)  rabbit 
Cell Signalling 
Technology 
(9271) 
1:1000    
anti-phospho-p44/42 
MAPK  
(Erk1/2) (Thr202/Tyr204)  
(D13.14.4E) XP 
rabbit 
Cell Signalling 
Technology 
(4370) 
1:1000    
anti-phospho-VEGF 
Receptor2 (Tyr1175) 
(19A10) 
rabbit 
Cell Signalling 
Technology 
(2478) 
1:1000    
anti-p44/42 MAPK 
(Erk1/2) (137F5)  rabbit 
Cell Signalling 
Technology 
(4695) 
1:1000    
anti-rabbit 
conjugated to Alexa 
Fluor 647 
donkey 
Jackson Immuno 
Research 
(711-605-152) 
 1:400   
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anti-rabbit IgG  
linked to HRP goat 
Cell Signalling 
Technology 
(7074) 
1:10000    
anti-α-Tubulin mouse Sigma (T9096) 1:5000    
Anti-VE-cadherin rabbit Abcam (ab33168)  1:400   
anti-VEGF Receptor2 
(D5B1)  rabbit 
Cell Signalling 
Technology 
(9698) 
1:1000    
anti-Vinculin 
 mouse 
Sigma 
(V9131) 1:5000    
 
Table 3. List of antibodies. 
The table reports the antibodies that were used in this thesis project. Numbers in WB (western blot), 
IF (immunofluorescence) and CF (cytofluorimetry) columns refer to antibody dilution (v/v). 
Numbers in IP (immunoprecipitation) column refer to μg of antibody used to immunoprecipitate 
100 μg of total proteins. 
  
 93 
 
Table 4. List of murine strains. 
The table reports the murine strains that were used for this thesis project. 
  
Mouse strain Description of the strain Reference or Company 
General  
Deleter  
Cre 
Expression of Cre recombinase in the 
germline. 
(Schwenk, Baron et 
al. 1995) 
General  
Flp 
Recombinase 
Expression of Cre recombinase in the 
germline. 
(Rodriguez, Buchholz 
et al. 2000) 
 
Rosa26CreERT2 
 
Knock-in of the (Z)-4-hydroxytamoxifen-
inducible Cre recombinase in the Rosa26 
locus. 
(Ventura, Kirsch et al. 
2007) 
Tie2-Cre Expression of Cre recombinase in endothelial and hematopoietic cells. 
(Kisanuki, Hammer et 
al. 2001) 
Eps15-KO 
KO of Eps15 was obtained by replacing the 
first coding exon and 2 kb of the 5’ promoter 
region with a neomycin cassette. 
(Pozzi, Amodio et al. 
2012) 
Eps15L1-KO 
KO of Eps15L1 was obtained by inserting a 
PGK-neo cassette next to the first coding 
exon. Both were then removed by crossing 
with general deleter Cre mice. The Cre 
transgene was removed by subsequent 
breedings. 
Unpublished 
(Ozgene) 
Eps15tm1a(KOMP)Wtsi  
(=Eps15flp/flp) 
The PGK-neo cassette was removed by 
breeding to General Flp recombinase mice. 
The Flp transgene was removed by 
subsequent breedings. LoxP sites flank the 
10th exon of Eps15.  
Unpublished 
(Sanger Institute) 
 94 
Chapter 3 
RESULTS 
 
 
1. Eps15L1 regulates Dll1 biology in MEFs 
 
1.1. The FACS-based co-culture assay 
Since Eps15/Eps15L1-DKO mice phenocopy Notch loss-of-function mutants and the 
Notch target genes HES1, HES5 and NRARP are downregulated in these mice, we 
hypothesized that Eps15 and Eps15L1 redundantly regulate the Notch signalling pathway. 
Previous work in our laboratory exploited a luciferase-based co-culture assay to directly 
test whether Eps15 and Eps15L1 regulate the Notch signalling pathway either in the 
signal-sending cell or in the signal-receiving cell. Through this assay, in which OP9-Dll1 
and C2C12-Notch1 were used as signal-sending and signal-receiving cells, respectively, it 
was found that, in contrast to what we expected, Eps15 and Eps15L1 are required in a non-
redundant manner in the signal-sending cell to allow activation of the Notch signalling 
(Lucano et al., unpublished results). These findings were derived by siRNA interference of 
Eps15 and Eps15L1, alone or in combination, in OP9-Dll1 or C2C12-Notch1 cells.  
To confirm this finding in a cleaner and physiological setting, we decided to use, as signal-
sending cells, MEFs generated from KO mice for Eps15 and Eps15L1 and expressing 
inducible Dll1-mCherry as Notch ligand (MEF-Dll1 cells). Moreover, to increase the 
reproducibility of the read-out of the co-culture assay, we set-up a new co-culture cell 
model system, based on a FACS-assay, to measure Notch activity (Figure 14A).  
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As a model system for the signal-sending cell, we generated two different cell lines of 
MEF-Dll1: Eps15flp/flp/Eps15L1+/+/tgCreERT2 and Eps15flp/flp/Eps15L1-/-/tgCreERT2. In absence 
of (Z)-4-hydroxytamoxifen treatment, these cell lines were used as WT and Eps15L1-KO, 
respectively. When treated with (Z)-4-hydroxytamoxifen, deletion of Eps15 in WT cells 
lead to the generation Eps15-KO cells, while deletion of Eps15 in Eps15L1-KO cells lead 
to the generation of Eps15/Eps15L1-DKO cells (Table 5). 
 
Cell line - TMX + TMX 
 
Eps15flp/flp/Eps15L1+/+/tgCreERT2 
 
WT Eps15-KO 
 
Eps15flp/flp/Eps15L1-/-/tgCreERT2 
 
Eps15L1-KO DKO 
 
Table 5. Generation of WT, single and double Eps15 and Eps15L1 KO MEF-Dll1 cells.  
Eps15flp/flp/Eps15L1+/+/tgCreERT2 and Eps15flp/flp/Eps15L1-/-/tgCreERT2 untreated with (Z)-4-
hydroxytamoxifen (-TMX) were used as WT and Eps15L1-KO cells, respectively. Eps15-KO and 
DKO cells were generated by (Z)-4-hydroxytamoxifen treatment (+TMX) of WT and Eps15L1-KO 
cells, respectively,  
 
In all these cells, the expression of Dll1-mCherry was induced by doxycycline treatment, 
according to the T-Rex system (Figure 14B).  
As a model system for the signal-receiving cell, we used CHO cells expressing hN1Gal4 
(CHO-hN1Gal4 cells), generated in Michael B. Elowitz’s laboratory (Sprinzak, Lakhanpal 
et al. 2010). hN1Gal4 is a fusion protein between the extracellular portion of the human 
Notch1 receptor (NECD) and the transcription factor Gal4, which substitutes the NICD. 
When CHO-hN1Gal4 cells are co-cultured with signal-sending cells (in our case MEF-
Dll1 cells), binding of hN1Gal4 to the Notch ligand leads to the activation of the receptor, 
which undergoes two proteolytic cleavages.  
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Figure 14. The FACS-based co-culture assay. 
A. The figure depicts the FACS-based co-culture assay used to investigate the requirement of 
Eps15 and Eps15L1 in the regulation of Notch signalling. MEF-Dll1 and CHO-hN1Gal4 cells were 
used as signal-sending and signal-receiving cells, respectively. Notch signalling induction by Dll1-
mCherry is measured as expression of YFP in signal-receiving cells. B. The figure depicts the 
induction of Dll1-mCherry in signal-sending cells through the T-Rex system, in which the 
expression of Dll1-mCherry is under the control of the strong human CMV (cytomegalovirus) 
immediate-early promoter and two copies of TetO2 (tetracycline operator 2). In the absence of 
antibiotics of tetracycline class, TetR (tetracycline repressor) binds to TetO2, thus inhibiting the 
expression of Dll1-mCherry. When an antibiotic of the tetracycline class, such as doxycycline, is 
added, it binds to TetR and causes a conformational change in the repressor, which can no longer to 
bind to TetO2, thus allowing induction of Dll1-mCherry.  
 
These proteolytic cleavages result in the release of Gal4 in the cytoplasm, which 
translocates to the nucleus and bind to the UAS region (upstream activating sequence), 
leading to the expression of the histone H2B protein fused to citrine, otherwise called YFP 
(yellow fluorescent protein). YFP expression detected by cytofluorimetry is a direct 
measurement of receptor activation.  
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1.2. Set-up of the FACS-based co-culture assay 
We analysed the expression of Dll1-mCherry in WT MEF-Dll1 cells by FACS. First, we 
defined the optimal concentration of doxycycline required to induce Dll1-mCherry in these 
cells. At the same time, by surface staining with an anti-mouse Dll1 antibody conjugated to 
Alexa Fluor 647 dye, we measured, among Dll1-mCherry positive cells, the percentage of 
cells in which Dll1-mCherry was exposed on the PM. We detected a leaky induction of 
Dll1-mCherry when cells were cultivated in the absence of doxycycline (~20%). However, 
about 90% of the cells expressed Dll1-mCherry when treated for 24 hours with 50 ng/ml 
doxycycline.  
 
 
Figure 15. FACS analysis of MEF-Dll1 cells. 
MEF and MEF-Dll1 cells were analysed by FACS for the expression of mCherry and Alexa Fluor 
647. Cells were cultured for 24 hours in the absence (-DOX) or in the presence of 50 ng/ml 
doxycycline (+50 ng/ml DOX) and, then, surface stained with an Alexa Fluor 647 anti-mouse Dll1 
antibody. MEFs were used to define background fluorescence intensities for mCherry and Alexa 
Fluor 647 and to gate the following subpopulations: double negative cells for mCherry and Alexa 
Fluor 647, single positive cells for mCherry, double positive cells for mCherry and Alexa Fluor 
647 and single positive cells for Alexa Fluor 647. Numbers refer to the percentage of gated cells.  
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Of these, ~40% of the cells expressed Dll1-mCherry on the surface (Figure 15). Increased 
amounts of doxycycline (100 and 150 ng/ml) did not increase the percentage of Dll1-
mCherry expressing cells or the protein expression levels, as assessed by mean 
fluorescence intensity (data not shown). The same Dll1-mCherry induction was observed 
also when cells were cultivated in the presence of different doses of doxycycline (tested: 
50-100-150 ng/ml) for 48 and 72 hours (data not shown). In subsequent experiments, Dll1-
mCherry was induced by the addiction of 50 ng/ml doxycycline at the beginning of co-
culture. The antibiotic was maintained in the co-culture medium until the end of the 
experiment (48 hours). 
Next, we analysed the expression of YFP in CHO-hN1Gal4 cells when cultured alone. We 
observed that, at steady state, almost all cells expressed YFP (all positive cells for YFP are 
indicated as YFP+). Among the YFP-positive cells, about 20% expressed high levels of 
YFP (cells expressing high levels of YFP are indicated as YFP++, while the YFP++/YFP+ 
ratio refers to the percentage of cells expressing high levels of YFP relative to total 
positive YFP cells). As a control, we tested whether YFP basal expression was perturbed 
by doxycycline. We observed that neither the percentage of YFP-positive cells, nor the 
protein expression levels, assessed by mean fluorescence intensity, were perturbed when 
cells were cultured in the presence of the antibiotic (Figure 16).  
 
Figure 16. FACS analysis of CHO-hN1Gal4 cells. 
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CHO and CHO-hN1Gal4 cells were analysed by FACS for the expression of YFP when cultured at 
steady state in the absence (-DOX) or in the presence of 50 ng/ml doxycycline (+ 50 ng/ml DOX), 
administered for 48 hours. CHO cells were used to define background fluorescence intensities for 
basal YFP and to gate the following subpopulations: YFP-negative cells (YFP-, green gate) and 
YFP-positive cells (YFP+, blue gate). Among YFP-positive cells, a subpopulation of cells 
expressing higher levels of YPF was gated (YFP++, red gate). Numbers refer to the percentage of 
YFP-negative cells, YFP-positive cells and cells expressing higher levels of YFP, relative to total 
YFP-positive cells (YFP++/YFP+). 
 
After the analysis of the single populations of signal-sending and signal-receiving cells, we 
defined the optimal time and modality of doxycycline administration during co-culture of 
MEF-Dll1 with CHO-hN1Gal4 cells. To this end, we tested the following conditions: i) co-
culture for 24 hours and administration of 50 ng/ml doxycycline for the total co-culture 
time, e. g. 24 hours; ii) co-culture for 48 hours and administration of 50 ng/ml doxycycline 
for the first 24 hours; iii) co-culture for 48 hours and administration of 50 ng/ml 
doxycycline for the total co-culture time, e. g., 48 hours.  
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Figure 17. Optimal time and modality of doxycycline administration during co-culture. 
CHO-hN1Gal4 cells were analysed by FACS for the expression of YFP after co-culture with MEF-
Dll1 cells. A. Cells were co-cultured for 48 hours in the absence of doxycycline. B. Cells were co-
cultured for 24 hours in the presence of doxycycline. C. Cells were co-cultured for 48 hours in the 
presence of doxycycline, administered for the first 24 hours. D. Cells were co-cultured for 48 hours 
in the presence of doxycycline, administered for the total co-culture time. Cells expressing higher 
levels of YPF (YFP++, red gate), among YFP-positive cells (YFP+, blue gate), were gated. Notch 
induction was measured as the percentage of cells expressing higher levels of YFP, relative to total 
YFP-positive cells (YFP++/YFP+).  
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We found that Notch induction, measured as percentage of cells expressing higher levels 
of YFP relative to total YFP-positive cells, was higher when cells were co-cultivated for 48 
hours in the presence of doxycycline, both when it was administered for the first 24 hours 
and for the total co-culture time (Figure 17). Thus, in the following experiments, we co-
cultured cells for 48 hours in the presence of 50 ng/ml doxycycline, administered for the 
total co-culture time. 
We then defined the optimal percentage ratio of MEF-Dll1 and CHO-hN1Gal4 cells to be 
co-cultured. We observed an efficient Notch induction, measured as percentage of cells 
expressing higher levels of YFP relative to total YFP-positive cells, when signal-sending 
and signal-receiving cells were co-cultured at a percentage ratio of 60/40 (Figure 18). 
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Figure 18. The optimal ratio of MEF-Dll1 and CHO-hN1Gal4 cells in a co-culture.  
CHO-hN1Gal4 cells were analysed by FACS for the expression of YFP after co-culture with MEF-
Dll1 cells. Co-culture was performed for 48 hours, in the absence (-DOX) or in the presence 
(+DOX) of 50 ng/ml doxycycline. Doxycycline was administered for the total co-culture time. 
Different ratios of MEF-Dll1 and CHO-hN1Gal4 cells were tested, both in absence and in the 
presence of doxycycline: 20/80; 40/60; 60/40; 80/20. For simplicity, only the 60/40 ratio condition 
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is reported as a control of co-cultures performed in the absence of doxycycline (similar at all ratios). 
In CHO-hN1Gal4 cells, high levels of YPF (YFP++, red gate), among YFP-positive cells (YFP+, 
blue gate), were gated. Notch induction was measured as the percentage of cells expressing higher 
levels of YFP relative to total YFP-positive cells (YFP++/YFP+).  
 
After having set-up the experimental conditions for co-culture (time: 48 hours; modality of 
doxycycline administration: 50 ng/ml doxycycline, administered for the total co-culture 
time; ratio among signal-sending and signal-receiving cells: 60/40), we validated the co-
culture system. We observed that the increased percentage of cells expressing higher levels 
of YFP, among all YFP-positive cells, in the chosen experimental conditions, was Notch-
dependent, since it was not observable when cells were co-cultivated in the presence of 
DAPT, a Notch signalling inhibitor that acts by inhibiting the proteolytic cleavage of 
Notch receptor by γ–secretase (Figure 19).  
As a further control, we tested YFP induction in CHO-hN1Gal4 cells after co-culture with 
MEF-Dll1 cells knocked-down for Mib1. Mib1 is an E3 ubiquitin ligase that is required for 
the activation of the Notch signalling in the signal-sending cell (Le Borgne 2006). As 
expected, KD of Mib1 in MEF-Dll1 cells reduced Notch activation almost to basal levels 
(Figure 20A). Efficient downregulation of Mib1 protein levels after KD was confirmed by 
WB analysis (Figure 20B). 
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Figure 19. Increased YFP expression in CHO-hN1Gal4 cells upon co-culture with MEF-Dll1 cells 
is Notch-dependent.  
CHO-hN1Gal4 cells were analysed by FACS for the expression of YFP after co-culture with MEF-
Dll1 cells. MEF-Dll1 and CHO-hN1Gal4 cells were co-cultured at percentage ratio of 60/40 for 48 
hours, in the absence (-DOX) or the presence (+DOX) of 50 ng/ml doxycycline. Co-cultures were 
performed in the absence or in the presence of the Notch signalling inhibitor DAPT or DMSO as 
vehicle. Drugs (doxycycline and DAPT) and DMSO, when added, were administered for the total 
co-culture time. In CHO-hN1Gal4 cells, cells with high levels of YPF (YFP++, red gate), among 
YFP-positive cells (YFP+, blue gate), were gated. Notch induction was measured as the percentage 
of cells expressing higher levels of YFP relative to total YFP-positive cells (YFP++/YFP+). 
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Figure 20. KD of Mib1 in MEF-Dll1 cells reduces Notch signalling activation. 
A. The bar graph depicts Notch induction in CHO-hN1Gal4 cells when co-cultured with MEF-Dll1 
cells. MEF-Dll1 cells were transfected with a siRNA oligo targeting Mib1 RNA (Mib1) or a 
scrambled siRNA oligo (SCR) as a control. Co-cultures were performed both in the absence (-DOX) 
and in the presence (+DOX) of 50 ng/ml doxycycline. When added, doxycycline was administered 
for the total co-culture time. Notch induction, measured as the percentage of CHO-hN1Gal4 cells 
expressing higher levels of YFP relative to total YFP-positive cells (YFP++/YFP+), is relative to 
the induction observed when CHO-hN1Gal4 cells were co-cultured, in the presence of doxycycline, 
with MEF-Dll1 cells previously transfected with a scrambled oligo. Data are presented as an 
average of two independent experiments; error bars represent standard error deviation. Statistical 
significance was assessed using 2-tailed student’s t-test (***=p<0.005). B. WB of Mib1 protein 
levels in MEF-Dll1 cells transfected with a scrambled oligo (SCR) or a siRNA oligo targeting 
Mib1 RNA (Mib1). 20 µg of each cell lysate were separated on SDS-PAGE, transferred on a 
nitrocellulose filter and probed with antibodies for Mib1 and tubulin, as indicated. MWs (kDa) are 
indicated on the left. 
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1.3. Dll1 induction in WT, single and double Eps15 and Eps15L1 KO 
MEF-Dll1 cells 
Before testing the role of Eps15 and Eps15L1 in the regulation of Dll1 biology (using 
single and double Eps15 and Eps15L1 KO MEF-Dll1 cells as signal-sending cells), we 
compared the expression of doxycycline-inducible Dll1-mCherry in WT, single and double 
Eps15 and Eps15L1 KO MEF-Dll1 cells by FACS. At the same time, the cells were 
surface stained with an anti-mouse Dll1 antibody conjugated to an Alexa Fluor 647 dye in 
order to measure the percentage of cells in which the ligand was exposed on the PM and, 
therefore, available to absolve its biological function. We found that the percentage of 
Dll1-mCherry expressing cells was similar in WT, single and double Eps15 and Eps15L1 
KO MEF-Dll1 cells upon treatment with 50 ng/ml doxycycline for 48 hours (Figure 21A). 
Nevertheless, analysis of Dll1-mCherry mean fluorescence showed that, while 
Eps15/Eps15L1-DKO cells expressed similar levels of Dll1-mCherry compared to WT, the 
protein was differently expressed in single KO cells: Eps15L1-KO cells expressed lower 
levels of Dll1-mCherry compared to WT, while Eps15-KO cells tended to express higher 
levels of the protein (Figure 21B). These results might suggest that Eps15 could have a 
role in the degradation of Dll1-mCherry.  
Then, we analysed the percentage of cells that exposed Dll1 on the PM, e.g., the 
percentage of cells that were double positive for both mCherry and Alexa Fluor 647. We 
found that the percentage of cells exposing Dll1 on the PM was reduced in Eps15L1-KO 
and Eps15/Eps15L1-DKO cells, compared to WT cells, suggesting that Eps15L1 might 
have a role in the trafficking of the protein towards the cell surface (Figure 21C).  
When we analysed the levels of Dll1 on the cell surface by mean fluorescence analysis of 
Alexa Fluor 647, we found that both single and double Eps15 and Eps15L1 KO cells 
expressed high levels of Dll1. This result might suggest that Eps15 and Eps15L1 have a 
role in the internalization of Dll1 (Figure 21D). 
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Figure 21. Expression of Dll1 in WT, single and double Eps15 and Eps15L1 KO MEF-Dll1 cells. 
The bar graphs depict the percentage of cells expressing Dll1 and the levels of Dll1 in wild type 
(WT), Eps15-KO (15KO), Eps15L1-KO (L1KO) and Eps15/Eps15L1-DKO (15/L1-DKO) MEF-
Dll1 cells. A. Percentage of cells expressing Dll1-mCherry. B. Mean fluorescence intensity of 
Dll1-mCherry in the different cell populations relative to WT cells. C. Percentage of cells 
expressing Dll1 on the cell surface among Dll1-mCherry-positive cells. D. Mean fluorescence 
intensity of surface Dll1 relative to WT cells. All the measurements were obtained by FACS 
analysis of mCherry and Alexa Fluor 647 in the different populations of MEF-Dll1 cells, as 
indicated, after treatment with 50 ng/ml doxycycline, administered for 48 hours, and surface 
staining with an Alexa Fluor 647 anti-mouse Dll1 antibody. Data are presented as an average of 
three independent experiments; error bars represent standard error deviation. Statistical significance 
was assessed using 2-tailed student’s t-test (*=p<0.05; **=p<0.01; ***=p<0.005). 
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1.4. Eps15L1 is required in MEF-Dll1 cells for activation of the Notch 
signalling pathway 
To test whether Eps15 and Eps15L1 impact on the Notch signalling through the regulation 
of Dll1 biology in MEF-Dll1 cells, single and double Eps15 and Eps15L1 KO MEF-Dll1 
cells were co-cultured with CHO-hN1Gal4 cells. A representative FACS-based co-culture 
experiment is shown in Figure 22. Our first observation was that deletion of Eps15 alone in 
MEF-Dll1 cells did not affect Notch activation (Figure 22; 23A), in contrast to what has 
been previously observed in OP9-Dll1 cells, in which KD of Eps15 by RNA interference 
reduced Notch activation to ~50% (Lucano et al., unpublished results). Secondly, 
Eps15L1-KO MEF-Dll1 cells had a reduced ability to induce Notch activation (Figure 22; 
23A), as previously observed in OP9-Dll1 cells, in which a reduction (to ~50%) of Notch 
signalling activation following KD of Eps15L1 was shown (Lucano et al., unpublished 
results). Thirdly, we observed that the combined loss of Eps15 and Eps15L1 in MEF-Dll1 
cells did not further affect Notch activation compared to the KO of Eps15L1 alone (Figure 
22; 23A). Similarly, no further reduction of Notch signalling had been observed in OP9-
Dll1 cells knocked-down for both Eps15 and Eps15L1 (Lucano et al., unpublished results). 
These results indicate that, in MEF-Dll1 cells, Eps15L1, but not Eps15, is required for 
proper activation of Notch signalling. Efficient downregulation of Eps15 protein levels 
after (Z)-4-hydroxytamoxifen treatment of MEF-Dll1 cells was confirmed by WB analysis 
(Figure 23B). 
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Figure 22. Representative FACS-based co-culture experiment. 
CHO-hN1Gal4 cells were analysed by FACS for the expression of YFP after co-culture with wild 
type (WT), Eps15-KO, Eps15L1-KO and Eps15/Eps15L1-DKO MEF-Dll1 cells. MEF-Dll1 and 
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CHO-hN1Gal4 cells were co-cultured at a percentage ratio of 60/40 for 48 hours, in the absence (-
DOX) or the presence (+DOX) of 50 ng/ml doxycycline. When added, doxycycline was 
administered for the total co-culture time. In CHO-hN1Gal4 cells, cells expressing higher levels of 
YPF (YFP++, red gate), among YFP-positive cells (YFP+, blue gate), were gated. Notch induction 
was measured as the percentage of cells expressing higher levels of YFP relative to total YFP-
positive cells (YFP++/YFP+).  
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Figure 23. Eps15L1 is required for the activation of Notch signalling in MEF-Dll1 cells  
A. The bar graph depicts Notch induction in CHO-hN1Gal4 cells when co-cultured with wild type 
(WT), Eps15-KO (15KO), Eps15L1-KO (L1KO) and Eps15/Eps15L1-DKO (DKO) MEF-Dll1 
cells. MEF-Dll1 and CHO-hN1Gal4 cells were plated at a percentage ratio of 60/40 ratio and co-
cultured for 48 hours. The co-cultures were performed both in the absence (-DOX) and in the 
presence (+DOX) of 50 ng/ml doxycycline. When added, doxycycline was administered for the 
total co-culture time. Notch activation, measured as the percentage of CHO-hN1Gal4 cells 
expressing higher levels of YFP, relative to total YFP-positive cells (YFP++/YFP+), is relative to 
the activation observed when CHO-hN1Gal4 cells were co-cultured with WT MEF-Dll1 cells in 
the presence of doxycycline. Data are presented as an average of three independent experiments; 
error bars represent standard error deviation. Statistical significance was assessed using 2-tailed 
student’s t-test (**=p<0.01; ***=p<0.005). B. WB of Eps15 and Eps15L1 protein levels in wild 
type (WT), Eps15-KO (15KO), Eps15L1-KO (L1KO) and Eps15/Eps15L1-DKO (DKO) MEF-
Dll1 cells. Eps15-KO and Eps15/Eps15L1-DKO cells were generated through (Z)- 4-
hydroxytamoxifen treatment of WT and Eps15L1-KO cells, respectively. 20 µg of each cell lysate 
were separated on SDS-PAGE, transferred on a nitrocellulose filter and probed with antibodies for 
Eps15, Eps15L1 and tubulin, as indicated. MWs (kDa) are indicated on the left. 
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To confirm these observations and to exclude cell line-specific effects, we will investigate 
the role of Eps15 and Eps15L1 in isogenic cellular systems, in which single and double 
Eps15 and Eps15L1 KO cells will be directly compared with the parental WT cell line. In 
detail, we will use MEF-Dll1 cells transgenic for CreERT2 and floxed for both Eps15 and 
Eps15L1, e.g. Eps15flp/flp/Eps15L1flp/flp/tgCreERT2 (these cells are WT when not treated with 
(Z)-4-hydroxytamoxifen), in order to generate DKO cells upon (Z)-4-hydroxytamoxifen 
treatment. As control we will also use MEF-Dll1 cells transgenic for CreERT2 and floxed 
for only Eps15 or Eps15L1, e.g. Eps15flp/flp/Eps15L1+/+/tgCreERT2 and 
Eps15+/+/Eps15L1flp/flp/tgCreERT2 cell lines (these cells are WT when not treated with (Z)-4-
hydroxytamoxifen), in order to generate Eps15-KO or Eps15L1-KO cells upon (Z)-4-
hydroxytamoxifen treatment, respectively (Table 6). 
 
Cell line - TMX + TMX 
 
Eps15flp/flp/Eps15L1flp/flp/tgCreERT2 
 
WT DKO 
 
Eps15flp/flp/Eps15L1+/+/tgCreERT2 
 
WT Eps15-KO 
 
Eps15+/+/Eps15L1flp/flp/tgCreERT2 
 
WT Eps15L1-KO 
 
Table 6. Generation of single and double Eps15 and Eps15L1 KO MEF-Dll1 cells from the 
parental WT cell line.  
Eps15flp/flp/Eps15L1flp/flp/tgCreERT2, Eps15flp/flp/Eps15L1+/+/tgCreERT2 and Eps15+/+/Eps15L1flp/flp/tgCreERT2 
untreated with (Z)-4-hydroxytamoxifen (-TMX) are used as WT. Treatment of these cells with (Z)-
4-hydroxytamoxifen (+TMX) leads to the formation of DKO, Eps15-KO and Eps15L1-KO cells. 
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2. Eps15 and Eps15L1 redundantly regulate VEGFR-2 turnover, 
but vascular defects are not the main cause of lethality in 
Eps15/Eps15L1-DKO embryos 
 
2.1. Total expression levels of VEGFR-2 are reduced in DKO endothelial 
cells, but VEGFR-2 and Notch downstream signalling are not altered in 
these cells.  
Eps15/Eps15L1-DKO embryos show serious vascular defects (see section “5.1. Eps15, 
Eps15L1 and Eps15/Eps15L1 KO mice” in Chapter 1). We asked whether vascular defects 
were due to a cell–autonomous function of Eps15 and Eps15L1 in the vascular system and 
whether they were responsible for midgestation lethality of Eps15/Eps15L1-DKO mice. To 
address these questions, we exploited both an in vitro and an in vivo strategy. As an in vitro 
model system, we used murine endothelial cells to investigate whether the major signalling 
pathways regulating vascular development, e.g., the VEGFR-2 (vascular endothelial 
growth factor receptor 2) and the Notch signalling pathways, were altered upon 
Eps15/Eps15L1 impairment. We tested whether Eps15 and Eps15L1 had a cell-
autonomous function in endothelial cells. As an in vivo model system, we generated cDKO 
mice through the Tie2-Cre strategy, to see whether vascular defects were present also in 
these mice and whether they caused embryo lethality. 
In detail, as an in vitro model system, we generated isogenic endothelial cells to avoid cell 
line-specific effects. To this end, we established an immortalized endothelial cell line from 
Eps15flp/flp/Eps15L1-/- mice. These cells were floxed for Eps15 and KO for Eps15L1. We 
confirmed the endothelial origin of this cell line by IF staining of the main endothelial 
markers PECAM-1 and VE-cadherin (Figure 24). 
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Figure 24. Expression of the endothelial markers PECAM-1 and VE-cadherin in immortalized 
endothelial Eps15flp/flp/Eps15L1-/- cells. 
Endothelial Eps15flp/flp/Eps15L1-/- cells were stained with anti-PECAM-1 or anti-VE-Cadherin 
antibodies (red) to confirm their endothelial origin. Nuclei were identified through DAPI staining 
(blue). Images were acquired with a wide-field microscope. 
 
Next, we performed retroviral transduction of murine Eps15L1 to generate WT endothelial 
cells from Eps15L1-KO cells. Following deletion of the floxed Eps15 locus by in vitro 
treatment with Tat-Cre Recombinase, we generated Eps15-KO and Eps15/Eps15L1-DKO 
cells from WT and Eps15L1-KO cells, respectively (Figure 25). In these cells, we 
investigated whether Eps15 and Eps15L1 regulate the VEGFR-2 signalling pathway. 
VEGFR-2 triggers two different downstream signalling pathways that mediate cell 
proliferation or survival. In detail, activation of PLCγ induces the activation of a MAP 
kinase cascade, which leads to cell division (Takahashi, Yamaguchi et al. 2001). Instead, 
PI3K activation and Akt phosphorylation promote cell survival (Gerber, McMurtrey et al. 
1998). Reports in the literature claim that confluent endothelial cells are contact inhibited 
and respond poorly to VEGF-induced proliferation: in this condition, indeed, VEGFR-2 is 
clustered, together with VE-cadherin, in cell-cell contact sites, where it signals 
preferentially through PI3K and Akt for survival (Lampugnani, Zanetti et al. 2003).  
PECAM-1     VE-cadherin
 115 
 
Figure 25. Generation of WT, single and double Eps15 and Eps15L1 KO endothelial cells. 
The figure depicts the generation of WT, single and double Eps15 and Eps15L1 KO endothelial 
cells from the parental Eps15flp/flp/Eps15L1-/- cell line (L1KO). WT cells were generated through 
retroviral transduction of Eps15L1 into Eps15flp/flp/Eps15L1-/- cells. Eps15-KO (15KO) and 
Eps15/Eps15L1-DKO (15/L1-DKO) cells were generated through in vitro Tat-Cre treatment of 
Eps15L1-KO and WT cells, respectively.  
 
Instead, in sub-confluent endothelial cells, VEGF stimulation induces the CDE of VEGR-2 
in the endosomal compartment, where it activates the PLCγ and the p44/p42 MAP kinase 
cascade, thus promoting cellular proliferation (Lampugnani, Orsenigo et al. 2006).  
To study the possible role, if any, of Eps15 and Eps15L1 in VEGFR-2 signalling, we 
stimulated sub-confluent endothelial cells with VEGF and we analyzed, by WB analysis, 
receptor levels, receptor phosphorylation and activation of the MAP kinase cascade. We 
observed reduced receptor phosphorylation in Eps15/Eps15L1-DKO cells (Figure 26A, B), 
possibly due to decreased total VEGFR-2 levels (Figure 26A, C). Indeed, receptor 
phosphorylation relative to total VEGFR-2 levels was similar as in WT cells (Figure 26A, 
D). Nevertheless, even if total VEGFR-2 levels were decreased, we found that the 
activation of the p44/p42 MAP kinase cascade was not affected in Eps15/Eps15L1-DKO 
cells (Figure 26A, E), thus indicating that the available amount of VEGFR-2 was sufficient 
to sustain appropriate MAP kinase signalling. AKT signalling, instead, was activated at 
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similar basal levels in all genotypes (Figure 26A, F). These data indicate that no major 
impact by Eps15 and Eps15L1 is visible on canonical VEGFR-2 downstream signalling. 
However, since VEGFR-2 levels were reduced in Eps15/Eps15L1-DKO cells, thus 
indicating a defect in VEGFR-2 turnover, there might be spatio-temporal differences of 
downstream signalling difficult to access by WB analysis.  
  
 
Figure 26. VEGFR-2 downstream signalling is unaltered in DKO endothelial cells. 
        min.:      0      5    15    30    0     5    15   30     0     5    15    30   0     5     15    30
       WT                 15KO                L1KO                DKO
WB: pVEGFR-2 
           (Y1175)
WB: VEGFR-2 
WB: pERK1/2 
WB: ERK1/2 
WB: Eps15L1 
B
WT
15KO
L1KO
DKO0
50
100
150
0 5 15 30
Time (min.)
pE
RK
1/
2 
re
la
tiv
e 
to
 A
KT
 (a
.u
.)
0
50
100
150
0 5 15 30
Time (min.)
pV
EG
FR
-2
 re
la
tiv
e 
to
 A
KT
 (a
.u
.)
***
*
Time (min.)
VE
G
FR
-2
 re
la
tiv
e 
to
 A
KT
 (a
.u
.)
***
0
50
100
150
200
0 5 15 30
*** **** 0
50
100
150
200
pV
EG
FR
-2
 re
lati
ve
 to
 V
EG
FR
-2
 (a
.u
.)
0 5 15 30
Time (min.)
0
50
100
150
pA
KT
 re
la
tiv
e 
to
 A
KT
 (a
.u
.)
0 5 15 30
Time (min.)
***
**
FE
DC
WB: pAKT 
WB: AKT 
A
250 
250 
150 
150 
37 
37
50
50
WB: Eps15 
 117 
A. Representative WB of VEGF stimulation on wild type (WT), Eps15-KO (15KO), Eps15L1-KO 
(L1KO) and Eps15/Eps15L1-DKO (DKO) endothelial cells (n=3). Sub-confluent endothelial cells 
were stimulated with 80 ng/ml VEGF for 0, 5, 15 and 30 minutes and then lysed. 20 µg of each cell 
lysate were separated on SDS-PAGE, transferred on a nitrocellulose filter and probed with 
antibodies for pVEGFR-2 (Y1175), total VEGFR-2, Eps15, Eps15L1, pAKT, total AKT, pERK1/2 
and total ERK1/2, as indicated. MWs (kDa) are indicated on the left. B. Quantification in arbitrary 
units (a.u.) of pVEGFR-2 (Y1175) relative to total AKT at 0, 5, 15 and 30 minutes after stimulation. 
C. Quantification in arbitrary units (a.u.) of total VEGFR-2 relative to total AKT at 0, 5, 15 and 30 
minutes after stimulation. D. Quantification in arbitrary units (a.u.) of pVEGFR-2 (Y1175) relative 
to total VEGFR-2 at 0, 5, 15 and 30 minutes after stimulation. E. Quantification in arbitrary units 
(a.u.) of pERK1/2 relative to total AKT at 0, 5, 15 and 30 minutes after stimulation. F. 
Quantification in arbitrary units (a.u.) of pAKT relative to total AKT at 0, 5, 15 and 30 minutes 
after stimulation. WB bands for pVEGFR-2 (Y1175) (B and D), total VEGFR-2 (C), pERK1/2 (E) 
and pAKT (F) were quantified by Image Lab Software and each value was normalized to the 
corresponding total AKT value (B, C, E, F) or total VEGFR-2 value (D). Normalized values are 
represented as a ratio on the WT. Data are presented as an average of three independent 
experiments; error bars represent standard error deviation. Statistical significance was assessed 
using 2-tailed student’s t-test (*=p<0.05; **=p<0.01). 
 
To analyze alterations in the Notch signalling pathway, we cultured endothelial cells of the 
four genotypes to confluency, in order to allow cell-cell contact, a prerequisite for Notch 
signalling activation. We, then, assessed the activation of Notch signalling by WB analysis 
with an antibody detecting the cleaved-Notch1Val1744 (NICD). In lysates from WT cells, we 
detected the presence of the NICD, thus indicating that Notch signalling was activated in 
these cells. As expected, the NICD protein was not detectable in lysates from cells that had 
been cultured in the presence of the Notch signalling inhibitor DAPT. When we assessed 
the activation of Notch signalling in endothelial cells knocked-out for Eps15, Eps15L1 or 
both, we found no differences compared to WT cells (Figure 27).  
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Figure 27. Notch signalling is unaltered in DKO endothelial cells. 
WB analysis showing the levels of Cleaved-Notch1Val1744 (NICD) protein in wild type (WT), 
Eps15-KO (15KO), Eps15L1-KO (L1KO) and Eps15/Eps15L1-DKO (DKO) endothelial cells, 
cultured to confluency in the presence of the Notch signalling inhibitor DAPT (+) or DMSO as 
vehicle (-). 20 µg of each cell lysate were separated on SDS-PAGE, transferred on a nitrocellulose 
filter and probed with antibodies for Cleaved-Notch1Val1744 (NICD), Eps15, Eps15L1 and vinculin, 
as indicated. MWs (kDa) are indicated on the left. 
 
2.2. cDKO mice do not recapitulate embryo lethality of constitutive 
Eps15/Eps15L1-DKO mice 
In endothelial cells, we found that Eps15 and Eps15L1 regulate VEGFR-2 turnover, thus 
indicating that they play a cell-autonomous function in the vascular system by regulating 
VEGFR-2 and, possibly, other unexplored receptors.  
Through the Tie2-Cre strategy, we generated cDKO mice to see whether the lack of Eps15 
and Eps15L1 in the vascular system was sufficient to cause midgestation lethality, as 
occurs in constitutive Eps15/Eps15L1-DKO mice. To this end we crossed 
Eps15flp/flp/Eps15L1+/- females with Eps15flp/flp/Eps15L1+/-/tgTie2-Cre males and we 
generated Eps15flp/flp/Eps15L1-/-/tgTie2-Cre mice. In Eps15flp/flp/Eps15L1-/-/tgTie2-Cre mice, 
Eps15L1 is constitutively deleted in all tissues, while Cre expression, driven by the Tie2 
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promoter, leads to the deletion of the floxed Eps15 specifically in hematopoietic and 
endothelial cells. In this thesis project, these mice (Eps15flp/flp/Eps15L1-/-/tgTie2-Cre) are 
referred to as cDKO mice.  
PECAM-1 staining of 9.5 dpc embryos showed that cDKO mice present an altered 
angiogenesis, with enlarged vessels and reduced and disorganized branching in the head 
(Figure 28). Vascular defects due to the lack of Eps15 and Eps15L1 might contribute to the 
severe phenotype of constitutive Eps15/Eps15L1-DKO mice, together with other perturbed 
developmental processes. 
 
                                    
Figure 28. cDKO mice have vascular defects but do not recapitulate embryo lethality of 
constitutive Eps15/Eps15L1-DKO mice. 
IF PECAM-1 staining of the head vasculature of 9.5 dpc wild type (WT), conditional-Eps15KO 
(Eps15flp/flp/Eps15L1+/+/tgTie2-Cre, indicated as c15KO), constitutive Eps15L1-KO (indicated as 
L1KO) and conditional-DKO mice (Eps15flp/flp/Eps15L1-/-/tgTie2-Cre, indicated as cDKO). White 
arrows and white asterisks indicate enlarged vessels and blind vessels, respectively. 
 
 
WT c15KO
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* *
*
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Based on our in vitro data, vascular defects in cDKO mice might be linked to altered 
VEGFR-2 turnover. Nevertheless, these vascular defects were not sufficient to cause 
embryo lethality, indeed, in contrast to constitutive Eps15/Eps15L1-DKO mice, cDKO 
mice survived to birth. These results indicate that, even if Eps15 and Eps15L1 regulate 
cell-autonomously vascular development through the regulation of VEGFR-2 turnover and, 
eventually, of other receptors, vascular defects do not cause embryo lethality in cDKO 
mice. 
 
 
3. Eps15 and Eps15L1 regulate TfR internalization in a 
redundant-manner and are required for proper development of 
RBCs  
 
3.1. MEFs as a model system to study the role of Eps15 and Eps15L1 in 
the internalization of EGFR and TfR 
Previous in vitro studies demonstrated that Eps15 and Eps15L1 proteins regulate the 
internalization of EGFR and TfR. These results were derived through the use of specific 
antibodies blocking Eps15 and Eps15L1 (Carbone, Fre et al. 1997) or through siRNA 
interference of the proteins (Huang, Khvorova et al. 2004). To confirm the function of 
Eps15 and Eps15L1 in these pathways in a cleaner and in a physiological setting, we 
generated MEFs from KO mice for Eps15 and Eps15L1. In detail, to study the role of 
Eps15 and Eps15L1 in the internalization of EGFR and TfR, we used two different cell 
lines of MEFs: Eps15flp/flp/Eps15L1+/+/tgCreERT2 and Eps15flp/flp/Eps15L1-/-/tgCreERT2. In the 
absence of (Z)-4-hydroxytamoxifen treatment, these cell lines were used as WT and 
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Eps15L1-KO, respectively. When treated with (Z)-4-hydroxytamoxifen, deletion of Eps15 
in WT cells leads to the generation Eps15-KO cells, while deletion of Eps15 in Eps15L1-
KO cells leads to the generation of Eps15/Eps15L1-DKO cells.  
As better described in the next sections, in these cellular model systems, we performed 
radioactive assays with 125I-EGF and 125I-Tf to follow the internalization of EGFR and TfR, 
respectively. 
 
3.2. Eps15 and Eps15L1 have a minor impact on EGFR internalization 
To test whether Eps15 and Eps15L1 regulated EGFR internalization in MEFs, we 
performed radioactive internalization assays with 125I-EGF, at low (when only CDE is 
active) and high doses (when both CDE and CIE are active) of EGF. We observed that the 
Ke was slightly but significantly reduced (~20%) in Eps15-KO, Eps15L1-KO and 
Eps15/Eps15L1-DKO cells both at low and high concentrations of EGF (Figure 29A), 
suggesting that there might be an effect on both CDE and CIE of EGFR. 
By saturation binding with 125I-EGF, we measured the total number of EGFR at the cell 
surface. We found that surface levels of EGFR were altered only in Eps15L1-KO: in these 
cells, surface EGFR was reduced by ~15% (Figure 29B). Reduced surface levels of EGFR 
in Eps15L1-KO cells might indicate some alterations in the constitutive EGFR turnover, 
e.g. increased degradation and/or reduced biosynthesis of the receptor. 
These data indicated that Eps15 and Eps15L1 have a minor impact on EGFR endocytosis 
and that they act in a non-redundant manner, since no worsening of the phenotype was 
observed in DKO cells. 
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Figure 29. EGFR internalization is partially reduced in single and double Eps15 and Eps15L1 KO 
MEFs. 
A. The bar graph represents the endocytic rate constant (Ke) for EGFR in wild type (WT), 
Eps15L1-KO (L1KO), Eps15-KO (15KO) and Eps15/Eps15L1-DKO (DKO) MEFs, when 
stimulated with low (1.5 ng/ml) and high (30 ng/ml) doses of EGF. The Ke value was normalized 
as a ratio to WT. Data are presented as an average of three (EGF low) or four (EGF high) different 
independent experiments; error bars represent the standard error mean. Statistical significance was 
assessed using 2-tailed student’s t-test (*=p<0.05; **=p<0.01; ***p=<0.005). B. The bar graph 
represents steady state surface levels of EGFR in wild type (WT), Eps15L1-KO (L1KO), Eps15-
KO (15KO) and Eps15/Eps15L1-DKO (DKO) MEFs. The numbers of surface receptors/cell were 
normalized to WT. Data are presented as an average of four different independent experiments; 
error bars represent the standard error mean. Statistical significance was assessed using 2-tailed 
student’s t-test (**=p<0.01). 
 
3.3. Internalization of TfR is impaired in Eps15/Eps15L1-DKO MEFs 
To test whether Eps15 and Eps15L1 regulated TfR internalization in MEFs, we performed 
radioactive internalization assays with 125I-Tf, to follow CDE of the receptor.  
We found that the Ke of the TfR was strongly reduced in Eps15/Eps15L1-DKO cells 
(~50%), but only a minor effect in single Eps15 or Eps15L1 KO MEFs was detected, even 
if statistically significant in Eps15L1-KO cells (Figure 30A).  
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When we analyzed the total number of TfR at the cell surface by saturation binding with 
125I-Tf, we found that in DKO cells steady state surface levels of the TfR were increased 
with respect to WT or single KO cells, consistent with its reduced internalization (Figure 
30B). This result suggests a critical redundant role of Eps15 and Eps15L1 in the 
internalization of TfR. 
 
 
Figure 30. Internalization of TfR is strongly reduced in DKO MEFs. 
A. The bar graph represents the endocytic rate constant (Ke) for TfR in wild type (WT), Eps15L1-
KO (L1KO), Eps15-KO (15KO) and Eps15/Eps15L1-DKO (DKO) MEFs, when stimulated with 
125I-Tf. The Ke value was normalized as a ratio to WT. Data are presented as an average of three 
different independent experiments; error bars represent the standard error mean. Statistical 
significance was assessed using 2-tailed student’s t-test (*=p<0.05; ***p=<0.005). B. The bar 
graph represents steady state surface levels of TfR in wild type (WT), Eps15L1-KO (L1KO), 
Eps15-KO (15KO) and Eps15/Eps15L1-DKO (DKO) MEFs. The numbers of surface receptors/cell 
were normalized to WT. Data are presented as an average of four different independent 
experiments; error bars represent the standard error mean. Statistical significance was assessed 
using 2-tailed student’s t-test (*=p<0.05). 
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3.4. cDKO mice suffer from microcytic hypochromic anemia 
We demonstrated that TfR internalization was impaired in Eps15/Eps15L1-DKO MEFs. 
Since TfR mediates the internalization of iron (Ponka and Lok 1999), impaired TfR 
internalization is generally correlated with reduced iron uptake. In the organism, immature 
RBCs are the most avid consumers of iron as this mineral is fundamental in these cells for 
hemoglobin production (Ponka and Lok 1999). As a consequence, studies in genetically 
engineered mice indicate that perturbations in proteins involved in iron uptake, linked to 
TfR signalling, greatly impact on the development of RBCs (Levy, Jin et al. 1999, Zhu, 
McLaughlin et al. 2008, Ishikawa, Maeda et al. 2015).  
To assess whether defective internalization of TfR, due to the lack of Eps15 and Eps15L1, 
impacted on the development of RBCs, we analyzed the blood of cDKO mice, generated 
through the Tie2-Cre strategy, as reported in section “2.2. cDKO mice do not recapitulate 
embryo lethality of constitutive Eps15/Eps15L1-DKO mice”. In these mice, which have 
genotype Eps15flp/flp/Eps15L1-/-/tgTie2-Cre, Eps15L1 was constitutively deleted in all tissues, 
while floxed Esp15 was specifically deleted in hematopoietic and endothelial cells through 
Cre expression driven by the Tie2 promoter.  
Analysis of hematic parameters showed that, in cDKO mice, the MCV of RBCs was 
strongly reduced compared to WT mice. Of note, also in cEps15-KO mice, the MCV was 
significantly reduced, even if to a lesser extent compared to cDKO mice. Since MCV 
reduction had already been observed in constitutive Eps15-KO mice, this result confirmed 
and extended previous findings in the laboratory (Pozzi et al., unpublished results). A 
second observation was that the RDW, index of anisocytosis, was increased in cDKO, 
indicating a high degree of variation in the size of RBCs. The number of RBCs, instead, 
was unchanged in cDKO (Table 7). 
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Genotype MCV (fl) 
RBCs 
(10^6/μl) 
RDW 
(%) Total 
 
WT 
 
90 ± 1.0 
 
2.5 ± 0.3 
 
15 ± 0.4 
 
17 
 
L1KO 94 ± 2.2 2.6 ± 0.5 16 ± 0.5 3  
c15KO 87 ± 0.7** 2.6 ± 0.3 16 ± 0.4 21 
cDKO 83 ± 1.4 *** 2.2 ± 0.4 20 ± 1.6 *** 6  
 
Table 7. Hematic parameters of cDKO newborn mice. 
The table reports, in wild type (WT), constitutive Eps15L1-KO (L1KO), conditional Eps15-KO 
(c15KO) and conditional Eps15/Eps15L1-DKO (cDKO) newborn mice, the mean ± the standard 
error mean of the following hematic parameters: the MCV of RBCs, expressed in femtoliters (fl); 
the number of RBCs in 1 microliter of blood (10^6/μl); the RDW expressed in percentage (%). The 
total number of mice analysed for each genotype is indicated. Statistical significance was assessed 
using 2-tailed student’s t-test (**=p<0.01; ***=p<0.005). 
 
To directly visualize the morphology, the size and the maturation state of RBCs, we 
performed a May-Grünwald Giemsa staining on blood smears. We observed that the 
morphology and the size of RBCs were altered in cDKO mice. Moreover, in these mice, 
RBCs were paler, indicating a reduced content of hemoglobin.  
When we counted the number of immature RBCs, represented by blue colored cells and 
cells containing blue granules, we found an increase in the number of these cells in cDKO 
mice (Figure 31). 
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Figure 31. cDKO mice have an increased number of immature RBCs. 
A. Representative images of May-Grünwald Giemsa stainings of blood smears from wild type 
(WT), constitutive Eps15L1-KO (L1KO), conditional Eps15-KO (Eps15flp/flp/Eps15L1+/+/tgTie2-Cre, 
c15KO) and conditional Eps15/Eps15L1-DKO (Eps15flp/flp/Eps15L1-/-/tgTie2-Cre, cDKO) newborn 
mice. Images were acquired with a stereomicroscope. B. The bar graph represents the percentage of 
reticulocytes (immature RBCs) and mature RBCs, detected by May-Grünwald Giemsa staining of 
blood smears from wild type (WT, n=7), constitutive Eps15L1-KO (L1KO, n=6), conditional 
Eps15-KO (c15KO, n=6) and conditional Eps15/Eps15L1-DKO (cDKO, n=5) newborn mice. Error 
bars represent the standard error mean. Statistical significance was assessed using 2-tailed student’s 
t-test (***=p<0.005). 
 
All these observations suggest that cDKO mice suffer from microcytic hypochromic 
anemia. Altered development of RBCs might be caused by defective TfR internalization.  
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4. Defective internalization of TfR in Eps15/Eps15L1-DKO 
MEFs is paralleled by defective formation of clathrin endocytic 
structures  
 
4.1. Eps15 and Eps15L1 differentially interact with proteins participating 
in CDE 
Since we observed that TfR internalization was impaired in Eps15/Eps15L1-DKO MEFs, 
we wanted to elucidate the molecular mechanism by which Eps15 and Eps15L1 regulate 
this process. Since TfR is internalized via CDE, we initially investigated, by Co-IP 
experiments, in single and double KO MEFs the interaction of Eps15 and Eps15L1 with 
proteins of the clathrin endocytic machinery, AP-2 and Itsn1, previously characterized as 
major binding partners of Eps15 (Benmerah, Gagnon et al. 1995, Sengar, Wang et al. 
1999). In whole cell lysates, we found that, in WT MEFs, Eps15 and Eps15L1 
differentially bind to these two CDE components: AP-2 preferentially interacted with 
Eps15 (Figure 32A, B, C-a, b, c), while Itsn1 mainly associated with Eps15L1 (Figure 32A, 
B, C-d, e, f). Of note, the interaction between Itsn1 and Eps15 increased in Eps15L1-KO 
cells (Figure 32B, D-e, f). This result may suggest that at steady state Eps15L1 competes 
with Eps15 for the binding to Itsn1 and, when Eps15L1 is absent, Itsn1 becomes available 
for the binding with Eps15. In Eps15L1-KO cells we also observed an increased 
interaction between AP-2 and Itsn1 (Figure 32B), which could simply be the consequence 
of the increased association between Itsn1 and Eps15 that in turn brings down more AP-2 
to the complex. These data suggest that there is specificity embedded in Eps15 versus 
Eps15L1 interactions with the endocytic machinery and shows rearrangements of the 
interactions upon KO of Eps15L1. 
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Figure 32. Eps15 and Eps15L1 bind to different components of the clathrin endocytic machinery.  
A. Representative WB showing the Co-IP of intersectin1 (Itsn1), Eps15 and Eps15L1 proteins with 
anti-alpha Adaptin antibody. B. Representative WB showing the Co-IP of AP-2, Eps15 and 
Eps15L1 proteins with anti-Itsn1 antibody. In panels A and B, proteins were co-
immunoprecipitated from fresh lysates of primary wild type (WT), Eps15L1-KO (L1), Eps15-KO 
(15) and Eps15/Eps15L1-DKO MEFs (n=4). Immunoprecipitated lysates (IP), total lysates (INPUT) 
and post-immunoprecipitated lysates (POST) were separated on SDS-PAGE, transferred on a 
nitrocellulose filter and probed with antibodies for AP-2, Itsn1, Eps15 and Eps15L1, as indicated. 
In panel A, in the control of IP efficiency (filter probed with AP-2), INPUT and POST were 25% 
of the IP (20 μg of IP were loaded), while in the control of Co-IP efficiency of Itsn1, Eps15 and 
Eps15L1 (filters probed with Itsn1, Eps15 and Eps15L1), INPUT and POST were 1% of the IP 
(200 μg of IP were loaded). In panel B, in the control of IP efficiency (filter probed with Itsn1), 
INPUT and POST were 20% of the IP (20 μg of IP were loaded), while in the control of Co-IP 
efficiency of AP-2, Eps15 and Eps15L1 (filters probed with AP-2, Eps15 and Eps15L1), INPUT 
and POST were 5% of the IP (200 μg of IP were loaded). MWs are indicated on the left (kDa). C. 
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The bar graph depicts, in WT MEFs, the percentage of Co-IP of Eps15, Eps15L1 and Itsn1 proteins 
with anti-alpha Adaptin antibody (a, b, c) and the percentage of Co-IP of Eps15, Eps15L1 and AP-
2 proteins with anti-Itsn1 antibody (d, e, f). Data are presented as an average of four independent 
experiments; error bars represent the standard error mean. D. The bar graph compares: in wild type 
(WT) and Eps15L1-KO (L1KO) MEFs, the percentage of Co-IP of Eps15 with anti-alpha Adaptin 
antibody (a, b) or anti-Itsn1 antibody (e, f); in wild type (WT) and Eps15-KO (15KO) MEFs, the 
percentage of Co-IP of Eps15L1 with anti-alpha Adaptin antibody (c, d) or anti-Itsn1 antibody (g, 
h). Data are presented as an average of four independent experiments; error bars represent the 
standard error mean. Statistical significance was assessed using 2-tailed student’s t-test (*=p<0.05). 
 
4.2. Impairment of Eps15 and Eps15L1 alters the number of AP-2-
positive structures  
To further study the relation between these proteins, we performed preliminary co-
localization studies of Eps15, Eps15L1 and Itsn1 in clathrin-structures, using AP-2 as a 
marker. In WT MEFs, we observed that Eps15, Eps15L1 and Itsn1 proteins co-localized 
with AP-2-positive dots. Co-localization was observed predominantly with bigger AP-2-
positive structures but not with the smaller structures (Figure 33A). When Eps15 or 
Eps15L1 were individually knocked-out, we observed a reduction in the number of smaller 
AP-2-positive structures, while the bigger ones were unchanged (Figure 33A, B). 
Concomitantly, an increased percentage of co-localization of AP-2 with Eps15 and Itsn1 
(in Eps15L1-KO cells), or with Eps15L1 and Itsn1 (in Eps15-KO cells) was observed 
(Figure 33A, C). This apparent increase may be the result of the reduction in single KO 
cells of smaller AP-2-positive dots. This phenotype was completely reverted in DKO cells, 
which showed an increment of smaller structures, even compared to WT cells (Figure 33A, 
B). Moreover, in DKO cells the percentage of co-localization between AP-2 and Itsn1 was 
decreased (Figure 33A, D). This decrease may be the result of the increased number of 
smaller AP-2-positive dots in single KO cells. Since we observed only a minor defect in 
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the internalization of TfR in single KO MEFs, we may speculate that endocytic structures 
lacking Eps15 or Eps15L1 are still efficiently assembled, probably by rearrangement of 
interactions among CDE proteins, as observed in Eps15L1-KO through Co-IP analysis. On 
the contrary, in DKO cells, defective internalization of TfR might be linked to a defect in 
the maturation of endocytic structures, due to the lack of both Eps15 and Eps15L1 and 
reduced co-localization of Itsn1 with AP-2-positive structures. This hypothesis will require 
high resolution and live imaging studies to be addressed. 
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Figure 33. The number of AP-2-positive structures is altered following impairment of Eps15 and 
Eps15L1.  
A. The IF images depict the co-localization of AP-2 (green) with Eps15, Eps15L1 and Itsn1 (red) 
in primary wild type (WT), Eps15L1-KO, Eps15-KO and Eps15/Eps15L1-DKO (DKO) MEFs. 
Images were acquired with a SP5 inverted confocal microscope. B. The bar graph depicts the 
number of AP-2-positive structures of 0-500 nm diameter (green) and 500-1000 nm diameter (gray) 
in primary wild type (WT), Eps15L1-KO (L1KO), Eps15-KO (15KO) and Eps15/Eps15L1-DKO 
(DKO) MEFs. Error bars represent the standard error mean. Statistical significance was assessed 
using 2-tailed student’s t-test (***=p<0.005). C. The bar graph depicts the Pearson Coefficient of 
co-localization of a) AP-2 with Eps15L1 (AP-2/L1) in primary wild type (WT) and Eps15-KO 
(15KO) MEFs and of b) AP-2 with Eps15 (AP-2/15) in primary wild type (WT) and Eps15L1-KO 
(L1KO) MEFs. Error bars represent the standard error mean. Statistical significance was assessed 
using 2-tailed student’s t-test (***=p<0.005). D. The bar graph depicts the Pearson Coefficient of 
co-localization of AP-2 with Itsn1 (AP-2/Itsn1) in primary wild type (WT), Eps15L1-KO (L1KO), 
Eps15-KO (15KO) and Eps15/Eps15L1-DKO (DKO) MEFs. Error bars represent the standard 
error mean. Statistical significance was assessed using 2-tailed student’s t-test (**=p<0.01; 
***=p<0.005).  
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Chapter 4 
DISCUSSION 
 
The Eps15 protein family is composed of two members, Eps15 and Eps15L1, which share 
high co-linearity and homology. Since their discovery in 1993 as substrates of the tyrosine 
kinase activity of the EGFR, several studies delineating the cellular function(s) of these 
proteins have arisen. From these studies, it emerged that Eps15 and Eps15L1 are two 
scaffolding proteins, which serve pleiotropic functions in endocytosis: they regulate the 
early events of CDE and CIE of several cargoes, their sorting in the EEs and protein 
trafficking from the TGN. However, to our knowledge, most of the in vitro studies have 
been focused on Eps15, while fewer have addressed the functions of Eps15L1. The reason 
resides in the fact that Eps15 and Eps15L1 have always been thought to have a redundant 
role in several cellular processes due to their homology, their common binding partners 
and their similar cellular localization. Moreover, both Eps15 and Eps15L1 have been 
found to regulate the CDE of EGFR and TfR. Nevertheless, these findings were derived 
from in vitro studies dissecting the effects on EGFR and TfR internalization upon injection 
of antibodies blocking Eps15 or Eps15L1 (Carbone, Fre et al. 1997) or upon siRNA 
interference of the proteins (Huang, Khvorova et al. 2004). Therefore, their role in EGFR 
and TfR internalization has never been demonstrated in a clean and more physiological 
setting. Furthermore, no studies have been performed to investigate their role in vivo.  
Our laboratory addresses whether Eps15 and Eps15L1 exert redundant and/or non-
redundant roles in mammals, using genetically engineered mice as a model system. In 
these organisms, the genetical removal of the components of the endocytic machinery 
rarely impinge on viability, likely because functionally redundant proteins or pathways are 
capable to compensate for their loss. This is the case for Eps15, whose removal in the 
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organism has no evident effects, apart from a defect in the development of marginal zone 
B cells (Pozzi, Amodio et al. 2012) and mild microcytosis (Pozzi et al., unpublished 
results). In contrast to Eps15-KO mice, which are viable and fertile, Eps15L1-KO mice die 
at birth (Alberici et al., unpublished results). Moreover, deeper investigations showed that 
that Eps15L1 plays a non-redundant role in the regulation of SVR (Alberici et al., 
unpublished results), which is reminiscent of the role played by its orthologous in lower 
organisms (Salcini, Hilliard et al. 2001, Koh, Korolchuk et al. 2007, Rose, Malabarba et al. 
2007, Wang, Bouhours et al. 2008). Eps15/Eps15L1-DKO mice have a more severe 
phenotype and die at midgestation. The phenotype of Eps15/Eps15L1-DKO mice, together 
with the one of the single KO mice, suggests that Eps15 and Eps15L1 have both redundant 
and non-redundant functions. Thus, the severe phenotype of Eps15/Eps15L1-DKO might 
result from the impairment of a redundant function essential for embryo development or 
from the combined impairment of redundant and non-redundant functions, which, even if 
not essential, might addictively contribute to embryo lethality.  
The aim of this project was to investigate redundant and non-redundant functions of Eps15 
and Eps15L1 in order to unmask the underlying causes of embryo lethality in 
Eps15/Eps15L1-DKO mice.  
 
1. The non-redundant role of Eps15 and Eps15L1 in the 
regulation of the Notch signalling pathway 
Our initial hypothesis was that Eps15 and Eps15L1 are redundantly required in the 
regulation of Notch signalling. Indeed, morphological alterations of Eps15/Eps15L1-DKO 
mice phenocopied Notch loss-of-function mutants and the Notch target genes HES1, HES5 
and NRARP were found to be downregulated in Eps15/Eps15L1-DKO mice, similar to 
epsin1/2-DKO mice. Other considerations sustained this hypothesis: i) Eps15 and Eps15L1 
physically interact with Numb and epsin (Chen, Fre et al. 1998, Saffarian, Cocucci et al. 
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2009), key regulators of Notch receptor and ligand activity, respectively; ii) Eps15 and 
Eps15L1 act in complex with epsin1 to modulate EGFR endocytosis (Chen, Fre et al. 1998, 
Sigismund, Woelk et al. 2005); iii) Eps15 and Eps15L1 possess two UIM domains, one of 
two essential domains needed for epsin-dependent activation of Notch ligands (Xie, Cho et 
al. 2012). Previous in vitro work in the laboratory confirmed that Eps15 and Eps15L1 are 
effectively involved in the regulation of Notch signalling in signal-sending cells. Indeed, 
by a luciferase-based co-culture assay, in which OP9 cells overexpressing the Notch ligand 
Dll1 (OP9-Dll1 cells) (Schmitt and Zuniga-Pflucker 2002) were used as signal-sending 
cells, and C2C12 cells overexpressing human Notch-1 receptor (C2C12-Notch1 cells) were 
used as signal-receiving cells, it was found that transient KD of Eps15 or Eps15L1 in OP9-
Dll1 cells lead to a ∼50% reduction of Notch activation. Of note, no further reduction of 
Notch signalling was observed when both Eps15 and Eps15L1 were knocked-down in 
OP9-Dll1 cells (Lucano et al., unpublished results).  
To confirm this finding in a physiological setting, we investigated whether Eps15 and 
Eps15L1 played a role in the regulation of Notch signalling, using MEFs derived from KO 
mice for Eps15 and Eps15L1 as a model for the signal-sending cell (MEF-Dll1 cells). 
While in OP9-Dll1 cells transient KD of Eps15 or Eps15L1 reduced Notch activation, in 
MEF-Dll1 cells only deletion of Eps15L1 impaired Notch signalling. No further reduction 
of Notch signalling was observed when both Eps15 and Eps15L1 were deleted. Therefore, 
in MEF-Dll1 cells, Eps15L1 is required in a non-redundant manner for proper activation of 
Notch signalling. Of note, a partial downregulation of the Notch target genes had been 
observed also in Eps15L1-KO embryos.  
To reinforce our results in MEF-Dll1 cells, we will investigate the role of Eps15 and 
Eps15L1 in Notch signalling in an isogenic cellular system, in which parental WT cell 
lines, transgenic for CreERT2 and floxed for Eps15 and/or Eps15L1, will be directly 
compared with the single or double KO cell line generated by (Z)-4-hydroxytamoxifen 
treatment.  
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There are several possibilities that might explain the reason for which Eps15 seems to 
regulate ligand biology in OP9-Dll1 cells but not in MEF-Dll1 cells. One of these 
possibilities is that the role of Eps15 in this pathway is cell-context dependent. If so, Eps15 
and Eps15L1 may be differently expressed in OP9-Dll1 and in MEF-Dll1 cells. Expression 
levels of Eps15 and Eps15L1 in these model systems will be evaluated. Another 
observation is that deletion of Eps15 in OP9-Dll1 and MEF-Dll1 cells was obtained in two 
different ways, by siRNA interference in the first cell line and gene KO in the second one. 
Therefore, one risk is that reduced Notch activity upon KD of Eps15 in OP9-Dll1 cells is 
an off-target effect, even if this reduction was observed with three different siRNA oligos 
targeting Eps15. Another possibility, instead, is that the acute downregulation of Eps15, 
obtained by siRNA interference, may impact on Notch activity, while when chronically 
deleted, as occurs in MEF-Dll1 cells, other pathways compensate for the lack of Eps15.  
As mentioned before, luciferase-based co-culture assays showed that Eps15 and Eps15L1 
regulate Notch signalling in the signal-sending cell but not in the signal-receiving cell. 
Indeed, when Eps15 and Eps15L1 where knocked-down, alone or in combination, in 
C2C12-Notch1 cells, no reduction of Notch activity was observed. Moreover, no further 
reduction of Notch activity was observed when Eps15 and Eps15L1 were knocked-down 
both in the signal-sending and in the signal-receiving cell. To confirm this finding, we will 
test the role of Eps15 and Eps15L1 in signal-receiving cells using MEFs as a model system. 
Up to now, our in vitro studies of OP9-Dll1 and MEF-Dll1 cells indicate that Eps15 and 
Eps15L1 are required for the regulation of Notch signalling in a non-redundant manner. 
Since Eps15/Eps15L1-DKO mice, but not single KO mice, were found to be severely 
affected, similar to Notch-loss-of-function mutants, their non-redundancy was unexpected. 
Based on this, we can conclude that the severe phenotype of Eps15/Eps15L1-DKO mice 
cannot be exclusively assessed as a defect in the Notch pathway. Alternatively, we can 
speculate that, by acting in different cellular contexts, Eps15 and Eps15L1 additively 
contribute to this phenotype.
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2. The redundant role of Eps15 and Eps15L1 in the regulation 
of VEGFR-2 turnover 
PECAM-1 staining of 9.5 dpc Eps15/Eps15L1-DKO mice revealed reduced 
vascularization in different anatomical districts (head, somites, yolk sac), due to a defect in 
angiogenesis. We hypothesized that impaired vascular development might be the major 
cause of midgestation lethality of these mice (Rossant and Howard 2002). To directly test 
this hypothesis, we generated cDKO mice (in detail, we generated Eps15flp/flp/Eps15L1-/-
/tgTie2Cre mice, in which Eps15L1 is ubiquitously deleted, while Eps15 is specifically 
deleted in endothelial and hematopoietic cells), to see whether they recapitulated the severe 
phenotype of constitutive Eps15/Eps15L1-DKO mice. Angiogenesis was impaired also in 
these mice. Nevertheless, the morphology of cDKO mice was not as seriously 
compromised as constitutive DKO mice and arrived at birth. This observation indicated 
that impaired angiogenesis was not the primary lethality cause of Eps15/Eps15L1-DKO 
mice.  
Our in vitro studies on endothelial cells indicate that Eps15 and Eps15L1 have a redundant 
role in VEGFR-2 turnover, one of the major signalling pathways regulating vascular 
development: indeed, total receptor levels were reduced in Eps15/Eps15L1-DKO 
endothelial cells. Decreased receptor levels did not impact on the downstream signalling 
response, at least under the in vitro conditions tested. However, we cannot exclude that in 
the organism there are spatial and temporal defects in VEGFR-2 turnover that may 
addictively contribute to the in vivo phenotype of Eps15/Eps15L1-DKO mice.  
 
3. The redundant role of Eps15 and Eps15L1 in TfR 
internalization 
Previous in vitro studies showed that Eps15 and Eps15L1 regulate the internalization of 
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EGFR and TfR (Carbone, Fre et al. 1997, Benmerah, Lamaze et al. 1998, Huang, 
Khvorova et al. 2004). Mutant mice for EGFR are growth-retarded and die at different 
stages of development depending on their genetic background. Loss of EGFR in the CF-1 
background leads to peri-implantation lethality; in the 129/Sv genetic background, EGFR-
null embryos die around day 11.5 of gestation, whereas in other backgrounds mutant mice 
survive until birth (C57BL/6) or to postnatal day 20 (MF1 or C3H). Of note, all surviving 
mutant mice show abnormalities in various epithelia, including placenta, skin, lung and 
gastrointestinal tract (Miettinen, Berger et al. 1995, Sibilia and Wagner 1995, Threadgill, 
Dlugosz et al. 1995), and develop a progressive neurodegeneration, thus indicating an 
essential function for EGFR in epithelial and neuronal development. TfR-null mice die 
before embryonic day 12.5 (Levy, Jin et al. 1999) and have growth retardation, severe 
pallor and pericardial effusions and present both erythropoiesis and neural defects. Also 
Eps15/Eps15L1-DKO mice dye at midgestation and present morphological alterations that 
might be linked to impaired EGFR and/or TfR signalling, such as growth retardation, 
neural defects, pallor (indicative of defective vascular development) and pericardial 
effusions.  
We used MEFs, derived from KO mice for Eps15 and Eps15L1, to confirm whether the 
internalization of EGFR and/or TfR was impaired upon KO of Eps15 and Eps15L1. We 
found that the Ke of EGFR was slightly but significantly reduced (∼20%) in Eps15-KO, 
Eps15L1-KO and DKO cells to a similar extent. Instead, the Ke of the TfR was strongly 
reduced in DKO (∼50%), with only a minor effect in single KO MEFs. Moreover, while 
surface levels of EGFR were not altered in single and double KO cells, surface levels of 
TfR were increased in DKO cells.  
These results suggest that Eps15 and Eps15L1 have a major impact on the internalization 
of TfR and regulate it in a redundant manner. The function of Eps15 and Eps15L1 in this 
pathway may partially contribute to the in vivo phenotype of DKO mice.  
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4. The redundant role of Eps15 and Eps15L1 in the formation 
of clathrin-structures 
In vitro studies in HeLa cells demonstrated that Eps15 and Itsn proteins redundantly 
regulate the internalization of TfR: siRNA interference of Eps15, Eps15L1, Itsn1 and Itsn2 
reduced TfR internalization to 50% (Teckchandani, Mulkearns et al. 2012). In order to 
understand the molecular mechanism by which Eps15 and Eps15L1 regulate TfR 
internalization in MEFs, we performed co-localization studies of Eps15, Eps15L1 and 
Itsn1 in clathrin-structures, using AP-2 as a marker of CDE. We found that in single 
Eps15- and Eps15L1-KO cells, the number of AP-2-positive structures was decreased. 
However, Eps15 (in Eps15L1-KO) or Eps15L1 (in Eps15-KO) and Itsn1 still co-localized 
with AP-2 in AP-2-positive structures. Since TfR internalization was only mildly impaired 
in single KO cells, we may speculate that endocytic structures lacking Eps15 or Eps15L1 
are still efficiently assembled, probably due to compensatory rearrangement of protein 
interactions. Instead, in DKO cells, we observed an increase in the number of AP-2-
positive structures, and a reduced co-localization of AP-2 with Itsn1. This result suggests 
that in DKO cells the endocytic structures are not efficiently assembled. High resolution 
and live imaging studies are required to better clarify perturbations in the formation of 
clathrin-structures in Eps15/Eps15L1-DKO cells.  
The protein levels of Itsn1 were found to be downregulated both in Eps15L1-KO and DKO 
cells, thus suggesting a possible role of Eps15L1 in the stabilization of Itsn1. Of note, 
downregulation of Itsn1 protein levels has been observed also in lower organisms null for 
Eps15 (Koh, Korolchuk et al. 2007, Rose, Malabarba et al. 2007, Wang, Bouhours et al. 
2008) and in brain extracts from Eps15L1-KO mice (Alberici et al., unpublished results).  
As reported before, the lack of one of the components of the endocytic machinery may 
cause compensatory rearrangement of protein interactions. By Co-IP analysis, we 
encountered such a mechanism in Eps15L1-KO cells. In these cells, we found that Itsn1 
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associated with a higher fraction of the available cellular Eps15 protein. Probably through 
Eps15 itself, Itsn1 associated also with more molecules of AP-2. Whether such a 
mechanism exists also in Eps15-KO is still under investigation. We will evaluate whether 
interaction of other accessory adaptor proteins, such as FCHo1/2 proteins, with the clathrin 
machinery are rearranged in MEFs lacking Eps15 and/or Eps15L1. Our hypothesis is that 
interaction of Eps15L1 with FCHo1/2 might increase upon KO of Eps15, thus overcoming 
the lack of Eps15. The reason to why we postulate an interaction between Eps15L1 and 
FCHo1/2 is based on previous mass spectrometry analysis in our laboratory, which 
identified an interaction between Eps15L1 and SGIP1 in the mouse brain, where SGIP1 is 
a protein that shares a µ-homology domain with FCHo1/2.  
  
5. The redundant role of Eps15 and Eps15L1 in the 
development of RBCs 
We tested whether the role of Eps15 and Eps15L1 in TfR endocytosis had a physiological 
relevance in vivo. In the organism, erythroid cells are the most avid consumers of iron and, 
because of this, they express high levels of TfR on the membrane. As a consequence, 
perturbations in proteins involved in iron uptake by TfR primarily affect the development 
of erythroid cells. In detail, studies in murine models indicate that the complete deletion of 
TfR is not compatible with life due to erythroid and neural defects (Levy, Jin et al. 1999). 
Instead, a less severe phenotype is observed in mice in which TfR levels are reduced or 
proteins involved in the intracellular trafficking of TfR are altered. These mice, indeed, 
suffer from microcytic hypochromic anemia, a condition characterized by defective 
maturation of RBCs. Based on these data, we decided to investigate whether erythroid 
development was affected in cDKO mice (Eps15flp/flp/Eps15L1-/-/tgTie2Cre) as an in vivo 
readout of impaired TfR internalization. In agreement with the in vitro finding that Eps15 
and Eps15L1 are redundantly required for TfR internalization, we found that cDKO mice 
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suffered from microcytic hypochromic anemia: they had reduced MCV and high RDW, 
pale RBCs (indicative of reduced haemoglobin content within them) and high reticulocyte 
count. Of note, even if to a less extent, also cEps15-KO mice 
(Eps15flp/flp/Eps15L1+/+/tgTie2Cre) had reduced MCV, as previously observed in constitutive 
Eps15-KO mice (Pozzi et al., unpublished results). Since the erythroid defects were more 
severe in cDKO mice, these results indicate that Eps15 and Eps15L1 are redundantly 
required in erythroid development. Similarly to cDKO mice, data from literature show that 
also hematopoietic-specific KO mice for the clathrin adaptor protein PICALM suffer from 
microcytic hypochromic anemia and have a high RDW and an increased number of 
reticulocytes in the blood (Ishikawa, Maeda et al. 2015). PICALM is essential for the 
maturation of erythroid cells: indeed, PICALM-KO hematopoietic progenitors barely 
develop into an erythroid lineage when cultured for three days. This maturation defect can 
be linked to a role for PICALM in the regulation of TfR internalization: indeed, PICALM-
KO splenic erythroblasts are characterized by impaired TfR internalization and, as a 
consequence, increased amounts of surface-bound Tf. Since the number of CCPs is 
reduced in PICALM-KO splenic erythroblasts, impaired TfR internalization is due to a role 
for PICALM in the maturation of CCPs (Ishikawa, Maeda et al. 2015).  
Similar to PICALM, Eps15 and Eps15L1 might take part in the endocytic machinery, 
regulating TfR internalization in erythroid cells. Of note, PICALM contains NPF motifs 
for the binding to Eps15 proteins. It would be interesting to unravel the interplay among all 
these proteins in TfR internalization. Moreover, to investigate whether surface levels of 
TfR correlate with the altered development of Eps15/Eps15L1-DKO erythroid cells, we 
will perform a FACS analysis for CD71/TfR in these cells. 
Even if Eps15 and Eps15L1 redundantly regulate erythroid development, impaired 
maturation of RBCs is not the major lethality cause of Eps15/Eps15L1-DKO mice as their 
phenotype is not recapitulated by cDKO mice (Eps15flp/flp/Eps15L1-/-/tgTie2Cre). This 
observation suggests that defective erythtroid development is, among others, one of the 
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factors that addictively contribute to the in vivo phenotype of DKO mice.  
 
6. Conclusion 
From previous and here presented findings we have learned that: i) Eps15L1 plays a non-
redundant function in the nervous system (Alberici et al., unpublished results); ii) Eps15 
and Eps15L1 contribute to the regulation of the Notch signalling pathway in signal-
sending cells in a non-redundant manner; iii) Eps15 and Eps15L1 redundantly regulate 
VEGFR-2 turnover; iv) Eps15 and Eps15L1 play a redundant role in TfR internalization, 
possibly through the regulation of the assembly of AP-2-positive structures; v) Eps15 and 
Eps15L1 are redundantly required in vivo for the maturation of erythroid cells, possibly 
through control of TfR internalization.  
All together, these findings suggest that lack of Eps15 and Eps15L1 impacts on several 
cellular processes that, together with other unexplored processes, might addictively 
contribute to the phenotypes observed in Eps15/Eps15L1-DKO mice. Based on our results, 
we can explain the lethality of Eps15/Eps15L1-DKO mice as a combination of perturbed 
physiological processes.  
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